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ABSTRACT 
 
 
 
“Everything should be made as simple as possible, but not simpler.” 
Albert Einstein 
 xviii 
Scientific abstract 
 
During the last two decades, advanced treatment techniques have been developed in 
radiotherapy to achieve more conformal beam targeting of cancerous lesions. The advent of 
these techniques, such as intensity modulated radiotherapy (IMRT), volumetric modulated arc 
radiothreapy (VMAT), Tomotherapy etc., allows more precise localisation of higher doses to 
complex-shaped target volumes, thereby sparing more healthy tissue. In this context, motion 
management is a critical issue in contemporary radiotherapy (RT). That anatomic structures 
move during respiration is well known and much research is presently being devoted to 
strategies to contend with organ motion. However, moving structures are typically regarded 
as rigid bodies. The fact that many structures deform as a result of motion makes their 
resultant dose distributions difficult to measure and calculate, and has not been fully 
accounted for. The potential for ineffective treatments that do not take into account motion 
and anatomic deformation is self-evident.  
 
This thesis addresses the pressing need to investigate dose distributions in targets that deform 
during and/or between treatments, to ensure robust calculations for dose accumulation and 
delivery, thus providing the most positive outcomes for patients. This involves the direct 
measurement of complex and re-distributed dose in deforming objects (an experimental 
model), as well as calculations of the deformed dose distribution (a mathematical model). The 
comparison thereof aims to validate the dose deformation technique, thereby to apply the 
method to a clinical example such as liver stereotactic body radiotherapy. 
 
To facilitate four-dimensional deformable dosimetry for both external beam radiotherapy and 
brachytherapy, methodologies for three-dimensional deformed dose measurements were 
developed and employed using radiosensitive polymer gel combined with a cone beam optical 
computed tomography (CT) scanner. This includes the development of a novel prototype 
deformable target volume using a tissue-equivalent, deformable gel dosimetric phantom, 
dubbed “DEFGEL”. This can reproducibly simulate targets subject to a range of mass- and 
density-conserving deformations representative of those observable in anatomical targets. 
This novel tool was characterised in terms of its suitability for the measurement of dose in 
deforming geometries. It was demonstrated that planned doses could be delivered to the 
deformable gel dosimeter in the presence of different deformations and complex spatial re-
distributions of dose in all three dimensions could be quantified. 
 
For estimating the cumulative dose in different deformed states, deformable image 
registration (DIR) algorithms were implemented to ‘morph’ a dose distribution calculated by 
 xix 
a treatment planning system. To investigate the performance of DIR and dose-warping 
technique, two key studies were undertaken. The first was to systematically assess the 
accuracy of a range of different DIR algorithms available in the public domain and 
quantitatively examine, in particular, low-contrast regions, where accuracy had not previously 
been established. This work investigates DIR algorithms in 3D via a systematic evaluation 
process using DEFGEL suitable for verification of mass- and density-conserving deformations. 
The second study was a full three-dimensional experimental validation of the dose-warping 
technique using the evaluated DIR algorithm and comparing it to directly measured deformed 
dose distributions from DEFGEL. It was shown that the dose-warping can be accurate, i.e. over 
95% passing rate of 3D-gamma analysis with 3%/3mm criteria for given extents of 
deformation up to 20 mm 
 
For the application of evaluating patient treatment planning involving tumour 
motion/deformation, two key studies were undertaken in the context of liver stereotactic body 
radiotherapy. The first was a 4D evaluation of conventional 3D treatment planning, combined 
with 4D computed tomography, in order to investigate the extent of dosimetric differences 
between conventional 3D-static and path-integrated 4D-cumulative dose calculation. This 
study showed that the 3D planning approach overestimated doses to targets by ≤ 9% and 
underestimated dose to normal liver by ≤ 8%, compared to the 4D methodology. The second 
study was to assess a consequent reduction of healthy tissue sparing, which may increase risk 
for surrounding healthy tissues. Estimates for normal tissue complications probabilities 
(NTCP) based on the two dose calculation schemes are provided. While all NTCP were low 
for the employed fractionation scheme, analysis of common alternative schemes suggests 
potentially larger uncertainties exist in the estimation of NTCP for healthy liver and that 
substantial differences in these values may exist across the different fractionation schemes.  
 
These bodies of work have shown the potential to quantify such issues of under- and/or over-
dosages which are quite patient dependent in RT. Studies presented in this work consolidate 
gel dosimetry, image guidance, DIR, dose-warping and consequent dose accumulation 
calculation to investigate the dosimetric impact and make more accurate evaluation of 
conventional 3D treatment plans. While liver stereotactic body radiotherapy (SBRT) was 
primarily concerned for immediate clinical application, the findings of this thesis are also 
applicable to other organs with various RT techniques. Most importantly, however, it is hoped 
that the outcomes of this thesis will help to improve treatment plan accuracy. By considering 
both computation and measurement, it is also hoped that this work will open new windows 
for future work and hence provide building blocks to further enhance the benefit of 
radiotherapy treatment.  
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CHAPTER ONE  
: Introduction 
 
 
 
“The man who removes a mountain begins by carrying away small stones.”
*
 
William Faulkner 
 
 
 
                                                     
* Carrying away small stones?  
: Describing the questions which should first be discussed, with a view to the physical science 
the author is investigating. 
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1.1 Motivation  
This thesis addresses one of major challenges in contemporary radiotherapy – anatomic 
variation due to organ motion and deformation, particularly when implementing highly 
conformal fields with high-dose delivery. Organ deformation inherent in intra- and inter-
fractional motion makes their resultant dose distributions difficult to measure and calculate. 
This has an effect not only on tumour control (i.e. has the tumour been given enough dose?) 
but also on the potential risk for adjacent healthy tissues (i.e. have local organs-at-risk been 
given too much radiation dose?). Whether by under-dosage to targeted tumours or over-
irradiation of surrounding healthy tissues, poor clinical outcomes may result. Such dosimetric 
discrepancies are investigated in this work with the development of a novel deformable 
dosimeters, and recommendations are provided on improved means of dosimetry, image-
registration, dose reconstruction and treatment planning for more accurate dose delivery. 
 
 
1.2 Context 
Radiation treatment has evolved over the past 20 years from two dimensional (2D) therapy to 
three-dimensional (3D) conformal treatment aimed at delivering lethal dose of radiation to a 
complex-shaped target whilst minimising damage to surrounding healthy tissues (normal 
tissue sparing). To facilitate this, it is necessary to spatially restrict the high dose to a volume 
of tissue that incorporates only the tumour, and a small margin to ensure elimination of 
microscopic tumour extensions and account for any error in setup (ICRU, 1999). During the 
last two decades, a number of advanced treatment techniques have been developed to achieve 
more conformal radiation beam delivery. These new and emergent techniques allow more 
precise localisation of higher doses to the target volume while sparing more healthy tissues. 
However, the fact that anatomic structures move during respiration has been a well-known 
key challenge facing physicists and clinicians in contemporary radiotherapy and much 
research is presently being devoted to strategies to contend with organ motion. In this context, 
many strategies for motion management have been addressed and investigated over the past 
few decades.  
 
The existence of organ deformation associated with anatomic motion adds a further layer of 
complexity to the problem of inter- and intra-fractional variation in anatomic structures; the 
resultant dosimetric consequences have not been explicitly investigated in current routine 
clinical practice. The variations could result from filling and emptying of bladder, rectum, 
stomach, etc., as well as respiratory and cardiac motion. The organ deformation inherent to 
inter- and intra-fractional anatomic motion complicates the measurement and calculation of 
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dose distribution. Any inaccuracy in dose prediction or delivery may have detrimental 
consequences for patients as a result of under-dosage of the tumour if improper margins are 
employed or over-irradiation of healthy tissues in the immediate periphery of a targeted 
lesion, which is not accurately known. Such doses can result in reduced tumour control and an 
increased relative risk of radio-carcinogenesis and other health complications as a 
consequence of the treatment.  
 
There is a pressing need to investigate dosimetry in deforming targets during and/or between 
treatments so as to ensure accurate calculations for dose accumulation and delivery. This has 
consequently driven the research and development of four-dimensional (4D) treatment 
planning in order to deliver the most positive outcome for patients. The techniques and results 
discussed in this thesis are applicable to a range of fields within radiotherapy such as complex 
3D dosimetry, deformable medical image registration, dose-warping, and adaptive 4D 
treatment planning. These have extensions to patient specific dose delivery. 
 
 
1.3 The objective and scope of this thesis 
The objective of this thesis is to model and verify doses delivered to deformable moving 
targets. This incorporates two key components: a tumour surrogate that enables 3D 
integrating measurement of complex and re-distributed dose in deforming objects (an 
experimental model); and calculation techniques that enable deformed dose distributions to be 
estimated (a mathematical model). The development of the novel deforming dosimeter is 
important for validation of the model. Such work is utilisable for the evaluation of 
conventional treatment planning, which does not take organ deformation into account in the 
treatment optimisation process. This is to improve the prediction and delivery of conformal-
field dose distributions and thereby reduce the probability of potential detriment to the 
patient. 
 
In this work, the most promising methods of experimental dosimetry and mathematical image 
processing are implemented for the verification of dose deformation: gel dosimetry and 
deformable image registration. The studies described in this thesis not only involve the 
application of these methods, but build on them fundamentally. In addition to the 
complexities of the dose distributions in deformable moving objects, is the issue of the lack of 
tools to predict dose deformations and of limitations of computation power and time 
consumption. In this context, the immediate clinical relevance of this work is application of 
the evaluated calculation method to patient treatment planning. To illustrate this capability, 
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this work investigates dosimetric discrepancies between planned and delivered doses in linac-
based stereotactic body radiotherapy for liver cancer. Furthermore, this work provides 
estimates of tumor control and normal tissue complications. Such complexities are not 
considered in current treatment optimisation processes, and limitations of current commercial 
planning systems do not allow accurate dose calculations on deformable moving anatomy. 
 
In summary, the structure of this thesis, titled ‘Modelling and verification of doses delivered 
to deformable moving targets’, and topics of each chapter are concisely described here: 
- Background of challenges/difficulties dealing with deformable moving targets (Chapter 2): 
Interfraction and intrafraction variation in anatomic structures is a significant challenge in 
contemporary radiotherapy. Understanding the cumulative dose distribution in deforming 
anatomy can be difficult due to complex dose redistribution and lack of measurement tools 
in order to verify computation of dose redistribution and its accumulation; 
- Developing a deformable dosimeter (Chapter 3):  
- The study in Chapter 3 develops and introduces a novel, tissue-equivalent 3D deformable 
gel dosimetric phantom, DEFGEL, which can be subject to deformation and relaxation 
followed by CT imaging and planning for irradiation of a certain field. This enables direct 
measurement of redistributed dose distribution and its accumulation in different state of 
deformation, i.e. 4D deformable dosimetry; 
- Assessing deformable image registration (Chapter 4): 
- One proposed strategy for calculating deformed dose distributions uses DIR. This 
approach is constrained by the accuracy of the results of the DIR calculation. In this 
chapter, the performance of 11 algorithms, which are available in the public domain, is 
assessed for deformations of the new deformable dosimeters, particularly in low-contrast 
region. 
- Validating dose deformation calculation (Chapter 5): 
- Having tools for i) direction measurements of dose redistribution in deforming geometry 
and ii) its corresponding caluclations via DIR, this chapter presents a novel approach to 
experimentally validate DIR based dose-warping technique. This study trials 11 DIR 
algorithms, of which accuracies have been evaluated in the previous chapter, for different 
complexities of beam geometry/deformation combinations; 
- Applying these to evaluate patient treatment planning (Chapter 6): 
- The straightforward application of the validated dose-warping method is to implement 4D 
dose accumulation into the evaluation of conventional 3D plans that feature step dose 
gradients and respiratory movement as well as the associated deformation. In this chapter, 
the 4D method is applied to several liver SBRT plans in order to give a better dose 
estimate for target as well as OARs and compare to the 3D planning results; and 
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- Conclusion and recommendations (Chapter 7). 
1.4 Scientific publications and presentations arising from this work  
The present work has yielded 6 publications in international peer-reviewed journals 
(including 5 full journal articles and 1 correspondence letter to a point-counterpoint paper), 3 
publications in international peer-reviewed conference series, 15 international and local 
conference presentations and 5 invited seminars. 
 
1.4.1 Publications in international peer-reviewed journals 
(1) UJ Yeo, ML Taylor, L Dunn, RL Smith, T Kron and RD Franich (2012) 
A novel methodology for 3D deformable dosimetry 
Medical Physics, 39 (4), 2203-2213. doi: 10.1118/1.3694107 
 
(2) UJ Yeo, ML Taylor, RL Smith, JR Supple, L Dunn,T Kron and RD Franich (2012) 
Is it sensible to ‘deform’ dose? 3D experimental validation of dose-warping 
Medical Physics, 39 (8), 5065-5072. doi: 10.1118/1.4736534 
 
(3) ML Taylor, UJ Yeo, T Kron, JR Supple, S Siva, D Pham and RD Franich (2013)   
Comment on “It is not appropriate to ‘deform’ dose along with deformable image registration in 
adaptive radiotherapy” 
Medical Physics, 40 (1), 0171011-0171013. doi: 10.1118/1.4771962 
 
(4) UJ Yeo, ML Taylor, RL Smith, JR Supple, L Dunn,T Kron and RD Franich (2013) 
Performance of 12 DIR algorithms in low-contrast regionsfor mass and density conserving 
deformation  
Medical Physics, 40 (10), 101701-101711. doi: 10.1118/1.4819945 
 
(5) UJ Yeo, ML Taylor, T Kron, D Pham, S Siva and RD Franich (2014) 
Evaluation of dosimetric misrepresentations from 3D conventional planning of liver SBRT using 
4D deformable dose integration 
Journal of Applied Clinical Medical Physics, 15 (6), 188-203. doi: 10.1120/jacmp.v15i6.4978 
 
(6) M Taylor, UJ Yeo, J Supple, S Siva, T Kron, D Pham, A Haworth and RD Franich (2015)  
The importance of quasi-4D path-integrated dose accumulation for more accurate risk estimation 
in stereotactic liver radiotherapy 
Technology in Cancer Research and Treatment, 14, 1533-0346 doi: 10.1177/1533034615584120 
 
1.4.2 Publications in international peer-reviewed conference series 
(1) UJ Yeo, ML Taylor, JR SuppleL, RL Smith, T Kron and RD Franich (2013) 
Deformable gel dosimetry I : Application to external beam radiotherapy and brachytherapy 
Journal of Physics: Conference Series, 444, 012032. doi:10.1088/1742-6596/444/1/012032 
 
(2) UJ Yeo, ML Taylor, JR SuppleL, RL Smith, T Kron and RD Franich (2013) 
Deformable gel dosimetry II : Experimental validation of DIR-based dose-warping 
Journal of Physics: Conference Series, 444, 012107. doi:10.1088/1742-6596/444/1/012107 
 
(3) UJ Yeo, ML Taylor, JR SuppleL, RL Smith, T Kron and RD Franich (2013) 
Potential dosimetric benefit of dose-warping based 4D planning compared to conventional 3D 
planning in liver stereotactic body radiotherapy (SBRT) 
Journal of Physics: Conference Series, 444, 012071. doi:10.1088/1742-6596/444/1/012071 
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1.4.3 Conference presentations 
(1) UJ Yeo, ML Taylor, JR Supple, RL Smith, T Kron and RD Franich 
3-D experimental validation of deformation-based dose accumulation  
Engineering and Physical Sciences in Medicine (EPSM) 2 – 6 Dec 2012, Melbourne, Australia 
(Oral) 
 
(2) UJ Yeo, ML Taylor, T Kron, D Pham, S Siva, RD Franich 
Dosimetric differences between conventional 3D-treatment planning and 4D dose-warping 
cumulative treatment planning: Patient study in the case of liver SBRT 
Engineering and Physical Sciences in Medicine (EPSM) 2 – 6 Dec 2012, Melbourne, Australia 
(Oral) 
 
(3) JR Supple, UJ Yeo, ML Taylor, RL Smith, T Kron and RD Franich  
Experimental assessment of intensity-based DIR accuracy in low-contrast regions  
Engineering and Physical Sciences in Medicine (EPSM) 2 – 6 Dec 2012, Melbourne, Australia 
(Oral) 
 
(4) ML Taylor, UJ Yeo, J Supple, S Keehan, T Kron, D Pham, S Siva and RD Franich 
Normal tissue complications and latent stochastic effects following liver SBRT: Quantitative 
differences between 3D and 4D planning methodologies 
Engineering and Physical Sciences in Medicine (EPSM) 2 – 6 Dec 2012, Melbourne, Australia 
(Poster) 
 
(5) UJ Yeo, ML Taylor, RL Smith, T Kron and RD Franich  
Deformable gel dosimetry I: Application in external beam radiotherapy and brachytherapy 
7
th
 International Conference on 3D Radiation Dosimetry (IC3DDose) 4 – 8 Nov 2012, Sydney, 
Australia (Oral) 
 
(6) UJ Yeo, ML Taylor, JR Supple, RL Smith, T Kron and RD Franich 
Deformable gel dosimetry II: Experimental validation of DIR-based dose-warping technique 
7
th
 International Conference on 3D Radiation Dosimetry (IC3DDose) 4 – 8 Nov 2012, Sydney, 
Australia (Oral) 
 
(7) UJ Yeo, ML Taylor, T Kron, D Pham, S Siva, RD Franich  
Potential dosimetric benefit of dose-warping based 4D planning compared to conventional 3D 
planning in the case of liver SBRT 
7
th
 International Conference on 3D Radiation Dosimetry (IC3DDose) 4 – 8 Nov 2012, Sydney, 
Australia (Oral) 
 
(8) UJ Yeo, JR Supple, ML Taylor, RL Smith, T Kron and RD Franich  
Experimental quantification of errors in low contrast regions during deformable image 
registration 
World Congress on Medical Physics and Biomedical Engineering (WC) 26 – 31 May 2012, 
Beijing, China (Oral) 
 
(9) UJ Yeo, ML Taylor, JR Supple, RL Smith, L Dunn, T Kron and RD Franich 
3D Experimental validation of DIR-based dose warping for interfraction deformation of soft 
tissue 
World Congress on Medical Physics and Biomedical Engineering (WC) 26 – 31 May 2012, 
Beijing, China (Oral) 
 
(10) UJ Yeo, ML Taylor, L Dunn, RL Smith, T Kron and RD Franich  
Dose integration with the first deformable tissue-equivalent gel phantom  
 7 
World Congress on Medical Physics and Biomedical Engineering (WC) 26 – 31 May 2012, 
Beijing, China (Poster) 
 
(11) L Priestley, UJ Yeo, D Pham, T Kron, A Thompson, F Foroudi and S Siva 
Renal Stereotactic Ablative Body Radiotherapy Treatment: Dosimetric impact of deep and 
shallow breathing 
10
th
 Annual Scientific Meeting of Medical Imaging and Radiation Therapy (ASMMIRT) 8 – 10 
Mar 2013, Hobart, Australia (Oral) 
 
(12) UJ Yeo, ML Taylor, L Dunn, RL Smith, T Kron and RD Franich  
A novel methodology for 3D deformable dosimetry  
Engineering and Physical Sciences in Medicine (EPSM) 14 – 18 Aug 2011, Darwin, Australia 
(Oral) 
 
(13) UJ Yeo, ML Taylor, RL Smith, JR Supple, T Kron and RD Franich 
Is it sensible to ‘deform’ calculated doses? Experimental validation of ‘dose warping’ with the 
first 3D deformable dosimeter  
Engineering and Physical Sciences in Medicine (EPSM) 14 – 18 Aug 2011, Darwin, Australia 
(Oral) 
 
(14) UJ Yeo, ML Taylor, JR Supple, RL Smith, L Dunn, T Kron and RD Franich  
Validation of common deformable image registration (DIR) algorithms with a novel deformable 
phantom  
Engineering and Physical Sciences in Medicine (EPSM) 14 – 18 Aug 2011, Darwin, Australia 
(Poster) 
 
(15) RL Smith, UJ Yeo, ML Taylor, L Dunn, T Kron and RD Franich  
3D Deformable Dosimetry in High Dose Rate Prostate Brachytherapy  
Engineering and Physical Sciences in Medicine (EPSM) 14 – 18 Aug 2011, Darwin, Australia 
(Poster) 
 
1.4.4 Invited seminars 
(1) Modelling and verification of delivered dose on deformable moving targets in  
radiotherapy 
RMIT University, Melbourne, Dec 2012 
 
(2) Complexities in computational modelling and verification of radiation beam delivery 
Victorian Life Sciences Computation Initiative (VLSCI), Melbourne, Nov 2012 
 
(3) Use of the first tissue-equivalent 3D deformable gel dosimetry (DEFGEL) to validate 
dose-warping technique 
Australasian College of Physical Scientists and Engineers in Medicine (ACPSEM), VIC/TAS 
Branch Seminar, Jun 2012 
 
(4) Quantitative assessment of intensity-based DIR accuracy in low-contrast regions  
using a tissue equivalent deformable gel phantom 
Australasian College of Physical Scientists and Engineers in Medicine (ACPSEM), VIC/TAS 
Branch Seminar, Jun 2012 
 
(5) A deformable gel ‘DEFGEL’ and its used in dose mapping: 4D dose calculation 
Urology Group, Peter MacCallum Cancer Insititute, Melbourne, Oct 2011 
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CHAPTER TWO  
: Dosimetric challenges in radiotherapy of moving 
and deforming targets 
 
 
 
“Nothing’s ever easy.” 
Rick Franich’s 1st Law, the author’s primary supervisor 
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2.1 Overview of chapter 
In this chapter, the literature is reviewed to demonstrate that motion and deformation are 
important issues in contemporary RT. The nature of dose prescription, conformal treatment 
planning and its delivery mean that uncertainties in the position and shape of targets can result 
in under-dosage of the target, over-dosage of neighbouring healthy tissues. Consequent 
miscalculation of cumulative doses from multi-fraction treatments is self-evident. Strategies 
for dealing with motion and deformation are described, together with a proposed strategy for 
modelling accumulated dose (dose-warping). Lastly, three dimensional dosimetry tools are 
presented, which provide the basis for experimental validation of deformable dosimetry and 
dose warping, enabling clinical application of deformable dose accumulation to evaluate 
patient treatment plans. 
 
 
 
2.2 The therapeutic cell killing mechanism through radiotherapy 
When ionising radiation is incident upon a human body, the radiation interacts with matter – 
tissues, in more depth cells, and ultimately with deoxyribonucleic acid (DNA). The desired 
outcome in the context of radiotherapy is the resultant biological damage from the cell-killing 
mechanism through the interaction of ionising radiation with the tissues. 
 
From a radio-biological perspective, DNA is recognised to be the primary target for cell 
inactivation by ionising radiation that causes chromosomes to break, exposing part of the 
DNA of rapidly dividing cells, including tumour cells. Cell death (i.e. cytotoxic effect) 
induced by radiation is most likely the result of lack of repair or misrepair of complex lesions 
in DNA (Goodhead, 1994, Hüttermann et al., 1978, Todd, 1983, Olive, 1998). 
 
From a radio-biochemical perspective, there is scientific consensus that the cytotoxic effect of 
ionising radiation is caused by the interaction of the DNA molecule with free radicals 
generated from a cascade of radiolysis products (mainly with hydroxyl free radicals), 
resulting in direct or indirect breaks of DNA strands (Gordon, 1957, Hagen, 1989, 
Hüttermann et al., 1978). The direct DNA breaks results in ionisation that can occur within 
DNA, while the indirect breaks occur via the interaction with the free radical(s) generated 
from the radiolysis of water molecules (Alpen, 1997), which is the predominant molecule 
existing in all living organisms. 
 
 10 
From a radiological physics perspective, the incident high-energy photons or electrons 
interact (either directly or indirectly) with surrounding tissues producing a cascade of high-
speed electrons that are able to split water molecules. It is these electrons that deliver a ‘dose’ 
to tissues, and in more depth that cause DNA breaks. 
 
From a clinical or physiological perspective, the DNA of a cell is vulnerable to breakage 
during all stages of the mitotic process (Barendsen, 1982). Normal cells do not experience as 
much of a deadly result as cancerous cells do because normal cells are not dividing as rapidly 
and normal cells have the ability to repair the damaged DNA while the cancerous cells cannot 
repair themselves after the DNA breaks. (Wolfson, 1999). Such relatively different 
radiosensitivities yield the concept of ‘therapeutic ratio’ that effectively works throught a 
probabilistic process (see Figure 2-1). 
 
 
In this context, the basis for multiple fractionations was conceptualised in radiotherapy 
(Arcangeli et al., 1979) in order to deliver a lethal dose to the cancerous cells whilst sparing 
adjacent (healthy) tissues by delivering a sub-lethal dose However, different healthy 
tissues/organs also have relatively different sensitivities to ionising radiation, thus different 
parameters are used to estimate tumour control probability (TCP) and normal tissue 
complication probability (NTCP) of different organs (Thames et al., 1983). The 
conventionally standardised fractionation scheme, used by most radiation oncologists use 
today, administrates 1.8 - 2.0 Gray (Gy) once daily prescriptions for up to six weeks; this has 
developed over many years as a result of both radiobiological experiments and clinical 
experience (Strauss et al., 1981, Peracchia and Salti, 1981, Lyman, 1985, Lee et al., 1995, 
Yamada et al., 1999). There are also many variations outside (either less or more) of the 
standard fractionation scheme in modern treatment techniques. 
Figure 2-1 An example of idealistic dose-response curve illustrating the concept of therapeutic ratio. 
Note in this example, about 30 % tumour control can be achieved for a 5% incidence of normal tissue 
damage or complication probability (NTCP).  
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2.3 Advanced treatment techniques and dose-to-volume specification 
With the emergence of advanced computer power and reliability in the late 20th century, it 
was a natural consequence that these advances would greatly impact the medical radiation 
physics era to develop new techniques. Such development does not only include medical 
volumetric (3D) imaging modalities, such as CT, Magnetic Resonance Imaging (MRI), 
Positron Emissioin Tomography (PET), ultrasound etc., but also accurate volumetric (3D) 
treatment planning and delivery.  
 
With the turn of the 21st century, a number of new techniques dealing with the ‘dynamic 
(temporal variation)’ paradigm for both imaging and dose delivery became clinically 
available. For examples, new imaging techniques such as four-dimensional CT (4DCT) and 
its fusion with PET/MRI are now routinely implemented in clinical practice; this yields the 
concept of 4D treatment planning and delivery (Keall et al., 2005). Cone-beam CT and MV 
imaging also allow more precise localization of target volumes. Consequently, dose-to-
volume specification has been evolved, which is briefly described below. 
 
For a dose prescription, volumes of interest (VOI) must be specified to deliver the prescribed 
dose to a target while sparing specific volumes of organs-at-risk (OAR). The International 
Commission on Radiation Units and Measurements (ICRU) Reports (ICRU, 1978, ICRU, 
1993, ICRU, 1999). provided the radiation oncology community a consistent language and a 
methodology, in terms of prescribing, recording and reporting for image-based volumetric 
treatment planning, in which the physician specifies the VOI, such as tumour or target as well 
as OARs. A summary of the ICRU volume nomenclature per report is shown in Figure 2-2. 
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Two dose volumes (irradiated volume and treated volume) are consistent throughout the 
history of ICRU publications; Report 29 defined two dose volumes: 
(i) the treatment volume that is enclosed by the isodose surface representing the minimal 
target dose; and 
(ii)  the irradiated volume that receives a dose considered significant in relation to normal 
tissue tolerance (e.g. 50% isodose surface). 
These volumes were not based on anatomy but instead were based on the dose distribution. 
The volumes of organs at risk (OARs) are defined for especially radiosensitive organs in or 
near the target volume whose presence influences treatment planning and/or prescribed dose. 
 
The definition of target volumes has been evolved to take into account spatial/temporal 
uncertainties stemming from inter- and intra-fractional anatomic changes due to organ 
motion/deformation. ICRU Report 62 (a supplement to the report 50) refined the definition of 
PTV by introducing the additional margin concepts as follows:  
(i) Internal margin (IM) – taking into account variations in size, shape, and position of 
the CTV referenced to patient anatomic coordinate system; 
(ii) Setup margin (SM) – taking into account all uncertainties in patient-beam positioning 
referenced to the treatment machine coordinate system; and 
As such, the definition of the target volume is separated into four distinct boundaries: 
(i) Gross target volume (GTV) – visible or palpable (via clinical examination) tumour 
region i.e. the volume of known tumour; 
(ii) Clinical target volume (CTV) – a region to account for uncertainties in microscopic 
tumour spread or subclinical extension;  
Irradiated Volume 
Target Volume 
Irradiated Volume 
Treated Volume 
PTV 
Irradiated Volume 
Treated Volume 
CTV 
GTV 
PTV 
CTV 
GTV 
ITV 
Treated Volume 
Target Volume 
(b) ICRU 50 (c) ICRU 62 (a) ICRU 29 
Figure 2-2 Schematic illustration of the volumes defined by ICRU reports: (a) ICRU Report 29, (b) 
ICRU Report 50, and (c) ICRU Report 62, illustrating different concepts of dose prescription. 
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(iii) Internal target volume (ITV) – formed by the CTV and the IM, representing the 
excursion of the CTV due to internal organ motions (e.g. breathing motion or filling 
and emptying of rectum, bladder, stomach etc.). 
(iv) Planning target volume (PTV) – formed by the ITV and the SM to account for 
geometric uncertainties. 
The GTV and CTV are anatomic-clinical concepts that are defined before a choice of 
treatment modality and irradiation technique, while the ITV and PTV are static-geometrical 
concepts defined by specifying the IM and SM margins. Using the analogy to the ITV, the 
supplementary report also introduced the concept of the planning organ at risk volume (PRV), 
in which a margin is added around the OAR to compensate for that organ’s geometric 
uncertainties.  
 
The implementation of spatial and/or temporal modulation of radiation beams with high-dose 
and steep dose-gradient has been necessitated for conformal treatment of cancerous lesions. 
The development of such delivery techniques could implement highly conformal and dynamic 
fields (e.g. IMRT/VMAT), and may include specific alterations to the conventional 
fractionation scheme, such as stereotactic body radiotherapy (SBRT) or streotactic 
radiosurgery (SRS). Consequently, in conjunction with precise imaging techniques, these 
treatment techniques could yield 3D dose distributions that are tightly conformed to the 
specific target volume (e.g. PTV). Such evolution enabled the advanced RT to increase its 
treatment quality, so as to achieve the fundamental goal of RT – ‘precise localisation of lethal 
dose to tumours while sparing surrounding organs’. In particular, dose escalated radiotherapy, 
at more extreme high-dose per fraction courses, for instance, 6 – 10 Gy per fraction) is the 
treatment standard for some locally advanced disease and is also viable treatment option for 
early stages (Peeters et al., 2005, Pollack et al., 2000, Kupelian et al., 2008). As such, 
accurate localisation is critical as the consequences for complications in irradiated tissues may 
be more significant, e.g. acute side effects may present a number of days after the treatment is 
complete.  
 
The treatment of a deformable moving target results in a ‘blurred’ dose distribution around 
the periphery occupying a large fraction of the field volume. This necessitates accurate 
knowledge of dosimetry and clear understanding of dose prediction that is difficult to measure 
and calculate in the case of implementing conformal small-fields. Such issues are discussed in 
the following section. The focus of the current work is to address issues associated with the 
accuracy of current dose measurement and calculation methodologies as applied to treatment 
planning and its delivery in the presence of deformation, which, if inaccurate, can lead to 
complications for the patient. 
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2.4 The challenge of anatomic motion and deformation 
2.4.1 Overview: why/how is it challenging? 
The human anatomy is subject to motion and deformation. Clinically, inter- and intra-
fractional uncertainties due to this fact lead to the systematic exposure of larger volumes of 
healthy tissue in the vicinity of the targeted tumour and a miscalculation of dose volume 
histograms, tumour control and normal tissue complication probabilities. Consequently, any 
inaccuracy in calculation or measurement of dose delivery can lead not only to over-dosage of 
healthy tissues, but also to tumour under-dosage if motion is not properly managed or 
accounted for and/or margins are not adequate. Unfortunately, the latency and stochastic 
nature of the potentially detrimental outcomes means that errors are often neither identified 
immediately nor estimated later as a long term risk. This renders clinicians less confident than 
when employing broader-beam treatment in 1990’s RT history. In this context, the use of 
conformal fields is often considered to add a level of uncertainty to radiation beam delivery 
for both targets and surrounding organs that are subject to motion and deformation. This fact 
challenges i) verification of dose delivery and ii) prediction of delivered dose through 
treatment planning; the former is the dose measurement and the latter is the dose calculation. 
In particular, inaccuracies in both components are more pronounced when implementing 
spatial and/or temporal modulations of radiation beams, compared to ‘stationary’ beams and 
targets.  
 
Many factors induce anatomic variations. Organ motion during patient breathing 
(intrafraction motion) causes the greatest variation; in addition, filling and emptying of 
bladder, rectum and stomach between treatments (interfraction motion) also results in 
significant variations. In such cases, there is a potential for the interplay between organ 
motion and dose delivery. Such interplay may occur within a treatment session called 
‘intrafraction effect’ or even between treatment sessions, referred to as ‘interfraction effect’. 
Hence, dose accumulation over the period of treatment is not a trivial practice at all. This 
implies a need for using image guidance and fixing devices such as a stereotactic localiser or 
abdominal pressure plate, to achieve precise localisation of the fields to the target. On the 
other hand, there is the lack of tools for 3D measurements necessary to verify the beam 
delivery when any volumes in the field move and/or deform. Dose-measurement-based 
verification, coupled with their greater dose distribution complexity and the temporal nature 
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of dose delivery, is complicated by loss of lateral electronic equilibrium and detector volume 
effect.  
 
All these issues make the resultant ‘blurred’ dose distribution difficult to measure and/or 
calculate. Such difficulty limits not only radiation dose delivery but also image acquisition 
and treatment planning. The aim of this chapter is to provide an overview of such issues that 
cause the difficulty, with the objective of giving the reader an understanding of the 
complexities and challenges with the use of advanced RT techniques. Such issues are mainly:  
(i) organ motion/deformation management due to breathing and emptying/filling of 
organs in advanced RT; 
(ii) various dosimeters that are subject to ‘volume averaging effect’ caused by the finite 
size of the detectors;  
(iii) limitation of dose calculation and associated treatment planning that implements a 
‘snap-shot’ of anatomic image which cannot adapt inter- and intra-fraction effects; 
(iv) lack of measurement tools such as 3D dosimetry that can verify/quantify 
discrepancies between dose estimate and actual delivery in the presense of organ 
motion and deformation. 
 
2.4.2 Management of anatomic variations: inter-fraction motion 
A number of studies have established strategies for motion management that are currently 
being used in clinics worldwide; much research is still increasingly being devoted to 
strategies to contend with organ motion. These strategies encompass the image acquisition 
through to treatment planning to radiation dose delivery. Interfraction motion occurs when the 
tumour position changes on a day-to-day level or between treatment sessions (i.e. 
fractionation). Various lesions are subject to interfraction motion including stomach, bladder, 
rectum, prostate, and gynaecological lesions, which are associated with organs that are part of 
or adjacent to the digestive system (Langen and Jones, 2001). In addition, the loss or gain of 
patient weight as well as organ atrophy can also affect the relative tumour position. The 
extent of interfraction motion for these lesions was investigated in numerous studies; some 
examples of interfraction motion are described below:  
 
- Wysocka et al. quantified the interfraction motion of gastric lesions (stomach) relative to 
point of interest (POIs; splenic hilum that is the point of attachment of the gastro-splenic 
ligament on the surface of the spleen) for 22 patients. A median displacement of ~6mm 
was seen in superior-inferior (SI) direction and ~2 mm in other directions (Wysocka et 
al., 2010). 
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- Turner et al. investigated bladder movement for 30 patients with invasive bladder 
carcinoma. A transversal bladder wall displacement over 15 mm was found in 60 % of 
the patients with the maximum displacement of 27 mm. The variation in rectal diameter 
ranged from 3 to 46 mm with median of 13 mm (Turner et al., 1997). 
- Ten Haken et al. evaluated interfraction motion in prostate position in response to 
variations in bladder and rectum filling. Prostate movement > 5mm was observed in 31 
of 50 patients with dominant directions of displacement being anterior and/or superior 
(Ten Haken et al., 1991). 
- Buchali et al. assessed the mobility of gynaecological lesions (i.e. cervical and 
endometrial tumours) for 29 patients in response to bladder and rectum filling levels. 
Superior-inferior (SI) direction movements were ~4 mm and ~7 mm for both the cervix 
and the corpus uteri respectively, without a significant AP direction movement (Buchali 
et al., 1999). 
 
Image guidance is a key technique to deal with interfraction changes. Image guidance is not 
only to improve patient setup but allows to ‘adapt’ to anatomic changes before or during the 
treatment sessions, which is often referred to as adaptive radiotherapy (ART). In the non-
adaptive case, the treatment is not altered, but daily images are used for patient set-up 
correction, referred to as image-guided radiotherapy (IGRT). There are various modalities 
used as image guidance to detect the variation via internal implanted fiducials or external 
markers; such are kilovoltage (kV) and/or megavoltage (MV) imaging, MRI, ultrasound, PET 
and so on. 
 
ART emcompasses a wide range of processes including image acquisitions from different 
imaging modalities, automated segmentation of planning CT images, dose reconstruction 
using the CT image set, deformable registration of the acquired images, and re-optimisation. 
One example of ART (e.g. bladder treatment) is to take one and/or multiple CT scans (up to 
3) in different phases of bladder filling/emptying and use to generate treatment plans. Daily 
CT imaging may indicate any subsequent changes since the original CT scan(s) and plan(s). 
According to the change in anatomy evident in the image, the best plan can be chosen. 
Treatments may not be adapted if the variation due to interfraction motion is under a certain 
action-level that is protocol-specific, depending on lesion site, size, motion, position relative 
to surrounding organs etc., which may vary in different hospitals. As such, the nature of the 
resultant dose distribution is less readily calculated than the one with the absence of anatomic 
changes and static dose distribution. 
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2.4.3 Management of anatomic variations: intrafraction motion 
Intrafraction motion mainly occurs due to respiration of the patient during a treatment session. 
Various lesions are subject to this issue, such as lung, liver, kidney and pancreatic lesions. 
Intrafraction motion can yield different degrees of extent of movement for tumours in these 
organs; a concise overview of such motion reported in the literature is described here: 
 
- Seppenwoolde et al. quantified three-dimensional motions of lung tumours using 
fluoroscopy in 20 patients whose tumours were located in different regions of the lungs, 
such as the lower, middle, and upper lobes. The mean peak-to-peak displacement was ~ 
2 mm (with a range of 0.2 – 2.8 mm), ~ 2 mm (with a range of 0.2 – 8.2 mm), and  ~ 12 
mm (with a range of 0.2 – 24.6 mm) for the lateral, AP, and SI, respectively 
(Seppenwoolde et al., 2002). 
- Suramo et al. measured liver movements in 50 patients using ultrasound. The mean peak-
to-peak displacement observed was 25 mm (with a range of 10 – 40 mm) and 55 mm 
(with a range of 30 – 80 mm) under normal- and deep-breathing, respectively (Suramo et 
al., 1984). 
- Weiss et al. assessed diaphragm movements in 30 patients using fluoroscopy. Under 
shallow breathing, the mean peak-to-peak diaphragm movement was found to be 13 mm 
and 8 mm for supine patients and standing patients respectively. During deep-breathing, 
the movement ranged from 12 to 75 mm for all patient positions (Weiss et al., 1972).  
- Moerland et al. studied kidney movements in 14 volunteers using MRI.  The mean peak-
to-peak displacement ranged 2 – 35 mm and 10 – 86 mm under normal-breathing 
condition (for 25 kidneys) and deep-breathing condition (for 22 kidneys), respectively 
(Moerland et al., 1994). 
- Bryan et al. investigated pancreas movements in 35 patients using ultrasonography. The 
mean peak-to-peak displacement of 18 mm, 19 mm, and 22 mm were measured for 
supine, prone, and lateral decubitus patient positions respectively, with a range of 0 – 35 
measured over all patient positions (Bryan et al., 1984). 
 
Various strategies were investigated to manage intrafractional breathing motion. This issue 
was comprehensively reviewed by the American Association of Physicists in Medicine 
(AAPM) Task Group 76 report (Keall et al., 2006), which advised on various forms of motion 
management, such as motion-encompassing CT, breath-holding, beam-gating technique and 
real-time tracking. 
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A. Motion-encompassing CT scanning 
Accurately estimating the mean position and range of motion during CT imaging is important 
because tumour motion induced by respiration will be present during radiation delivery 
(which is referred to ICRU Report 62, as mentioned in Section 2.). There are several CT 
scanning techniques in existence that account for the entire range of tumour motion during 
respiration, such as slow CT (Lagerwaard et al., 2001, van Sörnsen et al., 2001), inhalation 
and exhalation breath-hold CT (Keall et al., 2006), and respiration-correlated 4DCT (Vedam 
et al., 2002, Keall, 2004). These approaches are effective in obtaining a tumour-encompassing 
volume for the patient’s breathing, but limitations of such techniques exist.  
 
In the slow CT scanning, the limitation is the loss of resolution due to motion blurring from 
free-breathing for the slow scan, thus, additional margins are required to account for these 
variations (Lagerwaard et al., 2001, van Sörnsen et al., 2001). Although the blurring artefact 
is not caused in inhalation and exhalation breath-hold CT scanning, taking two CT scans at 
the both endphases takes longer, almost twice the time and it relies on the patients’ ability to 
reproduce their breath holding. Respiration correlated 4DCT is a promising solution for 
obtaining high quality CT data in the presence of respiratory motion (Vedam et al., 2002, 
Keall, 2004). The four-dimensional dataset provides the mean tumour position as well as the 
range of motion with the relation of tumour trajectory to the other organs. However, the 
AAPM report 76 provided an important note that the radiation dose to the patient from these 
imaging procedures can be greater than standard CT simulation procedures by a factor of 2–
15 if no efforts are made to reduce the dose delivered, and tumour motion may change 
between simulation sessions and treatment sessions (Keall et al., 2006) 
 
B. Beam-gating technique 
Beam ‘gating’ refers to the administration (switching on/off) of the radiation beam during 
both imaging and treatment delivery within a particular portion of the patient’s breathing 
cycle, e.g. both ends of respiratory phases (inhalation and exhalation).The duty cycle (the 
fraction of time a radiation beam is active during the delivery of a respiratory gated treatment 
field) can be determined by monitoring the breathing cycle by using different means. 
Examples are the use of an external respiration signal using an infrared light source from the 
camera attached to ceiling (or wall), being reflected from a IR reflector placed on the chest 
wall, e.g. the Real-time Position Management (RPM) system (Varian Medical Systems, Palo 
Alto, CA), or internal fiducial markers with image-guidance, e.g. gold spheres or rod implants 
monitored via digitally reconstructed radiograph (DRR) (Shirato et al., 2000, Shirato et al., 
2003). Respiratory-gated IMRT was demonstrated and evaluated for its clinical use by a 
number of studies (Kubo and Wang, 2000, Hugo et al., 2002, Duan et al., 2003). Mageras et 
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al investigated the gating technique by comparing it with deep-inspiration breath hold (DIBH) 
approach for reducing organ motion. It is noted that treatment session times with gated 
operation are increased relative to standard treatments by 2–10 min depending on patient 
compliance. Consequent considerations with increased delivery time are the increased 
likelihood of patient movement and decreased patient throughput as well as patient comfort 
(Mageras and Yorke, 2004).  
 
C. Controlled breathing methods 
There are several variations of breath-holding method depending on the location of lesion and 
patients’ ability to reproduce the desired holding patterns. Such variations are the deep-
inspiration breath hold (DIBH), active-breathing control (ABC) with the facilitation of a 
control device, self-held breath hold with or without respiratory monitoring and forced 
shallow breathing with abdominal compression. These controlled breathing methods have 
been favourably implemented in thoracic and abdominal cancer radiotherapy (e.g. lung, 
breast, liver etc.), because the methods are fairly simple and substantially reduce respiratory 
tumour motion. Consequently the breath-hold methods can significantly reduce doses in 
surrounding normal tissues such as breast (Remouchamps et al., 2003a, Korreman et al., 
2005), heart and lung (Sixel et al., 2000, Remouchamps et al., 2003b, Pedersen et al., 2004, 
Duggan et al., 2007) and liver and spinal cord (Lax et al., 1994, Blomgren et al., 1995, Lohr 
et al., 1999, Timmerman et al., 2005). These studies, including a study by Berson et al that 
reported on 108 patients treated with either a free-breathing gating technique or the breath-
hold technique (Berson et al., 2004), found several advantages of implementing the breath-
hold technique. Advantages cited are the reduction of time for a single-slice CT scan as well 
as treatment delivery by a factor of two relative to the free-breath gating; the elimination of a 
possible time delay between the tumour motion and the motion of external marker or internal 
fiducials; and improved diaphragm positional reproducibility. 
 
D. Real time tumour tracking methods 
Another approach to contend with intrafraction breathing motion, which can be differentiated 
from the other respiratory ‘compensation’ methods, is ‘real-time tumour tracking’. This refers 
to synchronising the position of radiation beam dynamically following the tumour’s changing 
position. The conceptual thought for this approach has been in existence for a long time but 
the first systematic implementation was consolidated by Keall et al (Keall et al., 2005). They 
addressed that the real-time tumour tracking can eliminate the need for a tumour-motion 
margin in the dose distribution, while maintaining a 100% duty cycle for dose delivery. This 
method can be performed using dynamic multi-leaf collimators (DMLC) for temporal/spatial 
beam modulations and various means of detecting/monitoring tumour position. Examples are 
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imaging of the tumour itself via e.g., fluoroscopy, implanted fiducial markers or surrogate 
breathing signals from an external device. Detecting the tumour position is the most important 
and challenging task in real-time tracking (Keall et al., 2005). In addition, since some tumour 
motion (e.g. lung lesion) can follow a complex 3D trajectory (Seppenwoolde et al., 2002), it 
requires heavy computational power to feed accurate information concerning the tumour 
position in real-time to DMLC, which changes its shape corresponding to the tumour position. 
A more detailed discussion is available in to the AAPM report 76 which provides a 
comprehensive review and recommendation of implementing this approach (Keall et al., 
2006). Recent studies from Keall’s group demonstrated the first clinical implementation of i) 
a real-time image guidance with kV intrafraction monitoring (Keall et al., 2015) and ii) 
DMLC tracking and gating deliveries into prostate treatment using VMAT modality (Colvill 
et al., 2014), which can improve target (CTV/PTV) converages while reducing the maximum 
doses to rectum and bladder. 
 
 
2.4.4 Management of anatomic variations: inter- and intra-fraction deformation 
Strategies dealing with motion, described in the two previous sections, do not necessarily also 
deal with deformation. IGRT approaches can help with improving conformality of beam 
shaping, but not with dosimetry associated non-rigid anatomic changes. There is clinical 
awareness of and interest in anatomic deformation and the dosimetric consequences thereof, 
and in adapting deformation to better simulate temporal/spatial anatomic changes compared 
to a model that linearly moves an organ as a rigid body.  
 
Most organs will deform to some extent, typically in the millimetre-centimetre range. The 
potential for under-dosage of the target, over-dosage of neighbouring healthy tissues, and 
miscalculation of cumulative doses from multi-fraction treatments, is self-evident. This issue 
is related to both (i) intra-fractional effect and (ii) inter-fractional effect. A particular example 
of the former is the case of dose-escalated treatment for a small brain (or neck) lesions (e.g. 
SRS) or treatment for a mobile lung or liver lesion (e.g. SBRT) using multiple conformal 
beams. The latter becomes a more significant challenge than the former since various multi-
fractionation schemes have been implemented in RT. A typical example is the case of 
treatment for a prostate that is subject to motion and deformation due to filling and emptying 
of the bladder and/or rectum. In such situations, it is a non-trivial practice not only to 
accurately deliver fractionated dose to changing anatomy, but also to calculate consequent 
dose accumulation in moving and/or deforming targets and the surrounding organs. The 
nature of the resultant dose distribution is less readily calculated than the one with the 
absence of anatomic changes and static dose distribution. For this reason, hypo-fractionated 
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treatment schemes (e.g. SBRT) that implement high doses per fraction with small number of 
total fractions may need strategies to adapt for non-rigid anatomy changes within the context 
of adaptive RT.  
 
As a non-rigid anatomy change makes the accurate merging of dose distributions difficult, 
strategies for dose accumulation in deforming anatomy are of interest in radiotherapy. A 
proposed solution is dose-warping via deformable registration of images and corresponding 
dose distributions. Algorithms exist for the deformation of dose based on patient image sets. 
The warped distribution can then be added to previous fractions in order to interpret the 
accumulated dose. The deformation of dose distribution via the resultant vector map 
associated with deformable image registration (DIR) calculation is so called ‘dose-warping 
via DIR’ or ‘DIR based dose-warping technique’. This technique is an existing process, 
proposed to accumulate doses from multiple image sets taken in different time frames. What 
is not well known, is the degree to which this approach is acceptable. As observed by the 
recent Point-Counterpoint article in Medical Physics (Schultheiss and Tomé, 2012), entitled 
‘It is not appropriate to “deform” dose along with deformable image registration in adaptive 
radiotherapy’, “the ultimate problem with deformed dose is our inability to measure it”.  
 
Next, we describe tools and techniques for the complicated business of dose measurement, 
and ultimately demonstrate a new approach to measuring dose in a deforming target and the 
application to validation of dose-warping. 
 
 
2.5 The difficulty of volumetric measurement of conformal fields using 
various dosimeters  
The implementation of highly modulated small fields pose challenges for properly measuring 
delivered dose, i.e. quality assurance (QA) of radiation dose distributions for the verification 
of treatment planning systems (TPS). For the accurate measurement of dose distribution, a 
detector with a high degree of spatial resolution is required and should not perturb the 
radiation field (i.e. media-matched dectector). In the dosimetry of small fields and of steep 
dose gradient regions (e.g. IMRT), a well-known source of error which can occur during cross 
beam profile measurement, is the artificial broadening of profile penumbra caused by the 
finite size of the measuring detectors (dosimeters). This phenomenon is called the ‘volume 
averaging effect’. If the size of the field approaches that of the active volume of the detector, 
this volume averaging effect may yield significant errors. Dose escalated radiotherapy using 
high dose and small field (e.g. stereotactic radiosurgery) is the particular case of possibly 
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having a negative impact on the measurement accuracy. Consequent detriment can be 
inaccurate prediction of tumour control and normal tissue complication probability thereby 
decreasing treatment quality. 
 
A number of established studies have investigated this issue both theoretically and 
experimentally (Attix, 1986, Higgins et al., 1995, Metcalfe et al., 1997, Low et al., 2003, 
Laub and Wong, 2003, Bucciolini et al., 2003, Yan et al., 2008, Low et al., 2011). Referring 
to these references, various conventional measurement techniques (i.e. dosimeters) and 
potential limitations thereof are briefly discussed in this section. 
 
 
2.5.1 Point-dose measurements 
A. Ionisation chamber 
Cylindrical ionisation chambers are the standard dosimeter for point-dose measurements of 
high energy (megavoltage, MV) photon radiation in a clinical medical physics department. 
This is because the ionisation chambers have high stability, a linear response to absorbed 
dose, small directional dependency, response independency to beam-quality, and traceability 
to a primary calibration standard. However, all ionisation chambers clinically used exhibit 
detector volume averaging effect, since the collected ions are created throughout the active 
chamber volume (Low et al., 2003). Significant perturbations in measurements of dose 
distribution caused by the volume effect will occur, in particular, in the steep dose-gradient 
regions of highly conformal beam delivery. Rice et al (2000) found that the finite size of an 
ionisation chamber introduces a volume averaging effect which can lead to overestimation of 
penumbras (Rice et al., 2000), implying substantial dose measurement errors for IMRT 
beams.  
 
B. Solid state (semiconductor) dosimeters 
When using detectors of smaller size, such as p-type silicon diode detector or metal oxide 
semiconductors transistor (MOSFET), there are various advantages for small-field 
measurements of MV photon radiation. Some examples include very small active volumes 
and high sensitivity to radiation, high stability, and in vivo real-time readout. However, these 
dosimeters introduce other problems. The relatively high atomic number of silicon in the 
diode detector will lead to a greater sensitivity to low-energy scattered photons (i.e. photo-
electric effect), thus, diode detectors are usually used only for relative dosimetry (Higgins et 
al., 2003). The response of solid state dosimeters also exhibits orientation dependency, 
resulting in its variation up to 15% (Westermark et al., 2000). Furthermore, this detector 
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exhibits a couple of other dependences including dose rate dependence (Wilkins et al., 1997) 
and temperature dependence (Grusell and Rikner, 2000).  
 
C. Solid state (diamond) dosimeters 
In contrast to silicon diode detectors, diamond detectors are almost soft-tissue equivalent in 
terms of atomic composition (i.e. comprised of carbon), although they have a physical density 
much greater than water at 3.5 g cm
-3
. Laub et al provided a good overview of the advantages 
of diamond detectors, highlighting that diamond detectors can produce clinically identical 
results to p-type silicon diodes for conformal small-field treatment (Laub et al., 1999). 
Diamond detectors also exhibit a small directional dependence and good mechanical stability. 
The most apparent problem is dose rate dependence that is attributed to the reduction in 
recombination time as dose rate increases, necessitating the use of correction factors. (Hoban 
et al., 1999). The diamond detector is less user friendly, since it requires a pre-irradiation dose 
before daily use to obtain sufficient response stability (Bucciolini et al., 2003).  
 
 
D. Thermoluminescent detectors (TLD) 
Another type of small-field dosimeter that has been routinely used in clinical environments is 
the thermoluminescence dosimeter (TLD), which is an integrating dosimeter formed in 
different shapes of small sizes, often a cubic or cylindrical chip with a typical physical density 
of 2.6 g cm
-3
. Kron provided a great overview of TLDs and their application in medicine, 
detailing both physical and radiological aspects (Kron, 1994). Taylor calculated effective 
atomic numbers (Zeff) for commonly used types of TLDs over 1 keV to 100 MeV, showing 
that Zeff of TLDs is approximately 1.8 times greater than Zeff of water (Taylor, 2011). The 
most prominent difference in the Zeff is due to the relatively high atomic number of metal 
components. Supra-linearity of dose response is a well-known issue along with some energy 
response variations (Troncalli and Chapman, 2003), so that it must be evaluated and corrected 
for before use. TLD implementation is laborious and it requires a routine QA of the TLD 
reader and annealing oven temperature control, (Low et al., 2011). 
 
 
2.5.2 Two-dimensional (2D) measurements  
A. Radiographic film (Silver halide film) 
The use of silver halide based radiographic film was until relatively recently standard practice 
in a clinical environment and is one of the earliest applied methods to detect x-rays (Trevert, 
1896). Radiographic film, is not reusable but relatively cheaper than the other dosimeters, and 
provides an attractive measurement technique considering the trade-off between the 
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information obtained (two dimensional map of complex dose distribution) and experimental 
complexity and labour. Despite this, there are many potential disadvantages when using this 
technique. Bogucki et al listed these factors, including variations in film sensitivity caused by 
film batch, processor conditions, densitometry artefacts, and deviation from water throughout 
photon beam spectrum resulting from the high atomic number of the active material (Bogucki 
et al., 1997). Of these variables, the factor of the greatest potential for causing dosimetry 
errors is the variation in optical density with film processor developer temperature. 
 
 
B. Radiochromic film 
In contrast to radiographic film, radiochromic film is nearly tissue-equivalent and does not 
require a processor for generating the optical density response to ionising radiation, as it is 
self-developing (Blackwell et al., 1998). This thin film is easy to handle and has very high 
spatial resolution, but underexposure at low-energy range may occur with radiochromic films 
(Muench et al., 1991). With all the advantages of film dosimetry, Cheng and Das addressed 
the several difficulties associated with conformal field measurement, such as energy 
dependence, film orientation, inter- and intra-film density variation, sensitometric 
nonlinearity and inhomogeneity due to trapped air pockets inside the film jacket (Cheng and 
Das, 1996). In general, radiochromic film should not be used for absolute dose measurements 
and to verify output measurement by ionisation chamber. The obvious limitation of 
radiochromic film is the restriction of 2D planar dosimetry, in particular for verification of 
irregular 3D dose distributions.  
 
C. Electronic Potal Imaging Device (EPID) dosimetry 
The use of electronic portal imaging devices (EPIDs) can be an efficient option as a pre-
treatment dosimetric measurement tool for patient-specific QA of modulated treatment plans. 
It is because of its properties such as high contrast, high spatial/temporal resolutions, large 
detecting surfaces, linear response to radiation dose, and efficient online capabilities. 
Consequently, various commercial vendors and clinical institutions have produced algorithms 
to convert calibrated EPID response into a simulated dose plane, in order to utilise EPID 
images as a verification tool for delivery of modulated fields (Luchka and Pistorius, 2001, 
Greer and Popescu, 2003, Greer, 2007, Bailey et al., 2010). At the same time, however, high-
Z component materials and large detector density render EPIDs far from water-equivalent. 
Another obvious limitation of using EPID dosimetry is associated with rotational delivery 
technique (e.g. performing VMAT QA). It is because EPID is mounted to the rotating gantry, 
that is, the lack of independent verification of gantry motion and the possibility of angle-
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dependent detector sag due to gravitational force, which is also machine dependent. In 
addition, EPID dosimetry is often restricted 2D plane. 
 
D. Array detectors 
A recent and popular new tool available for routine clinical quality assurance (QA) of 
conformal beam radiotherapy is a planar array of point dosimeters calibrated to yield multiple 
cumulative readings of absorbed dose (Low et al., 2011). Planar arrays have been used for 
QA of IMRT (Jursinic and Nelms, 2003) and helical tomotherapy (Langen et al., 2005). 
These studies implemented two-dimensional n-type diode array, which was the only 
commercially available product until recently and is called MapCheck (Sun Nuclear, 
Melbourne, FL). Ionisation chamber array detectors are also commercially available, e.g. IC-
profiler (Sun Nuclear, Melbourne, FL). Low et al. addressed the several limitations regarding 
dosimetry tools and techniques for IMRT in their review paper (Low et al., 2011). Limitations 
include the fact that existing array detectors have low spatial resolution (typically ~ 10 mm of 
detector spacing). This limits their role in routine QA for hypo-fractionated small fields 
delivery (e.g. SRS/SBRT), since initial commissioning should be performed with a higher 
resolution system (e.g. film) enabling thorough evaluation of the fine dose distribution 
structure. In addition, 2D array detectors cannot provide the composite 3D dose distribution 
from the superposition of all beams although each beam can be independently verified. In 
other words, both individual beam errors and the accumulation of all errors in the 3D 
distribution are unknown. 3D structured array detectors are now available, e.g. Octavius and 
ArcCHECK; however, these are still in limited use mainly due its low resolution and planar 
dose measurement (i.e. virtual 3D dose reconstruction from 2D measurements for Octavius 
and 2D measurements along the surface of 3D structure for ArcCHECK). 
 
2.5.3 Ideal dosimeter for measurements and verifications 
To be considered as the ideal dosimeter for measurements and verifications of the conformal 
fields, it would need to possess (i) a ‘volumetric’ property to act as a dosimeter as well as a 
volumetric phantom material, so as not to be subject to volume averaging issues and (ii) water 
or tissue equivalency (i.e. ‘media-matched’ properties), so as not to perturb the radiation field. 
Radiosensitive gel dosimeter is a tissue equivalent 3D dosimetric phantom, that is, a 3D 
version of radiosensitive film. Hence, gel can act as a moving tissue surrogate while enabling 
3D measurement of integrated dose in the volume. Consequently, gel dosimeters are a very 
promising tool to enable the measurement of highly conformal field(s) in moving objects. 
Following sections briefly describe the history of 3D gel dosimetry and discuss its 
radiochemical processes upon irradiation. In addition, use of different types of gels in 
radiotherapy is provided in greater details based on a comprehensive review of scientific 
 26 
literature. Subsequently, the next chapter (Chapter 3) will discuss another unique potential of 
gel, that is, a new development of deformable gel dosimetry that has the capacity to be a dose-
integrating deformable tissue surrogate. 
 
 
 
2.6 A review of fundamentals in 3D dosimetry: Radiosensitive gels 
2.6.1 An overview of 3D dosimetry 
Radiosensitive gels are material that can map the absorbed radiation dose in three dimensions 
(3D) via chemical processes upon irradiation, i.e. ionic conversion or polymerisation, as a 
function of the dose delivered. 3D gel dosimetry in radiotherapy has the potential to play an 
important role in commissioning new advanced treatment protocols, to help prevent 
potentially significant inaccuracies in test treatments at a variety of institutions (Doran and 
Krstaji, 2006, Venning et al., 2005a).  
 
In early studies, Day and Stein in 1950 first suggested the use of radiosensitive polymer gels 
for the purposes of radiation dosimetry. They investigated radiation-induced colour changes 
in gel matrices containing radiosensitive dyes, such as methylene blue (Fong et al., 2001). 
Spectrophotometry and a pH probe were also used to measure depth doses in the irradiated 
gels (De Deene et al., 2002). The feasibility of using radiosensitive gels for the dosimetry 
purpose, however, was founded by Gore et al in 1984. They initially demonstrated that 
changes due to ionising radiation in the ferrous sulphate chemical dosimeter, called the Fricke 
dosimeter (Gore and Kang, 1984), could be evaluated by nuclear magnetic relaxometry 
(NMR) signals, hence by magnetic resonance imaging (MRI) for dose readout (De Deene et 
al., 2006). 
 
Since then, numerous studies have been undertaken investigating the following:  
• new formulations of radiochromic gels using various gel matrices such as gelatin 
(protein), agarose (polysaccacharide), and PVA (polyvinyl alcohol) (TRCR, 2006, Xu 
et al., 2004, Hilts and Duzenli, 2004, Xu et al., 2003, ICRP, 2007);  
• various radiosensitive chemical reactants such as xylenol orange, leuco-malachite 
green and potassium ferricyanide (Turnbull blue) as radiochromic dyes (Rutqvist et 
al., 2003, Adamovics and Maryanski, 2004, Bomford and Kunkler, 2003, Zackrisson 
et al., 2003);  
• new types of polymer-based gel using radiation-induced polymerising monomers 
and/or crosslinker such as polymethylmethacrylate, polyacrylamide acrylamide 
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(AAm) and/or N,N’-methylene-bis-acrylamide (Bis) (Bleehen and Stenning, 1991, 
Gowda et al., 2003, Baldock et al., 1999);  
• spatial and temporal stabilities affected by ion diffusion for radiochromic gels and by 
oxygen diffusion for polymer based gels (De Deene et al., 2000, Schultheiss et al., 
2012, McAleese et al., 2003);  
• addition of diffusion suppressing chemicals for radiochromic gels such as anionic 
micelle (Bomford and Kunkler, 2003, Zhong et al., 2012) or genipin crosslinker (Mi 
et al., 2003, Zhong et al., 2010, Schultheiss and Tome, 2013);  
• addition of antioxidant such as tetrakis (hydroxymethyl) phosphonium chloride 
(THPC) for polymer-based gels (De Deene et al., 2002, Karim et al., 1996, Jirasek et 
al., 2006);  
• new types of radiochromic plastic dosimeter using polyurethane and leuco-malachite 
green dye (Mather and Baldock, 2003, Adamovics and Maryanski, 2004);  
• characterisation of radiological properties in 3D dosimeters fabricated using various 
formulations/compositions of materials (Salazar et al., 1979, McAleese et al., 2003, 
Venning et al., 2005a, González et al., 1994) and;  
• characterisation of different dose readout systems and development of new reading 
devices (Nilsson et al., 2004, Gore et al., 1999, Hilts et al., 2000, Oldham et al., 2001, 
Mather et al., 2002, Islam et al., 2003). 
 
Fundamental principles most of 3D dosimeters (except radiochromic plastic dosimeter) are 
governed by the interaction of ionising radiation with water, i.e. water radiolysis. 
Contemporary gel dosimetry is broadly categorised into three types depending on its 
composition: radiochromic gel, radiochromic (polyurethane) plastics, and polymer-based gels. 
For evaluation purposes, this gel dosimetry typically employs the following readout systems: 
magnetic resonance imaging (MRI), optical-computed tomography (optical-CT), x-ray CT 
imaging, or ultrasound imaging. This section discusses the advantages of gels (Section 2.6.2), 
the fundamentals of water radiolysis (Section 2.6.3), then basic chemical processes of 
individual gel types (Section 2.7) and the usage of each imaging modality (Section 2.8). 
 
2.6.2 Advantages of 3D gel dosimetry 
Gels have many inherent advantages over other more ‘standard’ dosimeters. Examples of the 
more standard point dosimeters include ion chambers or thermo-luminescent dosimeters 
(TLD). The use of gel dosimeters may also be preferred over the use of two-dimensional 
dosimeters, such as film or array detectors. Such detectors are unable to obtain three 
dimensional (3D) dose information and can only provide dose information at a limited 
number of points or two dimensional planes. The use of these detectors may perturb dose 
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information (e.g. volume averaging effect, angular dependence or media-mismatch). Gel 
dosimeters, on the other hand, contain not only radiological and physical properties similar to 
that of water and soft-tissue but are also capable of integrating dose distributions independent 
of the incident directions of beams. As such, gels possess the dual capacity to act as a 3D 
dosimeter and also as a tissue-equivalent phantom. Gels are not subject to the aforementioned 
perturbing factors, yielding dose information over a three dimensional volume through 
multiple beamlets during irradiation or multiple fractionations. 
 
These advantages are particularly significant in investigating the dosimetric impact on 
moving and/or deforming targets with advanced treatment techniques that implement steep 
dose gradients, high dose and beam modulation, such as in IMRT, VMAT or stereotactic 
therapy. There is no substitute for the 3D measurement of dose delivered to the deformable 
moving targets, i.e. 4D deformable dosimetry which has not previously been demonstrated, 
such application is the aim of the next chapter. Gel dosimeters also have specific advantages 
for brachytherapy dosimetry, which requires volumetric dose measurement with a high degree 
of spatial resolution. Further potential dosimetry applications (though not explicitly discussed 
in this thesis) include the use of gels for low-energy x-rays, high linear energy transfer (LET) 
particle and proton therapy, radionuclide and boron capture neutron therapy dosimetry 
(Venning et al., 2005a). 
 
 
2.6.3 Water radiolysis: the fundamentals of interaction of radiation with gels/tissues 
Water radiolysis refers to decomposition of water molecules by ionisation when ionising 
radiation deposits its dose (energy per mass, J/kg) into water. This phenomenon has been 
well-studied in various eras and industries since radiation was actively studied from isotope 
decays until now (Baldock et al., 1999, Senden et al., 2006, Wu et al., 2002b, Kirby et al., 
2013, Lepage et al., 2001a). In the radiotherapy field, this is particularly important to 
understand the consequence of irradiating the human body and gels, matter mainly composed 
of water, 60-70% for the former and 80-90% for the latter. 
 
Water radiolysis is commonly described in three distinct stages after incident radiation: (i) the 
physical stage has time scale in the order of 10
-14
s, (ii) the physicochemical stage in the order 
of 10
-12
s, and (iii) chemical stage in the order of 10
-7
s (Kirby et al., 2013, Lepage et al., 
2001a). When incident ionising radiation deposits its energy into the human body, ionised 
water molecules mainly form H2O
+
 + e
-
 pairs and partially excited (H2O
*
), which is 
decomposed into H• + OH• (or H2 + O) pairs in the body. These decompositions take place in 
localised spots where the energy deposition occurs in a time scale of 10
-14
s (i.e. physical 
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stage). The resultant ions readily react with surrounding water molecules to form hydrogen 
radicals (H•) and hydroxyl radicals (OH•). A cascade of radiolysis products are sequentially 
generated as forms of e
-
eq (a hydrated electron), H•, OH•, H
+
, H2 within 1 ps (10
-12
s) after the 
energy deposition. Initial inhomogeneous distributions of these radiolysis products are called 
‘initial yields’ (i.e. the physicochemical stage). Sequential homogeneous distribution of the 
initial yields occurs along simultaneous reactions with each other due to their high-reactivity 
and high local concentration. As a result, other cascades of radiolysis products are formed 
(e.g. e
-
eq, H•, OH•, H
+
, H2 H2O2) and distributed homogeneously further beyond the local 
spots 0.1 μs (10-7s) after the energy deposition occurs. The homogeneous distributions of 
these radiolysis products are called ‘primary yields’, which are involved in homogeneous 
reactions with each other (i.e. chemical stage). A schematic diagram of these processes is 
shown below:  
 
 
Figure 2-3 A schematic diagram of water radiolysis processes. 
 
Although most highly reactive free radicals formed in these reactions recombine to form 
oxygen and water in a time scale of ~10 μs (10-5s), some may interact with other chemical 
compounds in either tissues or gels irradiated. In terms of damage to DNA during treatment, 
the hydroxyl (OH•) radical (an oxidising species) is the most important radical of the products 
in water radiolysis, resulting in detrimental biological effects in tissues (Kirby et al., 2013). In 
the context of gel dosimetry, the most important products are H2O2 and the radicals e
-
eq, OH•, 
and H
+
 in the absence of oxygen, resulting in readable changes in gels (e.g. colour or opacity) 
(Trapp et al., 2002).  
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2.7 Polymer-based gel and other 3D dosimeters  
This section primarily sets out fundamental characteristics and practical considerations for 
polymer gel dosimeters which are used in the next chapter; other types of 3D dosimeters such 
as radiochromic gel and radiochromic polymer plastic are also brifely described. There are a 
series of excellent review articles regarding 3D gel dosimetry, all with different perspectives. 
The fundamental chemistry of radiochromic gels (Schreiner, 2004) and that of polymer gels 
(McAuley, 2007), and concisely summarised fundamentals of both gels and plastic dosimeters 
(Lepage and Jordan, 2010) have been previously published in International Conference in 3D 
Dosimetry proceedings (IC3DDose), formerly called DOSGEL. Members of the conference 
committee established a comprehensive review article that overlooks a full range of 3D 
polymer gel dosimetry (Venning et al., 2005a).  
 
2.7.1 Polymer gels  
In 3D gel dosimetry, a major stream to address the ionic diffusion problem has been the 
development and implementation of polymer gel dosimeters (Venning et al., 2005a). Polymer 
gels are predominantly water (~ 90 %), with a gelling agent (such as gelatine or agarose) and 
monomers (organic hydrocarbons). The monomers are readily involved in a chemical reaction, 
i.e. polymerisation, due to its relatively small molecule size characterised by a carbon-carbon 
double. The gelling agent forms a three dimensional matrix into which the polymer chain 
formed can hardly diffuse; this preserves the spatial integrity of the radiation dose distribution. 
The currently used formulation was initially proposed in 1993, which was based on the 
polymerisation of acrylamide and N,N’-methylene-bis-acrylamide monomers (referred to as 
Bis which also acts as a cross-linker) infused in an aqueous agarose matrix (Nilsson et al., 
2004).  
 
Since the inception of the polymer-based gel, many different variations on the gel 
composition have been investigated, examined and used. Fundamental processes of 
polymerisation in response to the irradiation have been thoroughly studied, yielding a 
rigorous understanding of the factors that affect important properties of the polymer gels, 
such as the radiation dose sensitivity, dose response linearity, water equivalency, spatial and 
temporal stability, and dose integrity (Keall and Baldock, 1999, De Deene et al., 2000, De 
Deene et al., 2002, Senden et al., 2006, Venning et al., 2005b, Taylor et al., 2007a, Taylor et 
al., 2009c).  
 
 31 
2.7.2 Polymerisation process  
Under irradiation, the monomers undergo a polymerisation process via a chemical interaction 
with highly reactive free radicals generated from the dissociation of water molecules i.e. 
water radiolysis (Section 2.6.3). These radicals are readily bound to the electron double-bond 
of a monomer, forming a monomer radical that initiates polymerisation by reacting with 
another monomer. The resultant polymer radical does not only contain a reactive site 
consisting of electron double-bonds but the loose ends of polymer chains that propagate the 
reaction with another radical and/or radical monomers and/or radical polymers exist nearby 
the polymer (i.e. successive polymerisation). This propagation progressively forms a larger 
polymer chain (i.e. macromolecules), resulting in the modification of the physical properties 
in the dosimeter, such as opacity (optical density), water molecule mobility and electron 
density. Such changes can be then probed using different techniques such as optical CT, MRI, 
x-ray CT, and ultrasound. 
 
Termination of polymerization occurs through various reaction processes of polymer radical 
with other chemicals; examples of reactions are the polymer radical–polymer radical reaction, 
polymer radical–gelatin reaction, and polymer radical–water free radical reaction. This 
terminating process is an important step in polymer gel chemistry because full polymerisation 
of the monomers only occurs after a significant radiation dose with an absence of termination. 
Following a cascade of the polymerisation process, approximately 10
4
 monomers form a 
polymer chain before terminating the propagation (Lepage et al., 2000).  
 
The gelling agent (e.g. gelatin), which mainly plays a role of the three dimensional matrix, is 
also involved throughout the polymerisation process. Due to its porous structure (albeit 
microscopic level), small molecules such as monomers may diffuse from the unirradiated 
region to the irradiated region; a direct consequence of the diffusion is the smearing effect of 
dose profiles/distributions, which does not reflect what happens in reality. However, gelatin is 
also known for its role as a ‘scavenger’ of water free radicals in acrylamide-based polymer 
gel dosimeter. In other words, a higher concentration of gelatin in the dosimeter implies that 
relatively fewer water free radicals become available for reaction with polymers, resulting in 
a decreased dose sensitivity with an increased stability both temporally and spatially (Lepage 
et al., 2001b). 
 
Oxygen is very reactive and it quickly reacts with water free radicals, yielding peroxide 
radicals. These peroxide radicals react rapidly with other radicals (e.g. monomer radicals or 
polymer radicals), inhibiting or terminating the polymerisation process. As such, polymer gels 
should be prepared in an oxygen-free environment to avoid exposure to oxygen, i.e. 
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preparation should occur in an inert gas atmosphere using a nitrogen-purged glove-box, 
requiring a more laborious manufacturing process.  
 
 
2.7.3 Normoxic polymer gel  
In 2001, Fong et al introduced an innovative strategy of adding an antioxidant that scavenges 
oxygen molecules present in the gel solution during manufacture, facilitating normal 
atmosphere (normoxic) condition throughout the gel manufacture process (Fong et al., 2001). 
This new type of polymer gel dosimeter, known as MAGIC, consists of methacrylic acid, 
ascorbic acid, gelatin and copper. Free oxygen present in the aqueous gelatin matrix can be 
bound to ascorbic acid, commonly known as vitamin C, forming metallo-organic complexes 
in a process initiated by copper sulfate.  
 
Subsequently, another oxygen scavenger, tetrakis hydroxymethyl phosphonium chloride 
(THPC) has been well-studied and incorporated to polyacrylamide-gelatin based polymer gel 
(hypoxic or anoxic gel dosimeters); such formulations include not only a patented commercial 
gel product such as BANG
®
 (Maryanski et al., 1994) but also in-house gels such as 
polyacrylamide-gelatin based polymer gel (PAG) (Baldock et al., 1999). A full understanding 
of the effect of its addition in gels has been acquired before its practical use via many studies 
(Fong et al., 2001, De Deene et al., 2002, Venning et al., 2005a, Brindha et al., 2004, De 
Deene et al., 2006).  
 
These types of polymer gel dosimeters became known as the new class of normoxic gel 
dosimeters, which are mainly used in current systems. Numerous studies have investigated 
different compositions and formulations of normoxic polymer gel dosimeters, which have 
been well-summarised by (Senden et al., 2006) and comprehensively reviewed by (Baldock et 
al., 2010) 
 
 
2.7.4 Different types of 3D polymer dosimeters  
Radiochromic gels present colour changes as a function of absorbed radiation dose, for 
example, via ionic conversion of ferrous (Fe
2+
) ions into ferric (Fe
3+
) ions in Fricke xylenol 
gels. There are different types of radiochromic gels depending on the aqueous solutions, 
gelling matrices and initiator dyes used.  
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Ferrous-sulphate doped gels are an aqueous ferrous solution integrated into a gelling matrix, 
often referred to as the Fricke dosimeter. Gore et al initially demonstrated that 3D dose 
distributions could be mapped with the Fricke gels and probed with MRI (Gore and Kang, 
1984) . Although these Fricke dosimeters will continue to be important for fundamental 
radiochemistry studies (Lepage and Jordan, 2010), the diffusion of ferrous and ferric ions in 
Fricke gels presents a fundamental problem in terms of time constraints for post-irradiation 
imaging. This issue becomes more significant for dose delivery involving fields of very high 
dose gradients. As such, other variations of radiochromic gels have been developed with 
different strategies for diffusion suppression. 
 
Gupta and Nilekani thoroughly investigated the infusion of xylenol orange (i.e. radiosensitive 
dye) into gelling matrix of Fricke solution, which allowed sensitive and reproducible 
measurement of the concentration change of ferric ions with visible light (Gupta and 
Nilekani, 1998). Appleby initially demonstrated the feasibility of adding xylenol orange into 
ferrous agarose gels (Rutqvist et al., 2003), this is often referred to as ferrous xylenol orange 
gels (FX gels or FXG). Jordan’s group introduced these new gel types providing thorough 
examination of their radiological and mechanical properties in practical aspects (Bomford and 
Kunkler, 2003, Zhong et al., 2012). These authors integrated water-insoluble leuco malachite 
green (LMG) with nonionic surfactants to create micelles in an aqueous gelling matrix. This 
is often referred to as radiochromic micelle gels (Lepage and Jordan, 2010). 
 
Another strategy of developing non-diffusing radiochromic gels is to use a crosslinking agent 
such as genipin that crosslinks gelatin to form a blue hydrogel (Mi et al., 2003). These gels 
are radiosensitive at low pH (i.e. low oxidisation of ions) and the blue crosslinked gels 
become opaque as a function of absorbed dose. Baldock’s group demonstrated that the 
genipin gels are stable at room temperature and the crosslinking provides stable gels with 
lower concentrations of gelatin (Baldock et al., 2010). This type of gel is referred to as 
radiochromic crosslinked (Genipin-gelatin) gels. 
 
A major challenge in gel dosimetry is an artefact at the boundary between the gel and the 
container wall (e.g. plastic material) due to the optical refractive index mismatch between gel, 
container, and surrounding medium, which can readily interfere with readout signal. In order 
to eliminate any interference, a promising material for routine clinical 3D dosimetry is the 
radiochromic plastic based on clear polyurethane as the host plastic, combined with leuco-
malachite green (LMG); thereby eliminating the need for the container to retain a certain 
shape. This plastic polymer dosimeter was initially proposed by Adamovics’s group, its 
commercial product name is PRESAGE
TM
 (Adamovics and Maryanski, 2006). There has been 
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a continuous improvement in optical quality and tissue equivalence from different 
formulations (González et al., 1994, Sakhalkar et al., 2009, Guo et al., 2006, Gorjiara et al., 
2010, Mostaar et al., 2010, Alqathami et al., 2012a, Alqathami et al., 2012b) 
 
 
 
2.8 Readout modalities of 3D gel dosimeters 
Various imaging techniques have been implemented as readout modalities to evaluate 3D gel 
dosimeters including MRI, x-ray CT, optical CT, and ultrasound (Doran and Krstaji, 2006). A 
review of these readout systems can be found in literature – MRI (De Deene, 2004) , optical 
CT (Oldham, 2007), x-ray CT (Hilts et al., 2000), and ultrasound scanning (Mather et al., 
2002). Their principles, use and limitations are concisely summarised in this section. 
 
2.8.1 Magnetic resonance imaging (MRI) 
Nuclear magnetic resonance was the earliest preceptor to evaluate radiosensitive gel 
dosimeter, which was firstly implemented by Gore (1984). As ferrous (Fe
2+
) and ferric (Fe
3+
) 
ions possess different magnetic moments, the oxidation of Fe
2+
 to ferric Fe
3+
 after irradiation 
of a Fricke dosimeter results in radiation induced changes in nuclear magnetic resonance 
(NMR) relaxation. The concentration of the different ions, proportional to the delivered dose, 
affect the spin-lattice relaxation time (T2) and the spin-spin relaxation time (T1) of the 
hydrogen nuclei in the gel, implying that dose-dependency of NMR signal can be quantified 
then calibrated. Commonly the relaxation rate, either R1 (= 1/T1) or R2 (= 1/T2), can be 
determined in the gel, which can be reconstructed in 3D via magnetic resonance imaging 
(MRI). 
 
Similar in principle, polymer gels can be evaluated via NMR relaxation measurement, as 
radiation induced polymerisation of gel dosimeters results in the mobility change of protons 
within the gel. There are three different circumstances surrounding protons (Lepage et al, 
2001b): 
i) protons associated with free water and monomer molecules,  
ii) protons associated with the polymeric chains and  
iii) protons bound to the gel matrix  
The mobility of the protons within these circumstances differs, consequently the thermal 
motion of the molecules containing those protons changes between before and after 
irradiation. Therefore, the extent of polymerisation, proportional to the delivered dose, 
influences the spin-spin interaction of protons in the gel, implying that dose-dependency of 
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NMR signal can be quantified then calibrated. For further details regarding MRI scanning of 
polymer gels refer to (De Deene, 2004), as MRI imaging is a large field of research area itself. 
 
Accessibility is a major limitation on the use of MRI for gel dosimetry, mainly due to its high 
cost, which would not apply to a research centre having access to a MRI facility. Even when 
MRI is available for use, substantial time is required for proper setup and parameter 
optimisation, equalising the temperature of the gel to the MRI room etc. These factors 
highlight the limitations of using MRI, as patient diagnostics generally take precedence over 
research. Consequently, research is highly likely to be undertaken out of hours, which may be 
prohibited by the administering department. 
 
In order for alternative 3D gel dosimetry imaging systems to be attractive, they need to be 
easily accessible, fast reading, and low cost, such as x-ray computed tomography or optical 
tomography systems. 
 
 
2.8.2 X-ray computed tomography imaging 
An alternative read-out system of polymer gel dosimeters to MRI is x-ray computed 
tomography (CT) scanning, which is the most commonly employed imaging modality in 
clinics today. Hence, new equipment is not required nor is there any additional time 
consumption for training and familiarisation with the system at the same time being easily 
accessible as well as fast-reading. Hilts et al (2000) initially demonstrated the idea of 
employing CT for read-out of polymer gel dosimeters, in which the underlying principle is 
that a density change associated with radiation-induced polymerisation of polymer gels results 
in different photon attenuation. Although a dose-dependent change in Hounsfield unit (CT 
number) can be achieved, CT implementation as a read-out system for gels is significantly 
limited due to its very low dose sensitivity and high noise level, i.e. a poor contrast-to-noise 
ratio (CNR) or signal-to-noise ratio. For example, a change in CT number is less than  1 
Hounsfield unit per Gy for PAG dosimeters (Trapp et al., 2002). Even a further reduction of 
the dose sensitivity to > 0.4 HU per Gy has been reported for normoxic gel formulations (i.e. 
adding antioxidants), compared to the anoxic gel formulations (Jirasek et al., 2006).  
 
Nonetheless, a dose related image with a sufficiently high SNR in CT can be achieved 
through image averaging from a number of images acquisitions (in the order of 100 scans), 
and by applying an image post-processing technique such as image filtering correction (Hilts 
and Duzenli, 2004). The additional high dose delivered to gel dosimeters through multiple 
scans (on the order of 100) is problematic as well as the low sensitivity with x-ray CT as a 
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readout system for gel dosimetry. These limitations preclude the image averaging strategy 
from many scans while increasing dosimetric uncertainty (Hilts et al., 2000).  
 
Another imaging modality that may overcome some of the limitations of x-ray CT is optical 
computed tomography (OCT) discussed below. 
 
 
2.8.3 Optical computed tomography (OCT) imaging 
Optical computed tomography (OCT) has particularly driven a strong interest in gel 
dosimetry because of its attractiveness as an easy-access, fast-reading, and low-cost imaging 
modality (Gore et al., 1999). With MRI increasingly being seen as an expensive option, 
optical CT scanning, using either charge coupled devices (CCDs) (Krstajic and Doran, 2007a, 
b, 2006; Doran et al., 2001; Wolodzko et al., 1999; Jordan et al., 2001) or laser-based 
instruments (Gore et al., 1996; Kelly et al., 1998), have been rapidly developed and 
considered to play a significant role as a cost-effective and efficient readout system in 3D gel 
dosimetry.  
 
Optical CT uses the same principles as the more conventional x-ray CT, except that a visible 
light source is used instead of an x-ray source. The source is used to acquire 2D projections of 
the volumetric object through full 360
0
 degree views and reconstruct an attenuation map in 
the corresponding scanned volume using the 2D information. The main difference in the 
geometric setup of OCT is that an object rotates during the scan with a fixed or translating 
optical source and detector pair in optical CT (analogous to first generation x-ray CT). In 
contrast, conventional x-ray CT possesses an x-ray source aligned with a fully distributed 
‘fan’ detector array that rotates around a fixed object. Because of the nature of optical beam 
(visible light), gels must be (semi-) transparent, so that the optical beam can partially 
penetrate the object to allow the partial transparency of gel to be measured. Beer’s law relates 
the measured signal intensity I to the signal in the absence of the sample I0 as below, 
I = I0 exp [-∫ray-path (r) dr] = I0 exp(-∙r), (in the case of linear ray-path) (2-1) 
where (r) is the optical linear attenuation coefficient for each voxel, and r is a distance along 
the selected ray-path through the sample. The integrated optical density (OD), also called 
absorbance (A), is defined as  
 A = log10 (1/T) = log10 (I0/I)    (2-2) 
where T is the transmittance (I/I0). The optical density is related to the linear attenuation 
coefficient µ in the following manner, using Eq.(2-1): 
A=log10(I0 / I) = -∙r / ln(10)     (2-3) 
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Often the integrated OD is seen as a whole and defined as Eq.(2-2), in that case, OD has no 
units. However, in this work the definition: 
OD = A / r= log10 (1/T) / r = -µ / ln(10) ≈ -µ / 2.3026  (2-4) 
is used, in which case OD does have units and these may be expressed in terms of distance 
(cm
-1
). OD then becomes an integral property of the sample that is imaged on a voxel-by-
voxel basis.  
Δ, changes in optical density, can be mapped in the 3D volume of object, which are 
proportional to the absorbed dose (or can at least be related by a calibration curve). Optical 
density may be composed of either an absorption term (abs) or a scattering term (scat), 
depending on which term dominates the attenuation mechanism of optical beam through 
object (i.e. colour changes for abs, opacity changes for scat).  
 
For radiochromic gels or radiochromic plastics, the ionic conversion of dye element upon 
irradiation causes a shift in its absorption peak, and then the change in abs can be measured 
throughout the volume of objects. Depending on the reactant, the absorption peak is in 
different wavelength regions (e.g. the ultraviolet or visible regions – yellow and green) and 
the dose sensitivity can be varied (i.e. the slope of the optical density vs. dose relation can be 
increased or decreased) (Doran and Krstaji, 2006). The issue of ion diffusion not only smears 
out the edge of radiation field but also deviates the optical density in the volume irradiated. 
 
For polymer based gel, radiation-induced-polymerisation leads the gels to turn cloudy, a 
feature which is immediately apparent when polymer gels are irradiated, i.e. the gels become 
more opaque white with higher dose. When the gel is scanned, the incident optical beam is 
scattered off by the particles (polymer chains) of polymer created by the irradiation. The 
increase in scat can be measured for each voxel in the irradiated volume and the dose 
sensitivity can be optimized by adjusting polymer, co-polymer and gel composition 
depending on its use. Polymer gel is minimally subject to the ion diffusion due to a relatively 
large size of polymer-chain comparing to its matrix, however, it should be noted that 
deviations from Beer’s Law of attenuation occur for high concentrations of scattering 
particles. 
 
Despite the challenge of optical artefacts, the field of 3D gel dosimetry by optical CT has 
recently become more accessible through commercially available optical CT systems such as 
OCTOPUS
TM
 laser scanner (MGS Research Inc., Madison, Connecticut, USA) and Vista
TM
 
cone-beam scanner (Modus Medical devices Inc., London, Ontario, Canada). Different types 
of optical CT scanner are summarized in (Baldock et al., 2010). Several groups have reported 
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very successful 3D dosimetry verifications with the characterisation of systems for the laser 
scanner (Xu et al., 2003, Xu et al., 2004, Lopatiuk-Tirpak et al., 2008b) and for cone-beam 
scanner (Bosi et al., 2009, Olding et al., 2010, Olding and Schreiner, 2011), indicating that 
workable low-scatter regimes are feasible. 
 
 
2.8.4 Ultrasound imaging 
The change in acoustic properties of polymer gel dosimeters, associated with radiation-
induced polarization, has been also investigated, including the acoustic speed of propagation, 
ultrasonic absorption and ultrasonic attenuation. Such changes following irradiation of gels 
can be reconstructed with ultrasound imaging (Mather et al., 2002). This system was 
developed to evaluate irradiated dose distributions in 3D (Mather and Baldock, 2003). 
Although relatively easy-access, fast and low-cost, the source of contrast (i.e. change in 
elastic modulus and density) is very small thus a high SNR is hardly achievable. In addition, 
the inherent low resolution of the imaging modality (for normal ultrasound image being used 
in clinics) makes the merit of 3D ultrasound dosimetry a less preferred option.  
 
Although significant artifacts have been observed in the transmission image, which is mainly 
due to an acoustic impedance mismatch between water and gels, this evaluation method is 
still in early stages and there is still much room for improvement of image quality (Baldock et 
al., 2010). 
 
 
 
2.9 Final comments 
The discussion in this chapter has aimed to provide some challenges and complexities in 
contemporary radiotherapy and an understanding of the fundamental principles of 3D 
dosimetry. The existence of organ deformation associated with anatomic motion adds a 
further layer of complexity to the problem of inter- and intra-fractional variation in anatomic 
structures, which have not been fully investigated in current clinical practice. Organ 
deformation inherent in intra- and inter-fractional motion makes their resultant dose 
distributions difficult to measure and calculate. Consequent dosimetric uncertainties and 
inaccuracies in dose delivery may have detrimental outcomes for patients as a result of under-
dosage of the tumour or over-irradiation of healthy tissues in the immediate periphery of a 
targeted lesion. 
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Accurate volumetric dosimetry to deformable moving objects is therefore critical for the 
verification of advanced delivery techniques. Robust calculation methods for the prediction of 
radiation dose distribution in deformable moving objects is therefore crucial in order to 
improve treatment planning accuracy. Once both components are available, then appropriate 
evaluation of conventional 3D planning can be performed to determine the degree of error 
associated with the assumption of static geometry. 
 
3D dosimetry has been used for 3D complex dose verification as well as studying motion 
compensation techniques. Each variant of 3D dosimeter has its own specific features that 
make them preferred for certain applications. Currently Presage™ (Heuris Pharma LLC, 
USA) and BANG (MGS Research, USA) are commercially available and all other 
formulations require preparation by the users. Other considerations for material development 
for clinical usage include: ease of preparation and disposal, reproducibility, toxicity and raw 
material costs. Of possible readout modalities for gels, MRI was previously the most popular 
option, its use as routine dosimetry system in medical physics department is likely limited by 
time, expense and accessibility. Optical CT has been favoured in the research field for 3D 
dosimetry as dedicated instruments can be built at a cost several orders of magnitude less than 
that of an MRI scanner. Numerous conference papers highlight the advantages of optical CT 
gel dosimetry over other modalities (IC3DDose 2010 and IC3DDose 2012).  
 
In the next chapter, we show how normoxic polymer gel dosimetery was employed to develop 
a novel deformable dosimeter, with the ability to map dose in three dimensions and 
accumulate the dose delivered in multiple different states of deformation. Optical CT (OCT) 
was used as the readout modality, principally due to advantages associated with availability. 
A procedure for reproducible exposure and readout is described. 
 
In Chapter 5, it is shown how this deformable dosimeter can be used to experimentally verify 
dose deformation computation (i.e dose-warping). Because the results from dose-warping are 
critically dependant upon DIR performance, we first show in Chapter 4 a technique for 
quantitatively assessing the accuracy of DIR algorithm, in particular, in low-contrast regions. 
 
Lastly, the validated dose warping technique is applied in Chapter 6 to the case of liver 
stereotactic body radiotherapy, where the consequences of the redistribution of dose due to 
deformation are quantified for target and OAR doses respectively.  
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CHAPTER THREE  
: A novel 4D deformable dosimetry system 
 
The measurement of complex re-distribution of dose in deforming and 
moving targets 
 
 
 
“Retention rather than deterioration is the opposite of innovation.” 
Stephen M.R. Covey, the speed of trust 
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3.1 Overview of chapter 
The objective of this chapter is to demonstrate a novel methodology for 3D deformable dosimetry 
using the first fully deformable dosimetric gel phantom. This allows experimental measurement of 
dose delivered to volumetric deformable moving targets; thereby the dosimetric impact of 
deformation on the targets is investigated according to the geometry changing in time (i.e. 4D). 
 
To establish the utility of 4D deformable dosimetric gel phantoms, a series of studies is presented in 
this chapter. These relate to the characterisation of both physical and radiological properties, 
calibration of dose response of gels, robust structural integrity and reproducibility of deformation. 
This measurement tool is then used to perform quantitative analysis of the complex dose 
redistribution in 3D and dose accumulation upon consecutive irradiations in different states of 
deformation, to demonstrate the cumulative effect of deformation on the dose distribution of a 
clinically relevant composite field. 
 
3.2 A novel 4D deformable dosimetry system: Intro 
Image guidance is a key technique to develop more conformal approaches to restrict the treatment 
beam to the shape and location of the tumour being targeted. Image guidance not only improves 
patient setup but allows for adaptive radiotherapy (ART) to improve conformity. In either case, 
deformation of anatomy presents challenges to interpretation of the cumulative effect of fractionated 
delivery of dose.  In the non-adaptive case, the treatment is not altered, but the target organ and 
surrounding tissue may deform during treatment, or between fractions. One can then be interested to 
know what the cumulative dose distribution is both within the target volume and nearby organs at 
risk. In the case of adaptive radiotherapy, subsequent treatment beams may be made more conformal 
(Wu et al., 2002a) but the distribution and re-distribution of dose as the organ changes shape, or even 
size, is critical to controlling the prescription dose for local tumour control (Kron et al., 2010). The 
integration of subsequent dose delivered, with a non-identical fraction, is the goal. 
 
Mathematical algorithms which perform “dose warping” have been described (Janssens et al., 2009b, 
Zhong et al., 2008). For the most part, these algorithms apply a deformation vector field, derived from 
non-rigid image registration, to a dose distribution. Deformable image registration (DIR) is performed 
between images of the anatomy in different states of deformation.  The vector field that describes the 
“destination” co-ordinates of each pixel of the “before” image, is applied to the first TPS calculated 
dose distribution to predict the distribution in the “after” geometry. A number of studies have 
developed and validated methods for deformable image registration (Horn and Schunck, 1981b, 
Barron et al., 1994, Lu et al., 2004c, Thirion, 1998b, Rogelj and Kovačič, 2006) and dose calculations 
on deforming geometries (Schaly et al., 2004b, Rosu et al., 2005, Flampouri et al., 2006, Guerrero et 
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al., 2005, Velec et al., 2015). However, thus far no experimental means of validating three-
dimensional dose distributions delivered to deforming structures have been presented. 
 
Deforming phantoms have been developed for testing DIR algorithms, by being able to independently 
verify the position of specific features/points in each image (Serban et al., 2008, Kashani et al., 
2007a). Moving and deforming phantoms have had point dosimeters included for monitoring single 
dose reference points (Seco et al., 2010).  Two and three dimensional dosimeters (e.g. film and gel) 
have been incorporated into moving phantoms to assess “dose smearing” effects due to rigid motion 
only, but not deformation (Duan et al., 2006, Ceberg et al., 2008, Lopatiuk-Tirpak et al., 2008a). 
 
The novel deformable gel dosimeter (DEFGEL) described in this work enables, for the first time, the 
full 3-D experimental validation of both of these approaches: dose integration in a deforming target, 
and verification of dose warping calculations.  The high resolution 3-D dosimetry provided by 
radiochromic gels has been shown to be extremely valuable, particularly in small field dosimetry 
(Baldock et al., 2010, Taylor et al., 2011b).  Several shortcomings of other detectors can be overcome, 
such as detector volume averaging and coarse spatial sampling. 
 
The DEFGEL phantom can also provide an additional tool for validation of DIR to supplement the 
several published approaches (Kashani et al., 2007a, Kashani et al., 2008c, Wang et al., 2005c, Wang 
et al., 2005a). With DEFGEL, the particular case of a mass and density conserving deformation of a 
tissue-equivalent material is provided for.  This is likely to be relevant to a variety of anatomical 
cases.  The deformation-relaxation-deformation cycle is shown to be highly reproducible, and 
therefore useful for confirmation and validation of changes relative to known geometry.  
 
In this work, a modified version of the nPAG (Deene et al., 2006) polymer gel has been used as a 3D 
deformable phantom and dosimeter to investigate doses delivered to a deforming tissue-equivalent 
geometry. The deformable gel dosimeter/phantom is comprised of polymer gel in a latex membrane, 
moulded (in this case) into a cylindrical geometry and deformed with an acrylic compressor. 
Irradiations were performed coaxial and orthogonal to the axis of compression and resultant dose 
distributions were evaluated with the Vista™ optical cone beam scanner (Modus Medical Devices, 
London, Canada). Reproducibility of deformation was determined via fiducial marker implantation 
and x-ray CT imaging. The effect of deformation on absorbed dose distributions was investigated by 
applying beams to deformed and undeformed phantoms. Deformed phantoms were scanned before 
and after being released from compression and allowed to return to their undeformed states, for direct 
comparison with undeformed samples. Exposure of a single dosimeter in both deformed and 
undeformed states demonstrates the utility of the DEFGEL phantom as a dose fraction integrator 
accounting for organ/target deformation. 
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3.3 A novel 4D deformable dosimetry system: Method 
This section describes a modified nPAG formulation designed to be suitable for use in an elastic latex 
membrane container, and compatible for readout using OCT. The calibration procedure and 
radiological response properties of the gel are described. The deformation reproducibility of the gel is 
demonstrated before using the system to evaluate the dosimetric impact of deformations.  
 
3.3.1 Manufacture of DEFGEL 
The gel consists of a hydrogel matrix of 6 wt% (w/w) gelatine (from the porcine skin Type A, Sigma 
Aldrich Ltd, Oakville, Canada) in which 3 wt% (w/w) N,N’-methylene-bis-acrylamide (Bis) cross-
linking monomer and 3 wt% (w/w) acrylamide (AAm) monomer are dissolved (both monomers were 
obtained from Sigma Aldrich and are of electrophoresis grade). Bis [tetrakis (hydroxymethyl-
phosphonium)] sulphate (THP) as an antioxidant was added to the mixture in a concentration of 5 
mM. These polymer gels are henceforth identified according to literature convention as 6 % total 
monomers, 50 % cross-linker nPAG. Hydroquinone (HQ), a polymerization inhibitor, was added at a 
concentration of 0.01 mM, to compensate for oxygen permeation through the latex membrane which 
may occur to a greater extent than for nPAG in conventional polyethylene terephthalate (PET) 
containers. The monomers and gelatine were each pre-dissolved in DI water, which is 88% (w/w) of 
the total mass. The monomer solution was heated to 45 °C for 2 hours until all components were 
dissolved. The gelatine was soaked in water at room temperature for 15 min and allowed to swell. The 
solution was then heated to 45 °C, at which the gelatine dissolves. Subsequently, both solutions were 
cooled to 30 °C before mixing to prevent heat-induced polymerization. After mixing, the THP and 
HQ were added and the solution thoroughly stirred before pouring into the container. For calibration, 
900 ml of gel was transferred into a PET jar (Modus Medical Devices Inc, London, ON, Canada). For 
the deformation experiments, 110 ml of gel was transferred into the latex membrane. A cellulose-
acetate film cast was used to mould the DEFGEL into a cylindrical shape of 46 mm diameter.  After 
the gel was poured into containers, it was refrigerated at 4 °C for ~12 hours before irradiation.  
 
 
3.3.2 Dose readout: Optical computed tomography 
A cone beam optical CT (OCT) scanner (Vista
TM
 Optical Scanner by Modus Medical Devices Inc.) 
was employed in this study as a dose readout system. A brief description of OCT is provided here:  
 
The optical-CT consists of a light source and detector, placed on either side of the object to be 
imaged. The Vista OCT consists of a panel of LEDs shining through a translucent diffusing screen, 
illuminating (in transmission) a polyethylene terephthalate (PETE) screw-top jar (Modus Medical 
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Devices, London, Canada) which contains the medium to be imaged. The jar is mounted in an 
aquarium filled with refractive index matching liquid (12 wt% glycerol in deionised water), which 
acts as a refractive index matching medium to minimize the refraction of the transmitted light at the 
jar surface. A CCD camera takes snapshots of the transmitted image of the jar through a selectable 
wavelength filter. The scans are made with the program VistaScan (VistaScan Application © 2004 
Modus Medical Devices Inc.). These snapshots are used for the 2D measurements and as projections 
for the 3D reconstruction (see Figure 3-1). The program VistaRecon (VistaScan Application © 2004 
Modus Medical Devices Inc.) reconstructs the geometry of the image object according to Beers law).  
 
 
Figure 3-1 a) The schematic of cone-beam OCT scanner (Bosi et al., 2007), b) The cone beam scanner. 
 
The red LED light source (wavelength: ~633 nm) and bandpass filter pair were used. Camera gain 
was set to minimum, and shutter speed and frame rate were adjusted to 50 mps and 5.0 fps, 
respectively. Reconstruction using Feldkamp filtered back projection with high resolution mode (512 
projections) generated a CT array of 256 x 256 x 256 elements in 15 minutes using a dual processor 
3MHz PC. The reconstructed voxel size was approximately 0.86 x 0.86 x 0.86 mm
3
. The DEFGEL 
phantom was scanned within a PET jar filled with refractive index matching liquid (12 wt% glycerol 
in deionised water). Sample motion during scanning was eliminated by immobilising the DEFGEL 
via fixation of the cylindrical mould to the rotating jar. As the dosimeter reacts over a period of 
several hours after irradiation, a post-irradiation time of ~12h was chosen to ensure that the 
polymerization reaction was near completion at the time of imaging.  
 
 
3.3.3 Radiological properties and calibration of DEFGEL 
The radiological properties of gels have been well-studied, and they are generally considered to be 
‘water-equivalent’ (Venning et al., 2005c, Keall and Baldock, 1999). Here, the water equivalence of 
the new gel formulation is demonstrated using the energy-dependent effective atomic number method 
(Taylor et al., 2008, Taylor et al., 2009b) (see Section 3.4.1 DEFGEL: Calibration and properties). 
Irradiations were performed using a clinical linear accelerator (Varian 21EX). Each calibration PET 
jar was irradiated in a water tank with 6 MV photons at a source-to-surface distance (SSD) of 100cm 
(a) 
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and a dose rate of 600 cGy/min. The surface of gel in the container was perpendicular to the axis of 
the beam. Three 4 x 4 cm
2
 square fields were aligned on quarters of the jar with one quarter left 
unirradiated for the background dose calculation to account for cross talk (see Figure 3-2). Calibration 
using a large tub of gel with multiple fields has been shown to accurately represent dose to water to 
better than 1 % (Taylor et al., 2007b, Taylor et al., 2009a). Background radiation scatter was assumed 
to be linearly correlated with beam fluence and the weighted background-subtraction radiation 
scattering factor was calculated for each beam. Field edges were separated by 1 cm such that at Dmax 
the centre of each field was well beyond the range of secondary electrons from the adjacent fields, and 
the centre of each field was contained in the 90 % inner area of the PET jar. Using this method, 
irradiation doses of 0 cGy to 1889 cGy were delivered. Six vessels were used for this purpose and 
Figure 3-2 shows an example of the calibration arrangement.  
 
Figure 3-2 (a) Schematic of irradiations for calibration. (b) and (c) are examples of transverse planes of 
calibration samples: (b) irradiated with one 189 cGy field and two 472 cGy fields (i.e. the average of multiple 
measurements was used for each field to plot dose calibration curve, see Section 3.4.1), (c) irradiated with three 
different fields: 94, 283, 661 cGy. 
 
 
3.3.4 Reproducibility of deformation  
The reproducibility of the deformation state and the return to the rest state are important for the use of 
DEFGEL for applications involving DIR and dose integration. This is mainly because of two reasons: 
firstly, this is to correctly read out dose distribution from DEFGEL, i.e. the shape of DEFGEL should 
be identical between pre- and post- irradiation, so as to accurately measure dose integration between 
different deformation states; secondly, this is to use the same deformation for imaging and irradiation 
steps – particularly in the case for multiple irradiations or accumulation so that it enables to 
appropriately validate dose-warping calculation using DIR. To investigate possible displacement of 
the gel structure within the DEFGEL after deformation, phantoms were manufactured with 
Aluminium (Al) fiducial markers (FM) implanted into them and scanned with x-ray CT. Fifteen 
markers approximately 1-2 mm in diameter were implanted into the dosimeter during the gel setting 
phase (Figure 3-2 (a)). Marker sizes differed to aid in distinguishing them from each other. The 
phantom was scanned using a GE LightSpeed RT 4 slice, wide-bore CT scanner (GE Medical 
0.94 Gy 
2.83 Gy 6.61 Gy 
 
 
4 x 4 cm2 
 
PET Jar  
 
4 x 4 cm2 
 
4 x 4 cm2 
1cm 
1cm 
(a) (b) (c) 
4.72 Gy  
4.72 Gy  1.89 Gy  
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Systems, USA). The slice thickness and spacing were both 1.25 mm and a 150 mA/100 kV source 
was used.  
 
For a given deformation, the DEFGEL phantom (4.6 cm diameter) was compressed by 2.3 cm (a 
significant deformation) using an acrylic compressor, held for one second in that state, and then 
released. The pressure applied to each side was about 5.4 kPa (in atmospheric pressure condition). 
Using the in-room lasers and physical reference lines on the surface of the mould, the phantom 
position was replicated between scans; see  
Figure 3-3(b) and (c). 
 
A number of methods employing CT were used to establish reproducibility. Several DEFGEL 
phantoms with fiducial markers were deformed and CT scanned between deformations. Between CT 
scans the deformation was conducted 1, 10, 20, 30, 40, and 50 times (i.e. 151 in total). For the first 
set, all scans were undertaken with the DEFGEL in the undeformed state to examine the 
reproducibility of the return to the undeformed state. The procedure was repeated with another set, 
with the DEFGEL scanned in the deformed state each time to confirm the reproducibility of the 
compressions. A series of control scans were also undertaken. In the latter case, DEFGEL phantoms 
that had undergone no deformations were scanned and analysed in the same fashion to quantify the 
set-up error contribution to any observed shift. FM locations were evaluated by identifying the 
position of maximum intensity of all fifteen FMs in each scan (relative to an absolute reference 
position) using DoseLab version 4 (created by Nathan Childress, Ph.D., and Isaac Rosen, Ph.D., 
University of Texas, M.D. Anderson Cancer Center, Houston, TX) and Image J (National Institute of 
Health, Bethesda, Maryland, USA). FM locations were also determined relative to each other to 
isolate set-up error.  
 
 
Figure 3-3 (a) DEFGEL phantom (b) DEFGEL with fiducial markers and (c) setup for CT scanning of the 
DEFGEL with deformation using the acrylic compressor. 
 
 
c) b) 
 
a) 
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3.3.5 Deformation and irradiation  
DEFGEL samples were deformed in a controlled manner with the use of a parallel-plate acrylic 
compressor. The cylindrical samples were deformed such that their circular cross section became 
ellipsoidal.  
 
Two sets of irradiations are presented here. The first set of 3 samples was irradiated with a simple 1 x 
1 cm square field to illustrate the re-distribution of dose in a regular field (representative of a single 
beamlet) arising from the change in state of deformation. The beam was incident coaxial with the 
cylindrical samples and perpendicular to the direction of compression as illustrated in Figure 3-4. To 
observe pronounced effects of deformation, the distance between the two plates was set to 2.3 cm 
(half of the phantom’s diameter). DEFGEL phantoms were irradiated in three scenarios: (1) without 
deformation, (2) with deformation and (3) irradiated twice: first in the deformed state, then after 
release of the compression, in the undeformed state to integrate the cumulative dose.  
 
A second pair of samples was irradiated with a small stereotactic plan of three dynamic arcs adapted 
from a patient plan, to demonstrate the ability of DEFGEL to quantify severe under- and over-dosage 
associated with target deformation. 8.97 Gy was delivered to isocentre – half of the clinically 
prescribed dose, to remain near the centre of the calibration range. The treatment was delivered to an 
undeformed DEFGEL and also to a deformed sample. The sample deformation in this case was a 
compression from 46 mm to 30 mm. 
 
Samples were irradiated within a water bath to remove dosimetric effects of surface curvature. All 
doses were delivered with a Varian 21EX (VARIAN Medical Systems, Palo Alto, CA, USA) clinical 
linear accelerator, using 6MV photons at 600 cGy/min at an SSD of 100 cm. Figure 3-4 indicates the 
three scenarios described for the first set of 3 samples. For the second set of 2 samples, only the first 
two scenarios apply. 
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Figure 3-4 Arrangements of DEFGEL irradiation coaxial with the axis of the DEFGEL (and perpendicular to 
the direction of compression). The beam direction is indicated by the gray arrow. The gray hexahedrons in each 
figure represent the simplified dose distribution in the DEFGEL after irradiation. (a) and (b) correspond to 
irradiation of an undeformed DEFGEL (Scenario 1) and the deformed DEFGEL (Scenario 2), respectively. (c) 
corresponds to Scenario 3 - irradiation with and without deformation, resulting in an accumulated dose 
distribution. 
 
(a) Scenario 1: Undeformed. Irradiate and read out. 
(b) Scenario 2: Irradiate deformed. Read out undeformed. 
(c) Scenario 3: Irradiate deformed. Irradiate undeformed. Read out undeformed. 
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3.4 A novel 4D deformable dosimetry system: Results 
3.4.1 DEFGEL: Calibration and properties 
The radiological properties of DEFGEL closely represent that of water, as indicated in Figure 3-5. 
The energy-dependent effective atomic number is calculated for both electron and photon interactions 
between 10 keV and 10 MeV. The maximum discrepancy between DEFGEL and water is roughly 1.5 
% (in the low energy regime), indicating good water equivalence. The mass density of the gel is 0.969 
± 0.024 gcm
-3
.  
  
 
 
Figure 3-5 The energy-dependent effective atomic number (Zeff) of DEFGEL, plotted with water for 
comparison, and the ratio of the two (presented on the right axis) for (a) photon interactions and (b) electron 
interactions. Calculations were performed using the method of Taylor et al(Taylor et al., 2008, Taylor et al., 
2009b). The greatest discrepancy in both cases is ~1.5 %, indicating good water-equivalence. 
 
The dose response curve is plotted in Figure 3-6. The optical density at Dmax (~1.6 cm) was chosen for 
the plot, consistent with the requirements for minimal systematic error (Taylor et al., 2007b). The 
detection limit is approximately 30 cGy and dose sensitivity is 0.02 cm
-1
Gy
-1
. The R
2
 value is 0.9994 
implying a desirable linear dose response up to the maximum measured dose of 1889 cGy. The high 
degree of linearity although having a somewhat lower dose sensitivity coefficient compared with 
other gel formulations (Oldham et al., 2001, Wuu and Xu, 2006), indicates that the addition of HQ 
leads to an overall reduction of dose sensitivity due to scavenging of free radicals generated during 
water radiolysis while not resulting in an increase in threshold dose before polymerisation response. 
The optical density for 0 cGy was acquired by scanning an unirradiated dosimeter and averaging the 
value throughout the effective volume. For doses up to 500 cGy, the values plotted represent the 
average of multiple measurements. The error bars in Figure 3-6, (±1 of  two to three measurements 
per each point) are smaller than the symbol size.  
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Dose response curve at D max 
y = 0.0002x - 0.0028
R
2
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Figure 3-6 The optical density (cm
-1
) as a function of dose for DEFGEL is plotted. The detection limit is 
approximately 27 cGy and dose sensitivity is 0.02 cm
-1
Gy
-1
. The R
2
 value is 0.9994 indicating a strong linear 
relationship. The error bars (±1 of two to three measurements per each point) are smaller than the symbol size. 
The inset depicts the 0-500 cGy region with error bars. 
 
Dose distributions in exposed DEFGEL phantoms are highly stable. Repeated scans after 3 months 
and 6 months show no change in OD or penumbra sharpness in dosimeters stored at low temperatures 
(refrigerated at ~4 °C).  
 
 
3.4.2 Reproducibility of deformation  
Figure 3-7(a) and (b) show a 3D rendering of CT data of a DEFGEL phantom (containing Al FMs) in 
a non-deformed state (without compressor) and deformed state (with compressor), respectively.  
   
Figure 3-7 This figure shows the volume rendering of the DEFGEL phantom with fiducial markers implanted 
(a) without deformation and (b) with deformation. For reference, the same fiducial marker is encircled in red in 
both images. 
 
Two methods were employed for CT data analysis, as described in the Methods section. In the first 
instance, a comparison of the position of each FM relative to a reference point was undertaken. An 
illustration of this idea is shown for an example case in Figure 3-8. Figure 3-8 (a) and (b) show the 
DEFGEL before (left image) and after (middle image) 50 deformations, respectively, and the 
b) a) 
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difference (right image) indicates very good agreement. Example line profiles through the FMs of 
Figure 3-8(a) are provided in Figure 3-9 for both directions: (a) vertical and (b) horizontal. These 
show excellent agreement between maximum intensity peaks corresponding to fiducial marker 
locations before and after deformation (i.e. the two curves are almost perfectly overlapped). The pixel 
resolution of each image was 0.488 mm derived from image size/pixels (= 250 mm / 512). 
 
 
Figure 3-8 An example of fiducial marker location agreement (a) without compression and (b) with 
compression. The left column corresponds to the CT image before deformation, the middle column after 50 
deformations and the right column represents the difference between the two images. The scale bar is 10 mm.  
 
 
Figure 3-9 (a) horizontal and (b) vertical line profiles through the marker locations of Figure 7(a). The solid and 
dashed lines indicate the line profile before and after 50 cycles of deformation, respectively. The nearly identical 
line profile before and after deformation implies the deformation cycle was highly reproducible. The centroid of 
each peak was used as position coordinates to identify the location of each marker. 
 
The centroids of the peaks were used as the x, y and z coordinates of each marker. The z coordinates 
were obtained by rotating the sample 90° and repeating the CT scan to give the same resolution as for 
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the x and y coordinates. The shift of each marker was calculated after 1, 10, 20, 30, 40 and 50 
repetitions of the compression described in Section 3.3.4 Reproducibility of deformation. The mean 
absolute displacement of all markers is shown in Table 3-1. There is clear indication that all markers 
returned to their initial locations to within 0.15 mm (σ = 0.22 mm, maximum shift = 0.98 mm, the 
latter corresponding to two pixels). The control group shown in Table 1 was not deformed between 
repeated imaging, showing that the variations observed for the deformed cases are due only to setup 
error associated with aligning the samples with the CT alignment lasers. This illustrates that the 
DEFGEL returns to its initial undeformed state reproducibly, even after many compressions. Rows 3 
and 4 of Table 1 show analogous data for the sample in its compressed state. This shows the 
reproducibility of the compressed state.  
 
It is important to note that absolute values are shown in Table 3-1, i.e. the difference is not 
systematically higher. If positive and negative values are compared, the mean position differences are 
zero. The reason that the mean shifts are invariably less than the resolution is that the majority (77 %) 
of markers exhibited zero shift, 22 % exhibited a shift of one pixel, and in one case two pixels. The 
table indicates perfect deformation reproducibility, with all differences clearly being attributable to 
typical CT set-up error.  
 
Table 3-1 This table indicates the reproducibility of deformation of the DEFGEL. dabsolute refers to the shift (in 
mm) of ‘peak position’, i.e. the shift in fiducial marker location relative to a fixed reference point. drelative refers 
to the difference in the relative separation of fiducial markers. The DEFGEL phantoms were CT scanned in 
either deformed (Def.) or undeformed (Undef.) states as indicated. Control DEFGEL phantoms (that had 
undergone no deformations) were also evaluated for comparison. 
 
DEFGEL 
Scanned in state: dabsolute| (mm) drelative|(mm) 
Def. Undef. Mean Max.  Mean Max. 
Post-deformation   0.154 0.691 0.216 0.064 0.369 0.089 
Control (no def.)   0.226 0.988 0.242 0.061 0.280 0.107 
Post-deformation   0.251 0.691 0.233 0.065 0.450 0.081 
Control (no def.)   0.233 0.988 0.262 0.082 0.369 0.096 
 
 
To isolate the effect of setup error, the positions of all markers were also assessed relative to an 
arbitrarily chosen reference marker within the sample. Mean shifts were less than 0.1 mm with a 
standard deviation in the order of 0.1 mm. This confirms the reproducibility of the 
deformation/relaxation cycle, and that observed variations are due to setup effects.  
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3.4.3 Deformed dose distribution 
In the first irradiation scheme, the beam was incident upon the end of the cylindrical DEFGEL 
phantom. The cylinder was laterally compressed orthogonal to the cylinder and beam axes. Isodose 
contours are shown in Figure 3-10 for a plane through the depth of maximum dose for each of the 3 
deformation scenarios. Figure 3-11 shows line profiles through the same plane at the locations 
indicated by dashed lines in Figure 3-10, labeled A-A’, B-B’, and C-C’ respectively. 
 
The dose distributions corresponding to the undeformed (Scenario 1) and deformed (Scenario 2) states 
of the DEFGEL phantom were compared. A third arrangement involved irradiation of a DEFGEL in 
both deformed and undeformed states (Scenario 3). This demonstrates the capacity for integrative 
dosimetry over different states of deformation. 
 
 
 
Figure 3-10 Dose distributions for coaxial irradiation. (a) represents the schematic of irradiation. The gray 
arrow indicates the direction of the beam applied. Plane at Dmax was chosen for all cases. Three different 
scenarios are shown: (b), (c) and (d) correspond to scenarios 1, 2 and 3 respectively. Deformation/relaxation was 
applied along the y-direction for scenarios 2 and 3. Accumulated absorbed dose distribution in the DEFGEL 
phantom of scenario 3 is shown in figure (d). Isodose curves at 10% increments of maximum dose are displayed 
(10 to 90%). The grid spacing is 4.28 mm. Dashed lines along the y direction A-A’, B-B’ and C-C’ are plotted 
as line profiles in Figure 3-11. 
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Figure 3-11 Dose profiles corresponding to the dashed lines along the y direction A-A’, B-B’ and C-C’ 
in Figure 3-10. (a) shows the expected profile for this simple field in a sample without deformation (b) 
shows the significant dose redistribution that occurs as a result of the change in deformation state. (c) A 
line profile across the twice-irradiated DEFGEL shows the non-trivial profile arising from the 
integration of the 2 fields. 
 
When the sample is deformed, mass also moves in directions other than that of the applied 
compression. Dose redistribution in the z-direction is illustrated by depth dose (DD) plots in 
Figure 3-12. Curve A (dotted line) is the ‘normal’ DD curve on the central axis (CAX) of the 
undeformed sample. Curve B (solid line) shows an off-axis DD curve through the point of 
maximum dose of the deformed sample. Curve C (dashed line) shows the resulting DD curve 
on the central axis of the deformed sample, which no longer contains the point of maximum 
dose.  
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Figure 3-12 Depth Dose profiles for several different cases: (A) on the central axis of the sample 
without deformation (B) off axis through the point of maximum dose in the deformed sample. (C) on 
the central axis of the deformed sample. 
 
 
Figure 3-13 Dose distributions of three orthogonal planes for the stereotactic field irradiation. a), b) 
and c) show coronal plane dose distributions of Scenario 1, Scenario 2 and the difference of Scenario 1 
and 2, respectively. d), e), and f) correspond to the sagittal plane, and g), h) and i) to the transeverse 
plane. Compression & release was applied in the y-direction as indicated in Figure 3-4. Maximum 
doses were 9.17 and 9.03 Gy for Scenario 1 and Scenario 2, respectively, the difference being due to 
attenuation by the compressor used for Scenario 2. All doses are in Gy and the grid spacing is 5 mm. 
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Results for the second irradiation, the adapted patient plan, are shown in Figure 3-13. Three 
orthogonal planes through isocentre are shown for each of the deformed and undeformed 
samples. A dose difference map is also shown for each plane to demonstrate the ability to 
quantify the discrepancies arising due to deformation.  
 
 
 
3.5. A novel 4D deformable dosimetry system: Discussion 
The investigations of reproducibility have confirmed not only that there is no shift or 
displacement of in-structure geometry of the phantom resulting from the deformation, but also 
that the employed deformation method is highly reproducible. This validates the use of the 
released sample as equivalent geometry to an uncompressed sample. As only the two 
endpoint states of the compression cycle were of interest, hysteresis effects were not explored. 
These might be of interest in dynamic or multi-phase studies where intermediate states are 
important. 
 
Scattering effects, which have been associated with OCT scanning of polymer gels, are much 
lower in DEFGEL than we have encountered with other gel formulations. This is mainly 
attributable to the lower sensitivity of DEFGEL (due to lower monomer concentrations used) 
and the consequent lower total optical density of small field samples. Thus, light transmission 
dominates scattered light intensity – these are the conditions identified by Bosi et al (Bosi et 
al., 2007) as criteria for avoiding cupping artefacts. Fields of a few cm width in DEFGEL 
yield optical path length products (geometric path length x OD) in the order of 0.1. This is 
approximately a factor of 5 below the value at which Olding et al (Olding et al., 2010, Olding 
and Schreiner, 2011) have identified the onset of discernible cupping  (9 cm x ~0.05 cm
-1
). 
‘Doming’, attributable to scattering in the medium surrounding the field, illuminating the 
distal interface of a high OD region (also described by Bosi et al (Bosi et al., 2009)) is not 
seen in DEFGEL measurements of small fields. Small DEFGEL samples are scanned while 
suspended in the commonly used PETE jars (supplied by Modus Medical for use with Vista 
OCT) which are filled with the same RI matching fluid as outside the jar in the tank. Thus the 
vast majority of surrounding material is optically clear, and the scattering contribution is 
negligible. In summary, neither cupping nor doming artefacts, were observed in either 
calibration fields or sample measurements. However, the calibration jar (irradiated with 4x4 
cm
2
 field) and the measured 1x1 cm
2
 field in the DEFGEL phantom have similar scatter 
perturbation in the measurements that somewhat cancel out one another but not perfectly. 
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Hence, there is still an inherent uncertainty present in the absolute dose measurement due to a 
non-linear scatter perturbation with its reasonable expectation of 2-3% that will affect 
uniformly across the overall dose distribution. This may limit deformable polymer gel 
dosimetry to achieve an accurate absolute dose measurement within 3% uncertainty. In any 
future work this can be improved by correcting background scatter perturbation in calibrated 
measurement data. With larger fields measurements, the simplest approaches to reduce 
scatter-sourced stray light perturbation could be increasing the scanner light source 
wavelength into the infrared but also developing a new gel formulation and/or modifying the 
current formulation to reduce the dose contrast sensitivity as well as scatter attenuation 
background. However, both options will result in lower signal-to-noise ratio that is an 
inevitable trade-off to supress stray light perturbation. Alternatively, laser scanning method 
can be also used for larger fields. 
 
A preliminary examination of 2x2 cm
2
 field irradiation on undeformed DEFGEL shows that 
dose profiles of 2x2 cm
2
 field are well agreed with the corresponding TPS profiles, 
demonstrating there were no more confounding scatter effects present on 2x2 cm
2
 case 
compared to 1x1cm. It is also recommended that for the study of larger field sizes (therefore 
requiring larger phantoms than those used in this work) one should scale the doses delivered 
to maintain a pathlength-OD product below 0.45 (corresponding to a pathlength-dose product 
of 22.5 cm∙Gy). For such larger phantoms, the presence of doming is not easily predicted and 
should be explicitly tested for. One strategy for reducing its influence would be to work with 
phantoms no larger than needed for the fields to be used taking into account a margin of 
approximately 1 cm to avoid the usual optical artefacts associated with container walls.  
 
Figure 3-10 and Figure 3-11 show dose distributions and profiles from irradiation with the 
beam coaxial to the cylindrical phantom and perpendicular to the applied compression. Panel 
(b) of Figure 3-10 depicts the plane through Dmax for the undeformed case. Note the rounding 
of the expected square field. This illustrates the deficiency of the TPS at accurately estimating 
the lateral electron disequilibrium and collimator scatter for these small fields (of which 
results shown in Chapter 5) (Yeo et al., 2012). This has been confirmed in the study 
performed by our research group with Monte Carlo simulations which agree better with the 
gel results than with TPS calculations In the study, the Monte Carlo simulation of the 
treatment delivered to the phantom containing the gel was run on a 608-core high-
performance computing cluster, using the BEAMnrc and DOSXYZnrc codes with a model of 
the Varian iX linear accelerator and BrainLab m3 micro-MLC. A comparisons was performed  
between TPS (iPlan i.e. pencil beam calculation), MC (BEAMnrc), and the gel measurement 
in a heterogeneous head phantom Target statistical accuracy was 0.5% with voxel size of 0.5 
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× 0.5 × 0.5 mm
3
. Similar monte carlo verification of gel over TPS has been also been 
observed by Kairn et al. Gamma analysis with stringent acceptance criteria (2%/1mm) reveals 
that the passing rate is 10% higher for the comparison of the measurement and Monte Carlo 
results then for that of measurement and TPS results. This result provides valuable 
confirmation that although there are regions where the dose distribution obtained from the gel 
differs from the treatment planning prediction, the gel measurement nonetheless provides an 
accurate measurement of the dose, as calculated via Monte Carlo simulations (Kairn et al., 
2012, Yeo et al., 2012). 
 
For the case where a deformed sample was irradiated and allowed to release back to its rest 
state, a plane through Dmax  is shown in Figure 3-10 (c).  Note that this plane is through the 
point of maximum dose in the irradiated volume, and that this does not occur on the central 
axis (CAX) as might be expected, nor at the usual expected depth for this energy (≈ 16mm for 
6MV) but at 20.5 mm.  This demonstrates the complex spatial re-distribution of dose that can 
occur as a result of a change in shape of a target between irradiations, even for a relatively 
simple deformation.  Dose deposited near the CAX has moved outwards in the direction of 
the released compression.  The net result is a re-distribution of dose in all 3 dimensions. 
 
To illustrate the complexity of trying to calculate such a re-distribution, Figure 3-12 shows 
depth-dose profiles through each of the points B and C indicated, overlaid with a “normal” 
DD curve through the CAX of the undeformed sample (A). One can see the foreshortening of 
the DD curve on the CAX (C) and the re-shaping of the DD distribution off axis through (B). 
In Figure 3-10 (d), the capacity for integrative dosimetry is illustrated.  In this scenario (3), 
the sample has been irradiated twice with the same 1 x 1 cm beam – once in each state of 
deformation.  The plane through the point of maximum dose is shown, which in this case is at 
a depth of 16.2 mm as in the undeformed case. This situation arises because the maximum 
dose points from the deformed irradiation actually move beyond the boundaries of the 
nominal field. In the general case, the summation will be difficult to predict without a direct 
3-D measurement such as that made possible with the DEFGEL. 
 
For the adapted patient plan, Figure 3-13 depicts a comparison between the treatment 
delivered with and without deformation. For calculating dose difference maps, the pairs of 
distributions are registered to sub-mm accuracy using the latex container boundaries as shown 
in Figure 3-8. In this case, the deformation consisting of compression and release in the y-
direction can be seen to elongate the field in the y-direction coupled with contraction of the 
distribution in the x- and z-directions. Substantial dosimetric discrepancies are seen in all 3 
planes up to approximately 3 Gy, or ~30 % of the maximum dose delivered. 
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The use of DEFGEL for studying the effects of deformation on absorbed dose distributions is 
valid for mass and density conserving deformations. Obvious anatomical examples would 
include prostate, breast, liver etc. The relevant anatomical deformations would be those 
related to organ shifts induced by filling and emptying of bladder, rectum, stomach etc as well 
as respiratory and cardiac motion. The method and results presented here may not be 
applicable to the case of target organ atrophy for example over the course of treatment, where 
the notion of dose as a surrogate for biological response becomes complicated by changing 
target mass and volume. 
 
The effect of deformation on absorbed dose is of significant clinical relevance. Consider, for 
example, the prostate – which deforms up to half a centimetre in the anterior-posterior 
direction, with a 10-20 % variation in rectal volume (Kerkhof et al., 2008b, van der Wielen et 
al., 2008). From the results presented in this work, it is clear that under such circumstances 
(where the volume is compressed) one would expect the target volume to receive a lower dose 
than that calculated for the undeformed volume, with the adjacent tissues receiving a higher 
dose than otherwise expected. The general consequence is thus that organ deformation may 
influence the target coverage and organ-at-risk sparing. The DEFGEL phantom has the 
potential to quantify such issues of under/over-dosage. 
 
The deformable gel model is reasonably adaptable. The cost of this model is relatively low: 
approximately AUD$7 for each DEFGEL sample. Furthermore they are highly reproducible 
and it is possible to fabricate many of them with the same batch of gel.  
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3.6 Conclusion of this work 
This chapter has introduced 4D deformable dosimetry using a 3D volumetric deformable 
polymer gel, ‘DEFGEL’, as the first inherently coupled deformable dosimeter and phantom.  
In summary, this work has: 
 Developed the first three-dimensional, tissue-equivalent deformable integrating 
dosimeter. 
 Demonstrated robust structural integrity and reproducibility of deformation even after 
hundreds of deformations. 
 Demonstrated experimentally that a change of geometry due to deformation can 
induce a significant change in the absorbed dose distribution and that such a change 
can be measured.  
 Shown that consecutive irradiations delivered in different states of deformation can 
be integrated and read out as a single distribution.  
 Verified that multiple CT-scanning does not impact on sensitivity. 
This work has obvious potential for a number of applications, such as verification of 
deformable image registration, validation of dose warping strategies based on DIR, and the 
evaluation of motion compensation strategies in radiotherapy.  
 
The following chapter assesses mathematical tools used to register two images of a deforming 
object in different deformed states. Specifically, the performance of such algorithms when 
employed to calculate deformed dose distribution is systematically investigated. 
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CHAPTER FOUR  
: Deformable Image Registration 
 
Calculation of geometrical change and dose-warping 
 
 
 
“The Physics is real…you just have to explain it.” 
Rick Franich’s 2nd Law, the author’s primary supervisor 
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4.1 Overview of chapter 
For adaptive radiotherapy it is common to collect images of the patient throughout the course 
of therapy. Because of temporal variations, images from different modalities (e.g. CT/CBCT, 
PET, MR) are overlaid to create a correlation map between pixels in the images. Deformable 
image registration (DIR) can be used to correctly account for temporal variations. Such image 
registration methods exist and their calculations are, in general, driven by high-contrast 
regions such as bony anatomy or landmarks and interpolations between them. Hence, the 
analysis of registration accuracy in low-contrast regions is somewhat questionable, as image 
computation algorithms rely on high-contrast marks, i.e. the analysis can be circular. 
Knowing the registration accuracy in low-contrast regions is necessary for implementation of 
this tool in dose deformation algorithms in adaptive radiotherapy. 
 
The present work is an investigation of the spatial accuracy of deformable image registration 
(DIR) algorithms in low-contrast regions, aiming to establish the efficacy of using DIR as 
dose deformation algorithms (Mathematical Model), i.e. a means of dose-warping.  To 
achieve this requires an understanding of the principles and mathematics underlying the 
various DIR methods and algorithms.  This knowledge is required to ascertain which methods 
are likely to be most effective for dose-warping using our deformable dosimeter/phantom and 
form a shortlist of the vast number of algorithms to investigate. This chapter outlines 
theoretical aspects of developing a DIR algorithm in the first half (Section 4.2). Subsequent 
sections illustrate experimental results detailing the validation of DIR algorithms. In both 
sections, work by other authors is discussed to contextualise the present work. 
 
The following is a list of major terminologies for DIR used in this chapter: 
 
DIR = Deformable image registration 
Moving image = source image = data image = secondary image, 
Fixed image = target image = reference image = primary image, 
Deformed image = calculated image = predicted image = registered image, 
VOI = volumes of interest, 
DVF = Deformation vector field. 
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4.2 A review of DIR: Non-rigid image matching 
This section outlines principles of deformable image registration and work by other authors 
on validation of DIR algorithms, illustrating the broad range of approaches and the difficulty 
in determining a robust method for the quantitative analysis of DIR accuracy.   
 
4.2.1 Why DIR?: Choosing the right type of algorithm 
Organ motion is being dealt with via a number of strategies in contemporary radiothrapy 
(Keall et al., 2006, Langen and Jones, 2001, Keall et al., 2005). The clinically-driven 
requirement of image-matching for dealing with organ deformation over the past few decades 
has resulted in the development of a range of deformable image registration (DIR) algorithms, 
which are starting to become available as an option in commercial treatment planning 
systems. It is difficult to determine the number of clinics routinely employing such 
methodologies, but the growing research interest in deformable image registration within the 
context of medicine can be qualitatively indicated by the increasing number of publications in 
recent years i.e. from 70 in 2000-2005 to 244 in 2006-2010 and up to 520 in 2011-2015
†
. 
 
Image registration transforms the points in one image to their corresponding points in the 
other. The transformation can be conducted in several ways such as global or local, rigid or 
deformable. Rigid registration methods only allow six degrees of freedom (translations and 
rotations along the x, y, and z axes). When the shapes of target volumes and organs at risk 
(OARs) change, simple rigid-body correction techniques may not be sufficient for accurate 
registration. In contrast, deformable image registration (DIR) algorithms enable an alignment 
of two image sets that are mismatched in a non-linear or non-uniform way. They compute the 
deformation vector fields (DVFs) that uniquely map each voxel in the deformed anatomy 
(source image) to a corresponding voxel in the reference anatomy (target image).  Such 
mathematical tools can be particularly useful for a wide variety of applications such as i) 
image fusion from multi-modality, ii) geometrical change measurements in organs over time, 
iii) dose warping to map dose distribution corresponding to geometrical deformation that is, in 
particular, of interest in the present study. 
 
Attempts to contend with organ deformation in image-guided and adaptive radiotherapy 
dosimetry often involve the implementation of DIR algorithms (Samant et al., 2008, von 
Siebenthal et al., 2007, Klein and Huesman, 2000, Lu et al., 2006a, Zhong et al., 2008, Davis 
et al., 2005). Mathematical algorithms which perform ‘dose warping’ have been described 
                                                     
*
 as reflected by a PubMed search of deformable image registration, broken into several year periods. 
There are less than 10 publications prior to 2000. 
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(Zhong et al., 2008, Janssens et al., 2009b, Nehmeh et al., 2002). Typically, these algorithms 
apply deformation vector fields (DVFs) derived from non-rigid image registration to a dose 
distribution calculated by a treatment planning system (TPS). DIR is performed using images 
of the anatomy in different states of deformation. As DVFs describe the voxel-to-voxel 
relationship between the “source” and the “target” images, a small discrepancy in this vector 
can significantly influence the warped dose, particularly at high dose-gradient regions.  
 
DIR algorithms are available for a wide variety of applications. There are several approaches, 
but most techniques can be broadly categorized as either ‘‘point-based’’ or ‘‘intensity-
based’’(Maintz and Viergever, 1998). Matching is an essential task for many computerised 
image applications. A clear definition can be given for rigid or articulated bodies: it is to 
recover rigid displacements of rigid parts. The task is much more complicated for deformable 
objects with plastic (incompressible) or elastic (compressible) deformations. In this case, 
there is not a single definition of an ideal optimal match, but as many definitions as practical 
applications. Each time, one has to define precisely the set of deformations T which are 
explored (rigid, affine, spline, free-form etc), and the type of features which are used (points, 
curves, surfaces, intensities etc, in which curves and surfaces are an extended concept of 
point-based, so essentially these can broadly be grouped into two types: point-based or 
intensity based).  
 
 
4.2.2 The concept of “attraction” in image registration: an analogy with force and 
energy in thermodynamic concepts 
The energy in Newton’s thermodynamics is defined by the integral of force applied for given 
displacement. A very intuitive way to consider image-to-image matching is based on an 
analogy with attraction ‘force’ for measuring the displacement of the two images. One 
example is gravitation: a point P of the deformable model M is attracted by all the points P' in 
a static image S which are similar. For example, let K(P, P') be a similarity criterion, and D(P, 
P') a function of the distance (not necessarily Euclidean), ), the force f

on P, induced by the 
attraction of all the points of S can be expressed as: 

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M is deformed according to these forces, and also according to smoothness constraints 
internal to M. Such a method is computationally too expensive [O(n
2
)]. A less expensive 
method is to retain in the computation only one principal attractive point of S: a point P of M 
is attracted by the point P' of S which is the ‘closest and most similar’ to P. We perceive in 
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this definition that a balance between being ‘close’ (distance criterion) and being ‘similar’ 
(similarity criterion) must be determined. For example, in some methods, only contour points 
are used, and contour points in S are equally similar to contour points in M, making proximity 
the most important factor (see below figure).  
 
Figure 4-1 A schematic of deformable model with attraction. 
 
Then, calculations of (rigid and/or non-rigid) image registrations aim to minimise the integral 
of force for given images. This is the case for iterative closest point (ICP) methods; see Besl 
and McKay (1992) and Zhang (1992) for the rigid case. This is also a basic assumption in the 
‘snakes’ method introduced by Kass et al. (1987). This model is a controlled continuity spline 
under the influence of image forces and external constraint forces (high contrast such as bony 
anatomy and bifurcation or artery). The internal spline forces serve to impose a piecewise 
smoothness constraint. The image forces push the snake toward salient features like lines, 
edges, and subjective contours. The external constraint forces are responsible for putting the 
snake near the desired local minimum. These forces can, for example, come from a user 
interface, automatic attentional mechanisms, or high-level interpretations; more details are in 
Kass et al.(1987) see also Blake and Yuille (1992) for a review of these techniques. 
 
 
4.2.3 Point-based techniques 
Point-based techniques implement various transformation models including thin-plate splines 
(Bookstein, 1989), elastic body splines(Kohlrausch et al., 2005, Fornefett et al., 2001), B-
splines (Rohlfing et al., 2004b, Rueckert et al., 1999, Schnabel et al., 2003), free form 
deformations (FFD) (Lu et al., 2004b) and combinations (e.g. B-spline free form deformation) 
(Rietzel et al., 2005). These techniques, in principle, aim to match the deformed anatomy 
(source image) with the reference anatomy (target image) by minimizing the distance between 
features such as points, curves or surfaces of corresponding anatomical structures either 
manually or automatically. For identifying these features, detection/extraction process for 
Deformable 
model M 
Static image 
S 
Points attracted by the static image S 
Line of attractors 
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both images usually requires a certain amount of human interaction and it may result in 
potential error (Want et al 2005), it can be also time consuming. Moreover, point-based 
methods are based on physical models to follow the changes in anatomy. This requires 
consideration of the material properties and heavy computation demands. Once the 
deformation applied to the identified landmarks is known, the movement of the remaining 
voxels is calculated by interpolation. To be practical for use in radiotherapy it is desirable for 
DIR methods to be fully automated, able to handle large deformations, fast and, most 
importantly, accurate. This excludes the point-based methods that require manually selecting 
a large number of landmarks (Castadot et al 2008) although these methods are faster than 
intensity-based methods when performing image registration because they usually operate on 
a sparse set of features. However, the time spent on feature extraction can still be significant 
and error prone as mentioned above. 
 
 
4.2.4 Intensity-based techniques 
Intensity-based algorithms use pixel or voxel data directly, assuming that image intensities 
alone contain enough information for image registration. These techniques are particularly 
attractive and time-efficient to solve the problem of intra-modality deformable registration 
because the attraction force for matching images is based on the gradient of intensity of each 
voxel (not based on certain interpolation method e.g. affine, b-spline or thin plate spline). 
Therefore, intensity-based methods do not require feature detection/extraction and instead use 
similarity measures such as the root mean square error or mutual information between the 
images or it uses apparent motion of brightness patterns (optical flow)- and hence can be fully 
automatic.  
 
The well-known Horn and Schunck (Horn and Schunck, 1981a) (HS) algorithm, Lucas and 
Kanade (Lucas and Kanade, 1981) (LK) algorithm, combined HS-LK algorithm (Bruhn et al., 
2005a) and variations of the iterative optical flow algorithm (Barron et al., 1997, Lu et al., 
2004a) all fall into the intensity-based category along with the demons algorithm method. The 
latter incorporates the Thirion (Thirion, 1998a) algorithm, accelerated demons (Wang et al., 
2005b) algorithm, symmetric force demons (Rogelj and Kovacic, 2006) algorithm and several 
variations. It is worthy to note that these algorithms are widely available as Matlab 
(MathWorks, Natick USA) scripts and also conveniently accessible using the DIRART code 
developed by Yang et al (Yang et al., 2011b) for various applications such as image 
registration, auto-segmentation of anatomical structure contours, dose warping and dose 
accumulation. 
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Similarity measures for template (image) matching 
Intensity-based similarity measures work by optimising similarity functions based only on 
voxel values (not landmarks) with one of the simplest methods being the sum of squared 
differences (SoSD) between the source image, S, and the target image, T. The use of SoSD 
was motivated by the distance measure (the squared Euclidean distance=d) 
        
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where N is all pixels of 2D image or voxels of 3D in the region/volume of overlap between 
the source image S and the target image T which is shifted by j relative to image S. S(i) is the 
intensity (gray value) of the i
th
 voxel in the source image and T(i) is the intensity of the 
corresponding voxel in the target image. In this context, we assume similarity is measured 
after a rigid registration i.e., the amount of shift (j) is zero. In expansion of d
2
, 
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the term  )(2 iT  is constant as it is the target (reference) image. If the term  )(2 iS  is 
approximately constant then the remaining cross-correlation term  


Ni
iTiSc )(  is a 
measure of the similarity between the image S and T. SoSD is only suitable for single 
modality registration as it is highly sensitive to large differences in brightness at the 
corresponding voxels. SoSD is an appealing choice as it allows for fast optimisation schemes 
making it computationally very efficient.   
However, there are several disadvantages to using cross-correlation term for template 
matching: 
 In case of examining some part of a whole image, if the image energy  )(2 iS  
varies with position, then matching using cross-correlation (= c), is dependent on the 
absolute value of intensity i.e., similarity measurement can fail. For example, the 
correlation of exactly matching region between the images S and T may be less than 
the correlation of bright spot between the two images.  
 The range of c is dependent on the size of the feature.   
 Cross-correlation term, c is not invariant to changes in image amplitude such as those 
caused by changing background signal (or intensity) across the image sequence. 
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Pearson’s correlation coefficient (CC) overcomes these difficulties by normalizing the image 
and feature vectors to unit length, yielding a cosine-like correlation coefficient, which is 
defined as 
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S  and T  are the voxel intensity averaged in the considered volume N; |N| denotes the total 
number of pixels/voxels of the set N. The cross-correlation (CC) can be applied as a measure 
of similarity if there is a linear relationship between the brightness levels of the two images. 
CC allows the same optimisation techniques as SoSD and is therefore computationally fast 
however, again, cannot be used for multi-modality registration as a global linear 
transformation of the brightness levels in the two images cannot be assumed (Kaus and 
Brock, 2007). 
 
The Dice similarity index (DSI) can be also used to compare volumes of interest (VOI) in the 
reference (=target) image to the corresponding volumes in the moving (source) image after 
deformation. The DSI indicates the overlapping ratio between the two VOIs. It is defined as  
||||
||2
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(4-5) 
where A and B are the two sets of voxels (Dice LR, 1945). The perfect match between the 
volumes of interest gives a DSI of unity, whereas two disjoint volumes lead to a DSI of zero. 
 
 
 
4.2.5 Apparent motion of brightness (intensity) patterns  
4.2.5.1 The Optical flow method  
Optical flow is the distribution of apparent velocities of brightness pattern movements within 
an image (tracking the movement of high brightness gradients). The Optical flow method 
(OFM) was originally developed and studied for use in computer vision to perform video 
processing, object tracking and motion estimation between two successive frames in time. It 
has been adapted for use in three-dimensional image registration where the two images are 
not successive frames in time. This means that the velocities of the individual voxels actually 
have no time component and can be considered displacements. It is more general to consider 
v

 as being simply a displacement. In the last two decades the quality of optical flow 
estimation methods has increased dramatically. Starting from the original approaches of Horn 
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and Schunck (Horn and Schunck, 1981) as well as Lucas and Kanade (Lucas and Kanade , 
1982), research developed many new concepts for dealing with shortcomings of previous 
models. In order to handle discontinuities in the flow field, the quadratic regulariser in the 
Horn and Schunck model was replaced by smoothness constraints that permit piecewise 
smooth results (Deriche et al 1996, Schnorr 1994 and Weichert 2001). Some of these ideas 
are close in spirit to methods for joint motion estimation and motion segmentation (Farneback 
2001 and Mémin 2002), and to optical flow methods motivated from robust statistics where 
outliers are penalised less severely (Black 1991, Black 1996). Coarse-to-fine strategies 
(Anandan 1989, Black 1996, Mémin 1998) as well as non-linearised models (Nagel 1986 and 
Alvarez 2000) have been used to tackle large displacements. Finally, approaches to include 
temporal changes into spatial information have improved the results simply by using the 
information of an additional dimension (Nagel 1990, Black 1991, Weichert 2001 and 
Farneback 2001). 
 
However, not only new ideas have improved the quality of optical flow estimation techniques. 
Efforts to obtain a better understanding of what the methods do in detail, and which effects 
are caused by changing their parameters, gave an insight into how several models could work 
together. Furthermore, various derivative formulations of models gave access to the long 
experience of numerical mathematics in solving partly difficult optimisation problems. 
Finding the optimal solution to a certain model is often not trivial, and often the full potential 
of a model is not used because concessions to implementation aspects have to be made. 
 
In the context of medical physics, optical flow became a name given to a broad category of 
deformable image registration algorithms (Zhang et al, 2008) in which the intensity gradient 
based approach is the most commonly applied. A mathematical formulation for the optical 
flow method, including its constraints and associated fundamental assumptions, is derived in 
Appendix I.  
 
4.2.5.2 Demons method  
The demons method uses optical flow as an intermediate step to attraction based techniques 
by analogy with Maxwell’s demons. In this implementation, each image is viewed as a set of 
iso-intensity contours. Having two images to match, the main idea is that a regular grid of 
forces deforms an image by pushing the contours in the normal direction. The orientation and 
magnitude of the displacement is derived from the instantaneous optical flow equation. The 
main idea is to consider the object boundaries in one image as semi-permeable membranes 
and to let the other image, considered as a deformable grid model, diffuse through these 
interfaces, by the action of effectors situated within the membranes.  
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Figure 4-2 Diffusing models: a deformed image, considered as a deformable grid, is diffusing through 
the contours of the objects in the static image, by the action of effectors, called demons, situated in 
these interfaces (image reproduced from Thirion, 1998). 
 
There are two approaches to using the demons algorithm:  The first approach is to consider 
the contour of the object in the reference (target) image, R, to be a membrane with demons 
placed along the contour (where the boundary of the object is determined from the gradient of 
the brightness pattern). The demons will pull (attract) points on the object in the moving 
(source) image, M inside the contour in R using optical flow to estimate the “demons forces” 
(Thirion, 1998b). The second approach is to put a demon at every voxel location and calculate 
the “demons force” (again, estimated using optical flow) required to push the voxels in M to 
match R (Wang et al., 2005e).  
 
A mathematical expression of Thirion’s demons method is provided in Appendix I. For more 
details, the interested reader is referred to numerous studies of the demons algorithm for use 
in medical image registration (Guimond et al., 2001, Wang et al., 2005e, Xie et al., 2003). In 
these studies the demons algorithm is assessed using mathematically altered images or patient 
images. 
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4.3 Assessment of DIR algorithms performance: Intro 
When DIR is used for radiotherapy purposes, validation of the accuracy of a given DIR 
algorithm is necessary to make sure there is no misinterpretation in imaging analysis (e.g. 
image fusion or image shift). There are different ways of trying to validate DIR algorithms, 
each with its own challenges. Such options include i) physical phantoms and ii) patient CT 
images relying on high-contrast landmarks (bony anatomy or bifurcations). The first option 
can be criticised in that its results may not be directly related to actual scenarios (i.e. patient 
images); in contrast, the latter may have absence of knowledge of the ground truth, 
particularly in between landmarks used for validation (i.e. low-contrast region). 
 
4.3.1 Validation using physical phantoms 
A number of studies have demonstrated quantitative evaluation of the DIR accuracy using 
different strategies, including contour conditions, surface interfaces and implanted landmarks 
(Wang et al., 2005d, Coselmon et al., 2004, Rietzel and Chen, 2006, Lu et al., 2006b). Some 
other works also include biomechanical properties for multi-organ deformations (Schnabel et 
al., 2003, Zhong et al., 2007). Various deformable lung phantoms with known physical 
deformation have also been used (Cherpak et al., 2011, Seco et al., 2010, Nioutsikou et al., 
2006, Kashani et al., 2007c, Walimbe and Shekhar, 2006, Chang et al., 2009), in which the 
phantom motion can be accurately measured with identifiable land marks.  
 
Wang et al. (2005) validated the original demons algorithm (as proposed by Thirion (1998)) 
by registering CT images of a pelvic phantom with and without an endorectal balloon 
inflated. 23 fiducial markers were implanted and used to assess spatial disparity. The demons 
algorithm was found to track the fiducial markers to an accuracy of ~0.8 mm. This result is 
consistent with the case they tested on pelvic CT images of a patient obtained on two separate 
days. 
 
A novel method for verifying DIR algorithms in two dimensions was developed by Kirby et 
al. (2011), whereby a phantom representing a single plane of anatomy in a head and neck 
patient was used.  A balloon catheter inside the phantom could simulate tumour growth while 
CT and camera images were taken before and after the deformation.  Non-radiopaque fiducial 
markers on the surface of the deformable anatomy were visible through an acrylic plate, 
which enabled an optical camera to measure their positions; thus, establishing the ground 
truth of deformation. This measured deformation is directly compared to the predictions of 
DIR algorithms, using several similarity metrics. The ratio of the number of points with more 
than a 3 mm deformation error over the number that are deformed by more than 3 mm was 
 72 
used for an error metric to evaluate algorithm accuracy.  Different deformation errors resulted 
from the different similarity metrics.  The most accurate deformation predictions had an error 
of 75 %. 
 
 
4.3.2 Validation using patient CT 
Various studies directly applied DIR to patient CT image sets or digital phantoms generated 
by Monte Carlo simulation then investigated the accuracy of DIR based on high-contrast 
features such as bony anatomy and bifurcations (Lu et al., 2004b, Coselmon et al., 2004). 
Castadot et al. (2008) conducted a study into 12 different DIR strategies based on intensity-
based measures including the demons algorithm, level-set and fast free-form. The strategies 
were assessed using five patient CT data sets (imaged once before and once during treatment). 
Registrations were performed in both directions (chronological and anti-chronological) and 
were evaluated using a volume-based criterion (Dice similarity index) and an intensity-based 
criterion (cross-correlation) on manually contoured volumes. It was found that for both 
evaluation methods the strategies utilising the demons algorithm performed best. 
 
 
4.3.3 Using DIR for calculation of accumulated dose in a deforming object 
Calculation of dose deformation using DIR – dose-warping, which is the topic of the next 
chapter – is of particular interest in adaptive radiotherapy (ART). This results in attempts to 
embed a dosimeter within physical phantoms for validation of such calculations, which can 
provide an additional point comparison between source and target images for validation of 
DIR algorithms (i.e. the location of an embedded detector and its dose measurement readings). 
 
Several studies have made use of deformable phantoms with one and two-dimensional 
dosimeters (ion chambers, radiosensitive film, diodes and MOSFET). The demons DIR 
algorithms were evaluated by Janssens et al. (2009) in order to apply it to dose accumulation. 
A deformable cubic silicon phantom with implanted markers and a cylindrical silicon 
phantom with MOSFET detectors were used. The phantoms were deformed and images were 
acquired using a cone-beam CT imager. Dose calculations were performed on the CT scans 
using the treatment planning system and DIR was performed using the two different 
phantoms. The resulting DVF was applied to the dose distribution. For both phantoms, 
resultant warped dose distributions were compared to the original plan in order to investigate 
how much change could occur. For the cylindrical phantom, measured dose values in the 
deformed conditions were compared with the dose values of the registered dose distributions. 
Finally, interfraction dose accumulation for two treatment fractions of a patient with primary 
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rectal cancer was performed and evaluated using isodose lines and the dose volume 
histograms of the target volume and normal tissue.  A significant decrease in the difference in 
marker or MOSFET position was observed after registration (p < 0.001) for both phantoms 
and with both methods, as well as a significant decrease in the dose estimation error (p < 0.01 
for the cubic phantom and p < 0.001 for the cylindrical) with both methods. 
 
A number of different approaches to using deformable image registration as a method of 
calculating accumulated dose distributions in deforming anatomy have been proposed that 
utilise Monte Carlo simulations. Heath and Seuntjens (2006) and Peterhans et al (2011) 
proposed direct voxel tracking methods for lung tumours.  This method tracked the position 
and shape of each dose voxel as the anatomy changed resulting in irregular (non-rectilinear) 
voxels. The DOSXYZnrc Monte Carlo code was modified by the authors to calculate dose in 
voxels that are deformed according to DVFs obtained from DIR. The def-DOSXYZ code was 
validated by comparing calculations using DOSXYZnrc performed with no deformation of 
the phantom. These results agreed to within 1%, on average, indicating that the modifications 
made to the DOSXYZnrc code do not introduce any statistically significant errors; however 
the computation times were greatly increased due to the handling of irregular voxels. The 
method proposed by Peterhans et al. is essentially the same as that by Heath and Seuntjens 
however it is a modification of the Swiss Monte Carlo Plan framework rather than 
DOSXYZnrc. 
Calculations in deforming phantoms were compared with the dose remapping method 
employing trilinear interpolation described by Rosu et al. (2005). The trilinear method 
underestimated the dose by up to 25% within the field for a phantom consisting of 1 mm 
voxels and a 2 x 2 cm
2
 incident beam. Larger discrepancies occurred in the penumbra region. 
Dose differences within the field were increased to up to 29%, for the same voxel size, for 
beam incidence perpendicular to the direction of deformation. The discrepancies reduced with 
decreasing voxel size and deformation magnitude.  
 
 
4.3.4 Concluding thoughts and a summary of method used in the present study 
Assessment of DIR algorithms used for a wide variety of applications, in practice, cannot rely 
on a single metric. A review of published literature reveals that although a great amount of 
work has been put into assessing the accuracy of DIR algorithms, the use of DIR for dose-
warping has never been validated by comparison to measured high resolution 3D dose 
distributions. This study delves into several DIR algorithms that are available in the public 
domain for research purposes and were determined to most likely yield accurate deformation 
 74 
vector fields (DVFs) from images of our deformable phantom. Note that in this context the 
image registration is in three dimensions, which is the extended version of 2D method that it 
historically originated from. 
 
Studies developing DIR algorithms and/or validating these algorithms have used one or more 
of the aforementioned strategies and usually rely on identifiable markers, such as bony 
anatomy or implanted fiducial markers (FMs). However, these markers are high contrast 
features and hence positively influence the DIR result. This implies that analysis of these 
points may not be representative of the global DIR accuracy. They are nonetheless important 
to the field, as the accuracy of dose warping will be highly dependent on the accuracy of the 
DIR used to effect it. 
 
Different operational parameters, used with the same algorithm, can also affect the 
registration accuracy (Samant et al., 2008, Klein and Huesman, 2000, Lu et al., 2006b). This 
implies that using automated, standard or default settings may not give estimates with the 
greatest accuracy, suggesting a need for parameter optimisation. Several popular tool-kits 
such as Computational Environment for Radiotherapy Research (CERR) (Deasy et al., 2003), 
Insight Tool Kit (ITK) (Shelton et al., 2005) and Deformable Image Registration and 
Adaptive Radiotherapy (DIRART) (Yang et al., 2011c) include the capability of adjusting 
various parameters. DIRART with the associated published technical note has attracted a 
great deal of attention – the code has been downloaded more than 1400 times over the last 
few years
‡
. DIRART implements three main classes of intensity based DIR algorithms: 
Optical flow methods (Horn and Schunck, 1981b, Bruhn et al., 2005b, Barron et al., 1994, Lu 
et al., 2004b, Yang et al., 2008), demons algorithms (Thirion, 1998b, Wang et al., 2005d), and 
level-set motion algorithms. There exist multiple variations for each class. Available software 
applications for clinical use do not necessarily facilitate such flexibility in algorithm selection 
or parameter optimisation while DIRART allows parameters setting to be adjusted so that 
each algorithm can be optimised for its best performance. 
 
Previous studies pertaining to anatomic change have focused on tumour motion in the lung, as 
this leads to major discrepancies between daily images and treatment plans (Nehmeh et al., 
2002, Jenkins et al., 2005a). Phantom studies have thus involved lung-like models with 
compressible elements, e.g. sponge (Cherpak et al., 2011, Seco et al., 2010, Nioutsikou et al., 
2006, Kashani et al., 2007c, Chang et al., 2009). In contrast, only a few studies have been 
                                                     
‡
 The number of source code downloads was obtained from: 
http://code.google.com/p/dirart/ in May 2015. 
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undertaken with involving incompressible deformable phantoms which could give insight into 
deformation of organs such as pancreas, prostate, liver, breast etc. 
 
Through the work described in the previous chapter (Chapter 3), a tissue equivalent, mass and 
density preserving deformable gel dosimetric phantom – dubbed DEFGEL was developed. 
This previous work enables the measurement of dose in deforming geometries. The next 
primary interest, as a natural logic, is to use the measurement of dose in deforming geometries 
for the validation of dose-deformation operations, whereby doses are morphed based on 
deformation matrices generated by DIR algorithms. However, clearly the accuracy of such an 
approach is critically dependent upon the accuracy with which DIR algorithms are able to 
morph the geometry of interest. Consequently, it is important to investigate the accuracy of 
available algorithms. The remainder of this chapter demonstrates a qualitative and 
quantitative evaluation process to systematically investigate a range of DIR algorithms in 
terms of their capacity to generate accurate DVFs for representative examples of deformation 
of DEFGEL phantoms. 
 
 76 
4.4 Assessment of DIR algorithms performance: Materials and Method 
This section describes a qualitative and quantitative evaluation process to systematically 
examine a range of DIR algorithms in terms of their capacity to generate accurate DVFs, 
particularly in low-contrast regions. CT images of DEFGEL phantoms with 16 implanted 
fiducial markers (FMs) implanted were acquired in deformed and undeformed states for three 
different representative deformation geometries. Non-rigid image registration was performed 
using 12 common algorithms already in the public domain. The optimum parameter setup was 
identified for each algorithm and each was tested for deformation accuracy in three scenarios: 
(I) the original images of the DEFGEL with all FMs; (II) images with half of the FMs 
mathematically erased; and (III) images with all FMs mathematically erased. The deformation 
vector fields (DVFs) obtained for all scenarios were then applied to the original images 
containing all 16 FMs. The locations of the FMs estimated by the algorithms were then 
compared to the actual locations as determined by CT imaging. The accuracy of the 
algorithms was assessed by evaluation of 3D vectors between true marker locations and 
predicted marker locations. The influence of the amount of visible information was assessed 
by interpretation of markers that had been erased and therefore did not contribute to driving 
the calculation. 
 
4.4.1 DEFGEL phantom and deformation 
Chapter 3 describes a deformable, tissue-equivalent, dose-sensitive gel phantom dubbed 
‘DEFGEL’ for use in deformable dosimetry. In this work, it is the first two properties that we 
exploit to assess the accuracy of a number of common deformation algorithms. The phantom 
consists of DI water of 88 wt% (w/w) and a hydrogel matrix of 6 wt% (w/w) gelatin in which 
3 wt% (w/w) N,N’-methylene-bis-acrylamide (Bis) cross-linking monomer and 3 wt% (w/w) 
acrylamide (AAm) monomer are dissolved. This formulation is identical to that used for the 
previous work. The tissue equivalence of DEFGEL was confirmed by two properties: (i) its 
mechanical properties: physical density of ~1 g/cm
3
 and Young’s modulus of ~2 kPa 
(Mahaffy et al., 2000), and (ii) its fundamental radiological properties (based on energy-
dependent effective atomic number) (Taylor et al., 2012) which match tissue up to a 
maximum discrepancy of ~1.5 % (see Figure 3-5) for a very broad range of photon and 
electron energies.  
 
To investigate displacement of the internal structure after deformation, sixteen Aluminium 
(Al) fiducial markers (FMs) approximately 1-2 mm in diameter were implanted into the 
DEFGEL during the gel setting phase. Some markers were made slightly larger than others to 
aid in distinguishing them from each other. The gel was poured into a thin latex membrane 
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and a cellulose-acetate film cast was used to mould the DEFGEL into a cylindrical shape of 
46 mm diameter. It was then refrigerated at 4 °C for 12 hours before being scanned with x-ray 
CT.  
 
CT images of the DEFGEL phantom used in this study feature a similar degree of 
contrast/uniformity and HU intensity as several relevant organs. Figure 4-3 below shows 
profiles taken from images of DEFGEL and patient organs of relevance. Table 4-1 
characterises these via their mean HU and standard deviation over a 60 mm profile. 
 
Figure 4-3. Profiles taken through low contrast interior regions of DEFGEL and several organs/tissues 
illustrating comparable levels of HU (offset at zero to air, as used in treatment planning system) in 
terms of both mean value and noise. Fat tissue is also shown for comparison, exhibiting similar noise at 
a different HU level. 
 
Table 4-1 Mean CT number (HU) and standard deviation from CT images of DEFGEL and several 
organs/tissues which would be considered ‘low contrast’ within their visible boundaries. Mean and Std 
Dev are taken over a 60 mm linear profile selected to be interior to the organ/tissue/DEFGEL 
boundary. 
Organ: 
HU 
DEFGEL 
Fat 
tissue 
Liver Pancreas Kidney Prostate Stomach 
Small 
bowel 
Diaphragm 
Mean: 1027 935 1030 1033 1026 1030 1026 1026 1027 
Std Dev: 15.6 12.5 17.0 12.4 13.2 11.5 16.7 20.1 16.0 
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We applied a series of deformations representative of those observed in anatomical images, 
i.e. the encroachment on target volumes by adjacent anatomy featuring a displacement or 
expansion by a convex curved surface (such as in the case of a filling organ). We have 
considered three variations that describe a range of possibilities:  
(i) a bilateral compression of equal displacement from both sides;  
(ii)  an asymmetric bilateral compression where the convex indentation from one side causes a 
larger displacement; and  
(iii) the combination of a symmetric bilateral compression with an asymmetric indentation of 
the type described in (ii).  
These configurations cover geometric deformations featuring two, one, and zero axes of 
symmetry in the deformed volumes respectively as well as a range of displacements and 
directions of marker movement. Each of the deformations was applied by purpose-built 
acrylic rigs and the compressions were applied principally in a direction perpendicular to the 
central axis of the cylindrical phantom as indicated in Figure 4-4. 
 
The reproducibility of the deformation and the return to the rest state are important for 
applications involving DIR and dose integration. The previous chapter shows reproducibility 
of deformation for hundreds of deformations of a single DEFGEL to the order of ~100 m, 
which is the same level of accuracy in the absence of any deformations (see Figure 3-9 and 
Table 3-1).  
 
 
Figure 4-4. The reference (undeformed cylinder) and three geometric deformations employed in this 
study. The maximum deformation displacements (3D vector) are 11.3, 19.9 and 9.4 mm for 
Deformations 1, 2 and 3 respectively. The coordinate system associated with the phantom is such that 
the z-axis is parallel to the axis of the cylinder (out of the plane in bottom row). The deformations were 
applied principally in the y-direction. 
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4.4.2 Data collection and processing 
The DEFGEL phantom (with 16 implanted FMs) was scanned coaxially in deformed and 
undeformed states for each deformation type using a GE LightSpeed RT, wide-bore CT 
scanner (GE Medical Systems, USA). The slice thickness and spacing were both 1.25 mm and 
a 150 mA/100 kV source was used. The voxel resolution was 0.488 x 0.488 x 1.25 mm
3
. To 
obtain a finer resolution in the third dimension the phantom was rotated 90° and scanned a 
second time orthogonally. This effectively gave a resolution of 0.488 mm in all three 
directions, where the x- and y-coordinates of markers were obtained from the coaxial scan 
and the z-coordinate from the orthogonal scan.  
 
The DICOM image files were converted to .mat files for use in DIRART via CERR (Deasy et 
al., 2003); an open-source toolkit developed using Matlab. Right-Left (RL), Anterior-
Posterior (AP) and Superior-Inferior (SI) were associated with x, y and z directions 
respectively (see Figure 1) as per DIRART convention. The FM locations were evaluated for 
both image sets – deformed and undeformed – by identifying the position of local maximum 
intensity (HU), using DoseLab version 4 (Childress and Rosen, University of Texas, M.D. 
Anderson Cancer Center, Houston, TX) and Image J (National Institute of Health, Bethesda, 
Maryland, USA).  
 
 
4.4.3 Assessment of DIR algorithms 
This study investigates twelve of the most commonly used algorithms in current clinical 
practice. Of these, most are intensity based, and can be grouped into four types: a free form 
deformation algorithm (Lu et al., 2004b), two variants of the level-set motion algorithm 
(Vemuri et al., 2000), four variants of the optical flow algorithm (Horn and Schunck, 1981b, 
Bruhn et al., 2005b, Barron et al., 1994, Yang et al., 2008), and four variants of the demons 
algorithm (Thirion, 1998b, Wang et al., 2005d, Yeo et al., 2008, Rogelj and Kovačič, 2006). 
We have deliberately used the DIRART implementations of these algorithms as these are 
freely available in the public domain. In addition to these 11, the point-based b-spline 
algorithm employed in the commercial software package VelocityAI (Velocity Medical 
Systems, Atlanta USA) has also been evaluated.  
 
Several of the algorithms investigated (as described later in Results) failed to adequately 
register even the boundary shape of the phantom. This paper focuses on the seven highest 
performing algorithms: original Horn and Schunck (Horn and Schunck, 1981b), combined 
Horn-Schunck and Lucas- Kanade (Bruhn et al., 2005b), inverse consistent Horn and Schunck 
 80 
(Yang et al., 2008), iterative optical flow (Barron et al., 1994), Thirion’s original demons 
(Thirion, 1998b), accelerated demons (Wang et al., 2005d) and modified demons (Yeo et al., 
2008). Notably, these are all classed as either optical flow or demons algorithms.  
 
To establish the optimum DIR performance for each algorithm, various parameters were 
systematically adjusted: four multi-grid stages were used (n = 1, 2, 3 and 4) with 10n 
iterations per pass, while the number of passes for each stage was systematically varied. 
Coarser stages were typically run with a greater number of passes to improve the agreement 
with the target image prior to resampling at finer resolutions (Yang et al., 2009). Ultimately, 
this corresponded to up to 72 pass criteria combinations per algorithm. Agreement was 
assessed in terms of the minimum difference from the target image for each calculation. 
Beyond an optimum number of passes, the difference tends to increase, with the observed 
effect generally being a ‘smearing’ of the image. Smoothing during a given iteration (2 in the 
optical flow equation (Horn and Schunck, 1981b) or low-pass filter window size of the 
Gaussian filter for the demons algorithm (Thirion, 1998b) along with smoothing after each 
pass, multi-grid stage and final stage (of the Gaussian low-pass filter applied to the DVF) 
were also systematically adjusted. The influence of these parameters was assessed using 3D 
vector errors associated with the calculated FM positions relative to the actual positions 
known from direct measurement (Section 4.3.2). The optimum parameter set for each 
algorithm was tested against small perturbations to verify that the change in mean error 
remained within < 0.24 mm implying absolute convergence within the intrinsic uncertainty 
resulting from the voxel size (~0.49 mm). 
 
After establishing the optimum parameters for each algorithm, the effect of the presence of 
high contrast FMs on deformation accuracy was investigated. This was accomplished for each 
algorithm by performing registrations for each deformation type in three scenarios: I) The 
original images of the DEFGEL with all 16 FMs. II) Images with eight of the FMs 
mathematically erased. III) Images with all of the FMs mathematically erased. The FMs were 
“erased” by replacing the relevant volumes with an array of nearby voxels so as to give a 
similar intensity distribution and noise level to regions of the DEFGEL where no FMs were 
present. Line profiles through the region of erased markers were inspected to ensure that no 
contrast feature remained, nor was introduced, which might influence the outcome of the 
algorithm in that region. As the required number of passes to achieve convergence may be 
image content dependent, convergence for the images with erased markers was explicitly 
confirmed via the method above. The parameters determined using the original images were 
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then used consistently in each scenario, to quantitatively assess the effect of high contrast 
features (rather than parameter setting changes).  
 
The DVFs obtained for scenarios II and III were applied to the scenario I data (which contains 
all 16 FMs). The purpose of this is to assess the accuracy of the calculated deformation in 
regions of low-contrast, where the DVF was generated without the influence of fiducial 
markers.  The spatial accuracy of the algorithms was assessed by calculating the magnitude of 
the 3D vectors between the calculated FM positions and their corresponding measured 
positions. This process is outlined in Figure 4-5. 
 
 
 
Figure 4-5 An example of the typical workflow for quantitative comparison of calculated and reference 
image sets in deformed geometries. In this case, the effect of deformation into an oblate shape is 
investigated (Deformation 1). Before performing registrations, 8 FMs and 16 FMs are erased from both 
source and target image sets for scenario II and scenario III, respectively. Raw image sets which have 
all 16 FMs are used for scenario I. Once DIR is performed, the source image is morphed from the 
oblate shape to the cylindrical shape to match the target image (calculated image 1). Another output of 
the DIR is a deformation vector field (DVF). This DVF is applied to the raw source image (rather than 
the image where FMs were erased) to generate calculated image 2. We compare all FM positions of 
this calculated image to those of the reference image. The mean and standard deviation of the 
displacement errors are used to evaluate the level of accuracy.  
 82 
4.5 Assessment of DIR algorithms performance: Results 
4.5.1 Determination of optimal parameters  
The first assessment of the DIR algorithms was to test whether the general shape of the 
boundary or contour of the DEFGEL phantom could reasonably be calculated. As shown in 
Figure 4-6, the original level-set motion, double force demons, free form and affine 
approximation of level-set motion algorithms were unable to replicate the DEFGEL contour. 
With the exception of the double force demons, it was observed that the optical flow category 
and demons category algorithms performed reasonably well, matching surface contours 
between the target image (undeformed state) and calculated image very well. This can be seen 
in the difference maps in which the target image was subtracted from each of the calculated 
images after DIR respectively (see Figure 4-6). Algorithms A-H are represented by a single 
difference map in which essentially no features are visible. The b-spline algorithm also 
matched the surface contour very well (which is to be expected as it is a point-based 
algorithm). 
 
For seven of the eight algorithms able to accurately match the surface of the phantom 
(Algorithms A to G in Figure 4-6), systematic analysis of algorithm arguments was performed 
to identify the optimum parameter sets for convergence. That is, the DIR calculation has been 
performed with four stages (n = 1, 2, 3, 4), each with 2n passes and each pass having 10n 
 
 
Figure 4-6 Example of initial evaluation of DIR algorithms for Deformation type 1. DIR is performed to 
match the source image (the oblate shape) to the target image (the cylindrical shape). The upper row 
shows the Target, Source and each of the calculated approximations to the Target image. Difference 
maps between Calculated images and the Target image are shown in the second row. A single image 
represents the eight algorithms (A – H) that successfully matched the boundary. The remainder can be 
seen to have not satisfactorily rendered the phantom boundary. 
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iterations. This was assessed in terms of the mean displacement error of the 3D vectors 
between calculated and measured marker positions. The fully optimised parameter 
combination for all three types of deformations is provided in Table 4-2. Optimal parameters 
are not shown for the algorithms unable to adequately register the phantom boundary. 
 
Table 4-2 The 11 algorithms investigated in this study together with their corresponding optimal 
parameters (not shown for the algorithms unable to adequately register the phantom boundary).  The 
parameters examined were smoothing during iterations (2 in the optical flow algorithms or Gaussian 
low-pass filter window size, , for demons algorithms), the number of passes at the first multi-grid stage 
(finest resolution), a, the increment that the number of passes increases for subsequent multi-grid stages, 
b, and the total number of iterations, N, run over the four multi-grid stages (n = 1, 2, 3, 4), where 



4
1
})1({10
n
bnanN . 
Algorithm Name 
Optimum parameters 
Smoothing 
(during 
iteration) 
Total number of iteration N (a,b) 
Def1 Def 2 Def 3 
A:  Original Horn and Schunck = 0.05 1100 (3, 4) 1000 (4, 3) 600 (4, 1) 
B:  Combined Lucas Kanade and Horn and Schunck = 0.05 1200 (4, 4) 500 (3, 1) 600 (4, 1) 
C:  Inverse consistent Horn and Schunck = 0.05 2400 (4, 10) 1400 (4, 5) 3200 (4, 14) 
D:  Iterative Optical Flow Method = 0.05 400 (2, 1) 600 (2, 2) 400 (2, 1) 
E:  Fast Demons 1 400 (2, 1) 500 (3, 1) 400 (2, 1) 
F:  Modified Demons 1 800 (4, 2) 500 (3, 1) 400 (2, 1) 
G:  Original Demons 1 600 (2, 2) 500 (3, 1) 400 (2, 1) 
H:  Double Force Demons     
I :  Original Level set motion method     
J :  Free form deformation method     
K:  Affine approximation of level set motion     
 
 
The b-spline algorithm (Algorithm H) could not be evaluated as the FMs were not identifiable 
i.e. the marker locations in the calculated image were so different from those measured, it was 
not possible to tell which predicted marker was associated with which reference marker. This 
clearly indicates that despite predicting the surface contour of the phantom very well, a 
significant error exists inside the target volume of interest. The remaining seven algorithms 
were assessed for their ability to match points in regions of low contrast.  The results for the 
three different deformations and three scenarios (described in Sections 4.3.1 and 4.3.3 
respectively) are presented in the next section (Section 4.5.2). 
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4.5.2 Three dimensional vector error 
Figure 4-7 shows line profiles through selected FMs and the region of an erased marker. This 
demonstrates that intensity and noise level in the erasure region is indistinguishable from a 
marker-free region. Coordinates of marker locations were determined from the peaks in these 
profiles. 
 
A 3D vector was calculated between each measured marker location and its calculated 
position, the mean, spread and maximum displacement (i.e. magnitude of 3D vectors), of 
which were used as quality indicators of the performance of each algorithm. Table 4-3 
summarises the mean displacement error ( ), standard deviation (σ∆), and maximum error 
(∆max) for each algorithm applied to each deformation and each FM scenario. 
 
 
Figure 4-7. (a) Horizontal and (b) vertical line profiles through the marker locations of the inset images 
(inset images not to scale). The solid and dashed lines indicate the line profile before and after erasing 
one of the FMs, respectively. The maximum of each peak was used to identify the location of each 
marker. 
 
A substantial difference can be observed between algorithms. For the first deformation 
geometry, the mean position error (  ) of 16 markers, varied from 0.3 mm for the best 
performing algorithm (A) to 2.7 mm for the worst (F). This increased to 1.9-3.9 mm when all 
of the markers were erased and therefore did not contribute to driving the DVF calculation in 
the low contrast interior of the sample (Scenario III). The mean position errors for Deformation 
3 were similar. However the errors were greater for Deformation 2 which featured the larger 
displacement of markers from their initial positions. The magnitudes of the errors observed are 
comparable to previous studies (Kashani et al., 2008b, Janssens et al., 2009c, Wen et al., 2012, 
Wang et al., 2005a). 
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Table 4-3. The mean, standard deviation and maximum displacement errors ( ,, max) of the 3D 
error vectors between calculated and measured marker locations. These are given for seven algorithms 
(A-G identified in Figure 3), three deformation geometries (1-3), and three different calculation 
scenarios (I-III) described in text. 
 
(a) Deformation 1 
 Magnitude of 3D error vector, ∆ (mm) 
Scenario I (all FMs) Scenario II (half FMs) Scenario III (no FMs) 
Algorithm    σ∆  Max    σ∆  Max    σ∆  Max 
A  0.3 0.4 1.5  1.2 1.3 4.4  1.9 0.9 4.3 
B  1.5 0.8 3.1  2.2 1.3 4.6  2.3 1.0 3.6 
C  2.2 0.7 3.0  2.4 0.6 3.1  2.5 0.6 3.1 
D  1.9 1.1 4.3  2.4 1.3 5.1  3.0 0.8 4.9 
E  1.9 0.9 3.8  2.3 1.1 4.9  3.1 1.0 4.9 
F  2.7 1.4 5.2  3.5 1.4 5.7  3.9 1.1 5.6 
G  2.1 1.0 3.5  2.6 1.2 4.7  3.3 0.9 5.1 
 
(b) Deformation 2 
 Magnitude of 3D error vector, ∆ (mm) 
Scenario I (all FMs) Scenario II (half FMs) Scenario III (no FMs) 
Algorithm    σ∆  Max    σ∆  Max    σ∆  Max 
A  1.3 1.1 3.7  3.0 1.6 5.7  3.7 1.6 6.4 
B  3.3 1.8 6.6  3.7 1.7 6.6  4.9 1.5 7.2 
C  3.5 1.0 4.8  3.6 1.1 5.3  3.7 1.2 5.8 
D  3.7 3.3 10.6  5.3 2.8 10.4  5.4 2.2 9.8 
E  2.0 1.6 5.4  3.9 2.4 10.4  4.9 2.0 8.3 
F  6.1 4.1 11.8  6.3 3.8 12.2  7.5 4.5 13.8 
G  2.0 1.5 4.9  3.2 1.8 6.1  3.7 1.7 6.7 
 
(c) Deformation 3 
 Magnitude of 3D error vector, ∆ (mm) 
Scenario I (all FMs) Scenario II (half FMs) Scenario III (no FMs) 
Algorithm    σ∆  max    σ∆  max    σ∆  max 
A  0.3 0.3 0.7  1.0 0.8    2.5  1.3 0.6 2.5 
B  1.6 0.7 2.5  2.0 0.6    3.1  2.1 0.6 3.1 
C  1.3 0.7 2.5  1.6 0.8    3.2  1.8 0.7 3.2 
D  2.0 1.2 3.8  2.8 1.6 5.7  3.0 1.4 5.6 
E  2.3 1.0 4.6  3.1 0.9 4.5  3.3 0.9 5.1 
F  2.5 1.3 5.0  2.9 1.2 5.5  3.2 1.1 5.3 
G  2.6 1.2 6.0  2.8 1.1 4.9  3.0 1.0 5.1 
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The maximum error for a marker in each sample,max, was typically in the order of 1.5-2 times 
  for all algorithms, except for A where the smallest mean error actually makes this ratio 
larger. This algorithm also featured the smallest max in almost all cases. The largest errors 
were in the order of 30 % of the phantom diameter. It was noted that the largest component of 
the 3D vector errors was usually in the longitudinal direction, orthogonal to the direction of the 
applied compression, however, for some algorithms, the components in the remaining 
directions were also quite large. This confirms that mass re-distribution is sufficiently complex 
that DIR must be performed and assessed in three dimensions.  Two dimensional calculations 
are likely to be inadequate. 
 
Comparing deformations 1, 2 and 3, there is a trend across all algorithms of increasing   with 
increasing magnitude of displacement of the markers during deformation. This was the largest 
for Deformation 2 and a little smaller for Deformation 3 than for Deformation 1 (see Figure 
4-4). The mean errors for deformations 1 and 3 were similar, despite the extra complexity of 
the latter having less symmetry and multiple directions of intrusion. This indicates that the 
magnitude of deformation has a much larger effect on the accuracy of registration than the 
complexity of deformation (see Section 2.3.1). This trend also becomes more pronounced as 
the number of FMs present during registration is decreased.  
 
To achieve a better understanding of the impact of the number of high contrast features, a 
comparison of   across the three scenarios is illustrated in Figure 4-8. For all deformation 
types,   becomes significantly larger when less FMs are present during registration.  This is 
true for all algorithms except inverse consistent Horn and Schunck (Algorithm C), which 
shows relatively little difference ( Diff ~10 %) for deformation type 1 and 2. Interestingly, the 
algorithm yielding the smallest mean error (original Horn and Schunck) exhibited a large 
difference between scenarios ( Diff up to 550 %), while the algorithm with the largest mean 
error (modified demons) had a relatively small difference between scenarios ( Diff up to 45 %) 
(See Figure 4-8). Ultimately, the greatest accuracy was exhibited by the original Horn and 
Schunck optical flow algorithm. This featured errors in the order of half of those exhibited by 
most other algorithms for scenario III, where there were no high-contrast fiducial markers 
assisting the registration in the low contrast regions. The modified demons algorithm showed 
the largest errors. 
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Figure 4-8. Comparison of mean displacement errors across three different scenarios for each 
registration algorithm: (a) Deformation type 1, (b) Deformation type 2, and (c) Deformation type 3. Inset 
pictures show representations of DEFGEL phantom in deformed states for each deformation.  
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4.6 Assessment of DIR algorithms performance: Discussion 
Optimisation prior to evaluation of algorithms was necessary because it was found that 
without this step, some algorithms produced a good match for the boundary contour, but 
performed poorly for the interior markers. This is important to note, since commercial 
applications for clinical use do not necessarily incorporate this flexibility, as was the case with 
the VelocityAI (b-spline) implementation. Properly establishing the best parameters may offer 
as much improvement as algorithm selection. This is likely to be important when using DIR to 
facilitate dose-warping, as the largest improvements (from optimisation) are found in areas of 
low contrast rather than at the surface contours. It was found that a greater number of passes 
was needed for the coarser resolution stages before re-sampling at a finer resolution, and that 
this helped to increase the convergence speed, the motion capture range and the registration 
accuracy (Yang et al., 2009). The optimised parameter set was determined using the scenario I 
images (all markers present) with convergence evaluated via marker position analysis, (i.e. the 
optimisation process required fiducials to be present). Convergence was also explicitly tested 
for using the perturbation method and confirmed to be stable. This implied that the optimal 
parameter set was not a strong function of the number of markers visible inside the phantom 
boundary. Some algorithms could not even reasonably register the shape of the phantom 
boundary. This demonstrates that not all algorithms can cope with all DIR tasks, and that a 
qualitative check of results from multiple algorithms should form part of the algorithm 
selection and QA process for a given application. The poor performance of some algorithms 
may be mathematical limitations inherent to the algorithm or due to poor implementation of 
the algorithm. The developers of DIRART acknowledge in the software documentation that 
certain implementations may be “buggy” or need “minor changes” and that this may be 
attributable to insufficient maintenance of original source codes. It is beyond the scope of this 
study to investigate the reasons for an algorithm’s poor performance, with the focus being on 
the methodology used to quantitatively analyse DIR accuracy. The need for proper assessment 
of algorithm performance is, however, abundantly clear. 
 
Figure 4-9 shows the range of displacements undergone by markers (1-26 mm) and the 
calculated position error for the best (Algorithm A) and worst (Algorithm F) performing 
algorithms. This shows that for the original Horn and Schunck (Algorithm A) the errors are 
reasonably well correlated with the displacements and, from the gradient of the linear fit, 
errors can be expected to be in the order of 20% of the displacement (R
2
=0.76). For the 
modified demons (Algorithm F), the actual displacement is a poor indicator of the errors to be 
expected for individual locations. In several points, the errors in the calculated positions 
actually exceeded the displacement from the original position. 
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Figure 4-9 Magnitude of 3D error vector (|) for each marker as a function of its original displacement 
caused by the deformation, for Algorithms (a) A and (b) F. The individual errors of the original Horn 
and Schunck optical flow are quite well correlated to the markers’ magnitudes of true displacement. For 
the poorer performing modified demons, the errors are not well correlated. 
 
 
The above discussion relates to the performance of algorithms with no markers present (i.e. all 
markers erased, Scenario III). A comparison of scenarios I, II and III (16, 8 and 0 markers 
present during registration and DVF calculation) clearly shows that a greater number of high 
contrast features per volume increases registration accuracy. While not surprising, this 
demonstrates two important issues. Firstly, if the performance of deformable image 
registration algorithms is evaluated by analysis of features that are present during the 
calculations, then the outcome will be biased and the results will not be representative of the 
true performance in low contrast regions. These are precisely the regions we require a 
quantitative assessment for, as they are not apparent from visual inspection of image 
matching. It is worth noting that the preferred DIR algorithm is the fastest out of all studied 
algorithms with respective optimum parameters for each of studied algorithm as shown in 
Table 4–2. 
 
Secondly, these results permit an evaluation of the benefit achievable by using fiducial 
markers clinically to improve DIR. This is common practice, for example, in prostate 
radiotherapy where FMs may be implanted to compensate for the absence of organ contrast 
when aligning a patient with the treatment beam. Scenario II (half of the markers erased and 
half present during registration) is of interest in this case. The volume of a prostate is typically 
~ 40 mL and up to three fiducial markers are implanted to improve daily patient setup (~14 
mL per marker) (Nichol et al., 2007b). Daily patient setup using FMs reduces interfraction 
setup variation, thereby improving the therapeutic ratio of dose-escalated prostate RT. The use 
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of FMs assumes that they serve as an accurate surrogate for the position of not only the 
centroid (centre of mass) of the prostate, but also the surface of the prostate. The volume per 
marker in scenario II (15 mL per marker) is comparable and gives insight into the accuracy 
throughout areas of uniform intensity as well as points of high contrast, giving an indication of 
the overall accuracy obtainable.  Maximum deformations of the prostate have been measured 
to be 6 mm, 13 mm and 7 mm for the three orthogonal directions e.g. (Left-Right, Anterior-
Posterior, Superior-Inferior respectively) (Nichol et al., 2007b) which is comparable to 
Deformation 1 in this study.  As the accuracy of registration depends only on the extent and 
not complexity of deformation, one could expect mean overall registration accuracy in the 
prostate as good as 1.2 mm using three markers.  A comparison to the results for scenario I (16 
markers present, 7.5 mL per marker) implies the mean accuracy could be improved to 0.3 mm 
if six markers were used. 
 
Despite the simplicity of the phantom and deformation model, this system could represent 
typical deformations of organs such as pancreas, prostate, liver, breast etc. (see Figure 4-3 and 
Table 5-3 which exhibit similar radiological (Taylor et al., 2009c, Taylor et al., 2012)
 
and 
physical properties, such as electron density and physical density. The method and results 
presented here are not necessarily applicable to either the case of deforming targets in lung or 
tissue atrophy over the course of treatment, where mass and/or density are not conserved. This 
is not to say that the DIR approach will not work, only that we have not validated those cases 
here. In any case, in these situations the notion of dose as a surrogate for biological response 
becomes complicated by changing target masses and volumes. Thus the relationship between 
the original plan and the mathematical integration of dose over multiple fractions will not be 
simple. Moreover, the homogeneity of the phantom may not be representative of organs which 
have other sub-structure such as vasculature, density inhomogeneities or, for example, the 
urethral architecture in the case of the prostate. The algorithms investigated here were 
compared to each other in the context of understanding the implications for deformable 
dosimetry and dose-warping calculations associated with DEFGEL. Implanted substructures 
such as Nylon wires and Lucite beads (Serban et al., 2008) are under consideration to 
investigate the effects of sub-structure on DEFGEL modelling of deformable targets. 
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4.7 Assessment of DIR algorithms performance: Conclusion 
Using a tissue equivalent, mass and density preserving deformable gel (DEFGEL) phantom 
implanted with high contrast fiducial markers, we were able to demonstrate a quantitative 
evaluation process to systematically investigate the accuracy of DIR algorithms. The results of 
this study represent DIR performance for analogous mass and density conserving anatomical 
deformations (rather than lung case) where low contrast image regions are common. Using a 
method of mathematically erasing the markers prior to registration, we were able to assess the 
accuracy of algorithms within areas of near-uniform intensity, rather than only at known 
landmarks. This eliminates bias introduced when using intensity-based algorithms. 
Algorithm performance varied substantially. Some were unable even to register the phantom 
boundary contour satisfactorily. Of those that could, there was a wide range of errors between 
calculated marker positions and the measured locations. The best performing algorithm – 
original Horn and Schunck – yielded positional errors in the order of ~1 mm up to about 20% 
of the magnitude of displacement of individual markers.  For the worst of the results – 
modified demons algorithm – larger errors were observed and were poorly correlated with the 
magnitude of displacement, indeed sometimes exceeding the latter.  
For most algorithms, larger deformation induced displacements generally resulted in larger 
errors while there was no trend with respect to the complexity of deformation. The distribution 
of individual errors was generally characterised by a standard deviation of about ½ to ⅔ of the 
mean error. The sensitivity of the performance metrics to the number of fiducial markers 
present shows that if deformable registration is evaluated by analysis of features that are 
present during the calculations, then the outcome will be biased and the results will not be 
representative of the true performance in low contrast regions. 
A greater number of high contrast features per volume increases registration accuracy, and the 
technique presented here enables quantification of improvements achievable using fiducial 
markers for DIR. For example, introducing one marker per 15 mL volume reduced errors 
typically by up to ~ 30%. Raising the marker density to one per 7.5 mL reduced errors by up 
to 84% for the best performing algorithm (the original Horn and Schunck). As an example of 
clinical relevance, for treatment of a typical prostate (with volume ~40 mL and three FMs) the 
achievable accuracy of deformation would be of the order of ~1-2 mm, however this could be 
improved with the addition of more markers. This information could provide insight for 4D 
treatment planning strategies including dose warping and deformable dose accumulation. 
The next chapter (Chapter 5) discusses the implementation of validated DIR methods from 
this chapter as dose deformation algorithms, and therefore, the validity of dose deformation.
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CHAPTER FIVE  
: Validation of dose-warping: Is it sensible to 
deform doses? 
 
The calculation of complex re-distribution of dose in deforming and 
moving targets 
 
 
 
“Fire is the test of gold; adversity, of strong men.” 
Lucius Annaeus Seneca 
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5.1 Overview of chapter 
Algorithms exist for the deformation of dose based on patient image sets, though these are 
sometimes contentious because not all such image calculations are constrained by physical 
laws (i.e. a perceived ‘lack of physics’). What is not well known is the degree to which this 
approach is acceptable. Before it can be adopted, it needs, therefore, to be validated – ideally 
by direct experiment. 
 
This chapter aims to demonstrate a full 3D experimental validation of results from dose 
deformation using the evaluated DIR algorithms from the previous chapter (Chapter 4). 
Complex and re-distributed dose distributions in deforming objects are measured with 
DEFGEL (i.e. an experimental model) followed by irradiation and dose readout using OCT; the 
corresponding deformed dose distributions are also calculated by DIR and dose-warping 
using CT image sets of DEFGEL (i.e. a mathematical model). The quantitative comparison 
thereof is performed via 3D -analysis to investigate the validity of dose-warping. 
 
 
 
5.2 Validation of the dose-warping technique: Background 
A variation in anatomic structures due to organ motion and deformation is recognised as a 
major challenge in contemporary RT. Over the past decade, motion has been a ‘big issue’ in 
radiotherapy; as technology to contend with motion improves one might suggest that 
deformation could be the focus of the coming decade (See Figure 5-1). 
 
Figure 5-1 Deformation: the next big issue? This figure shows number of publications over the last few 
decades relating to motion and deformation in radiotherapy (from a simple PubMed search), illustrating 
that clinical interest in deformation within the context of radiotherapy is on the rise and is perhaps 
poised to be the next ‘big issue’ in the coming decade. 
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Dose accumulation requires that moving and deforming tissues be accurately tracked between 
images. Hence, understanding the cumulative dose distribution necessitates deformable 
registration of the two images and corresponding dose distributions. This may be effected by 
‘dose deformation’, whereby an initially planned dose distribution is morphed according to 
the geometric changes of anatomy evident in the new patient image set. The warped 
distribution can then be added to previous fractions in order to interpret the accumulated dose. 
The deformation of dose distribution via the resultant vector map associated with deformable 
image registration (DIR) calculation is so called ‘dose-warping via DIR’. This technique is an 
existing process, proposed to accumulate doses from multiple image sets taken in different 
time frames. It is sometimes contentious because it is not inherently evident that dose-warping 
via DIR reflects the underlying physical and anatomical processes accurately. Inaccurate dose 
accumulation could be hazardous in the presence of temporal/spatial anatomy change, as it 
may lead to treatment decisions being based on incorrect dose distributions.  
 
This contentious (but investigation worthy) topic is reflected by the recent Point-Counterpoint 
article in Medical Physics (Schultheiss and Tomé, 2012) by Drs Schultheiss and Tomé 
entitled ‘It is not appropriate to “deform” dose along with deformable image registration in 
adaptive radiotherapy’. The authors presented two opposite viewpoints on this very 
interesting topic. Dr Tomé – who is against the proposition – provides fascinating case 
examples of when there is a need of implementing deformable dose accumulation in adaptive 
radiotherapy: 
“For example, target cold-spots may overlap in reality. Lack of this knowledge could 
be detrimental to the treatment outcomes, since a significant dose deficit to even a 
very small portion of a high-risk area within the GTV can have a detrimental effect 
on the achievable tumor control probability. The same also holds for organs at risk, 
which by treatment plan design see a highly nonuniform dose distribution. Hence, if 
accurate estimation of expected normal tissue complication probability for organs at 
risk is desired for plan adaptation then it is necessary to warp the dose.” 
 
The above statements can be applicable to dose warping of both cases i) over multiple 
fractions (inter-fraction effect) and ii) during a single fraction (intra-fraction effect). The 
potential advantages of dose-warping for the purpose of accurate dose accumulation may 
seem self-evident, but one quote from Dr Schultheiss – who is for the proposition – 
summarises quite succinctly the cause for concern regarding dose deformation effected via 
DIR: 
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“The ultimate problem with deformed dose is our inability to measure it. Comparison 
with measurement is always the standard in the mathematical modelling of physical 
phenomena. Until we can deform dose with algorithms that have been validated 
against measurement, rather than being merely based on image manipulation, we 
should withhold all commercial use of this misleading process.” 
 
This article relates, of course, very closely to the study of this chapter - a methodology for 
experimental validation of dose warping – reported in Medical Physics just several issues 
prior to the article of discussion, entitled ‘Is it sensible to deform dose? 3D experimental 
validation of dose-warping’ (Yeo et al., 2012). Following these articles, our group has 
responded to the above Point-Counterpoint article, contributing to discussions on the issue – 
‘the validity of dose-warping’.  
 
There have been a number of groups that have developed deformable phantoms (Chang et al., 
2010, Kashani et al., 2008a, Kashani et al., 2007b, Wang et al., 2005b) and attempts to glean 
dosimetric information through measurements have previously been facilitated by implanting 
point detectors such as TLD, MOSFET (Cherpak et al., 2010, Janssens et al., 2009a) and two-
dimensional detectors (e.g. film) (Nioutsikou et al., 2006, Serban et al., 2008). The ideal 
approach would be to use a three-dimensional, deformable tissue surrogate that also acts as 
the dosimeter. Published studies evaluating the efficacy of dose-warping using experimental 
methods are summarised in a table below: 
 
Table 5-1 Published studies evaluating the efficacy of dose-warping using experimental methods.  
Dosimeter DIR algorithm Phantom  Target Reference 
TLD (0D) and film (2D) Surface landmark 
based method 
(i) Sponge with acrylic disk 
(ii) Cork with acrylic disk 
(i) Deform & move 
(ii) Move only 
(Vinogradskiy 
et al., 2009) 
Film (2D) Optical flow method Lung surrogate Move only (Zhang et al., 
2008) 
Ion chamber (0D) Optical flow method Cork and acrylic rod Move only (Huang et al., 
2010a) 
MOSFET (0D) Demons and 
Morphons 
Silicon with elastic foam Deform & Move (Janssens et al., 
2009a) 
Polymer Gel (3D) MORFEUS 
(finite element) 
Gel (dosimeter = phantom) Deform & Move (Niu et al., 
2012) 
DEFGEL (3D)  12 different algorithms  Gel (dosimeter = phantom) Deform & Move (Yeo et al., 
2012) 
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Ultimately, from a clinical perspective, what is perhaps most of interest is an answer to the 
question: ‘is it sensible to warp doses via deformable image registration (DIR)?’ Although the 
answer is not likely to be without complexity, the present work attempts to answer this 
question by direct three-dimensional experimental evaluation of mathematical dose 
deformation calculation (i.e. dose-warping technique). The present work subjects the 
DEFGEL to different deformations and stereotactic beam irradiations, in order to compare 
warped doses to the corresponding measured doses obtained by DEFGEL. This study has 
trialled 11 DIR algorithms of which accuracies have been evaluated in the previous chapter.  
 
A novel approach to experimentally validate the calculation of dose deformation via DIR 
methods is concisely summarised here:  
i) DEFGELs are scanned via x-ray CT, in both deformed and undeformed states;  
ii) Dose deliveries are planned on the CT images of deformed states using TPS; 
iii) For experimental measurements as a ground truth of deformed dose distributions, 
planned doses are delivered to DEFGELs in deformed states; 
iv) Measured dose distributions are readout via OCT scanner (see Chapter 3), in which 
DEFGELs delivered with deformed states were released to undeformed state before 
its read-out
4
; 
v) For mathematical calculations of deformed dose distributions, DIR is performed to 
match the image in deformed state to the other image in undeformed state; 
vi) The planned dose on the deformed state is morphed based on deformation matrices 
obtained via DIR – called deformation vector fields (DVFs); and 
vii) The warped dose distribution is then compared to the corresponding measured dose 
distribution via 3D analysis in order to validate the dose-warping technique. 
viii) CT imaging, subsequent planning and its irradiation of DEFGEL are performed in an 
undeformed state as a control case to quantify the level of agreement expected 
between plan and measurement in the absence of deformation influence.  
 
The approach is described in more detail in the next section. Through this procedure, this 
work identifies the best performing of the algorithms studied in the previous chapter and 
presents a detailed evaluation of the results achievable. 
                                                     
4
 In the context of ART, ‘deformation’ is normally thought of as a change occurring after the original 
planning CT imaging. Because OCT requires the DEFGEL sample to be reproducibly mounted in its 
regular cylindrical shape, here we hold the sample in a rig for imaging and irradiation, then the 
deformation consists of releasing it, allowing it to return to its original cylindrical shape.  
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5.3 Validation of dose-warping technique: Material and Method 
5.3.1 Deformation and beam geometries: For both measurements and calculations of 
deformed dose distributions using DEFGEL 
The previous study described in Chapter 3 reported on a deformable volumetric gel 
dosimeter/phantom – DEFGEL – that can integrate dose in the presence of temporal/spatial 
changes in a non-rigid 3D object. This study implemented the same deformations described in 
Chapter 4 for which the algorithm performance has already been evaluated. The three 
deformations of the cylindrical phantom are illustrated in Figure 5-2 (which is the upper panel 
of Figure 4-4, depicted here again for clarity). The maximum deformations (3D vector) in 
millimetres are 11.3, 19.9 and 9.4 mm for Deformations 1, 2 and 3 respectively. 
 
Figure 5-2 Illustrationof the DEFGEL phantom in the Undeformed state and the three different states 
of deformation. Beam directions (indicated as red-coloured arrows parallel to z-axis) were aligned with 
the long axis of dosimeter for all cases. The lower panel shows CT images of cross cut of the DEFGEL 
without deformation and with deformations applied by purpose-built acrylic rigs. 
 
This study evaluates the results for three stereotactic fields (shown in Figure 5-3), possessing 
different degrees of complexities, which are combined with Def 1 only: 
i) A 10 x 10 mm2 field;  
ii) A cross shaped 20 x 20 mm2 field (each spoke 10 mm wide); and 
iii) A four dynamic-arc stereotactic treatment adapted from a patient plan (a brain 
metastasis) and recalculated on the DEFGEL (PTV volume of 0.413 cm
3
). 
 
Figure 5-3 Illustration of three planned fields. Transverse cut of Dmax plane was chosen for illustration 
of each field. These plans were delivered with their beam direction aligned with the long axis of the 
dosimeter in both deformed and undeformed state. 
 
Field 1 Field 2 Field 3 
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CT scanning of DEFGEL was conducted with the absence of deformation and with each of 
three deformations applied by purpose-built acrylic rigs (see Figure 5-2 as well as Figure 3–
3(c) and Figure 3–7(b)). In each case the DEFGEL was submersed in a water phantom. The 
arc plan was calculated with the iPlan pencil beam algorithm, while the other fields were 
calculated with Eclipse (pencil beam) – all fields planned with 6 MV and 6.0 Gy to isocentre. 
Transverse cut of Dmax planes of these three plans are shown in Figure 5-3. The treatment 
plans incorporated the tank and deformation rig. The first two fields (the square and the cross 
shaped) were shaped with the BrainLAB m3 micro-multileaf collimator.  
 
5.3.2 Experimental measurements of deformed dose distributions: irradiation and dose 
readout 
DEFGEL was used to measure dose distributions in both undeformed and deformed states. 
The arc plan calculated with the iPlan was delivered with a Novalis (BrainLAB, Feldkirchen 
Germany) dedicated stereotactic unit, while the other fields calculated with Eclipse were 
delivered with a Varian 21-EX as planned. In each case of irradiation the DEFGEL was set up 
as scanned and planned with the absence or the presence of deformation as shown in Figure 
5-2. Procedures for manufacture of DEFGEL and dose read-out using a cone beam optical CT 
system are described in Chapter 3 (Section 3.3). In deformed scenarios, DEFGELs delivered 
with deformed states were released to undeformed state before their read-out. This is because 
OCT requires the DEFGEL sample to be reproducibly mounted in its regular cylindrical 
shape. In the context of ART, ‘deformation’ is normally thought of as a change occurring 
after the original planning CT imaging). Hence, the deformation, in this case, consists of 
releasing it, allowing it to return to its original cylindrical shape  
 
5.3.3 Mathematical calculations of deformed dose distributions: DIR algorithms and 
assessment 
The study in Chapter 4 has evaluated 11 DIR algorithms. The major findings are that the 
Modified Demons algorithm delivered the poorest results and the Original Horn and Schunck 
algorithm was found to be the most appropriate – yielding the best estimates of deformation 
of low-contrast regions which are typically less accurately deformed than the high-contrast 
features that drive the vector field. In this study, these evaluated DIR methods are applied to 
the mathematical calculation of deformed dose distributions, i.e. used as dose deformation 
algorithms. The optimal parameter set of each DIR (found in Section 4.5.1) was mainly used 
to investigate the validity of dose-warping. The impact of smoothing parameters on dose-
warping accuracy was additionally investigated. 
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5.3.4 3D gamma-analysis 
For the experimental evaluation of mathematical dose-warping calculation, comparisons of 
experimental measurements vs. mathematical calculations were performed via a full 3D -
analysis. Before the concept of -analysis was introduced by Harms et al. (1998), dose 
distribution comparisons were subdivided into regions of low and high dose gradients as 
described by Van Dyk et al. (1993). In low gradient regions a simple dose-difference 
distribution was used while in high gradient regions this comparison was relatively 
unimportant (due to a small spatial discrepancy giving a large dose-difference) and instead 
distance-to-agreement (DTA) distributions were used to assess the acceptability of the dose 
calculation. Gamma-analysis is a composite method that utilises a dose-difference comparison 
and a DTA analysis. The original method proposed by Harms et al. (1998) generated binary 
distributions formed by the points that failed both the dose-difference and DTA criteria.  
However this did not lend itself to convenient display and so the convention was to display 
the dose-difference value at every point that failed the composite criteria. This accentuated the 
impression of failure in high gradient regions and led Low et al. (Low et al., 1998) to 
implement a numerical quality index based on the same criteria where a value less than unity 
is considered acceptable. This numerical indexing system is what we now know as -analysis. 
 
In the present study it was attempted to specify whether or not each point in the calculated 
dose distribution passed the criteria and so the -distribution was determined on the 
coordinate system of the calculated distribution. Hence, the calculated dose distribution, 
 cc rD

, queried for evaluation, is compared to the corresponding measured dose distribution, 
 mm rD

 
used as the reference. The dose difference (ΔD) at the position cr

 
relative to the 
reference dose Dm in mr

 is    mmcc rDrD

 . The distance (Δr in millimetre) between the 
reference point (from measured dose distributions) and compared point (from calculated dose 
distributions) is mc rr

  (Note that the voxels of the TPS calculated dose data are linearly 
interpolated to match that of the gel measured dose data). The -analysis criteria are denoted 
by ΔDcri and Δdcri for the dose difference criterion and the DTA criterion, respectively, i.e. 
each criterion is equally weighted. Then these acceptance criteria for -analysis are an 
ellipsoid in ‘ΔD vs. Δr domain’, that is, 
2
2
2
2
1
cricri d
r
D
D






      
(5-1)
 
Hence, Δr is less than or equal to Δdcri. For each voxel in the compared (calculated) 
distribution to match the reference dose in mr

, it needs to contain at least one point ),( cc Dr

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lying within the ellipsoid of acceptance criteria. A quantitative measure of -analysis is 
determined by the point with the smallest deviation from the reference point, i.e. a -index for 
the point ),( cc Dr

, ),( ccm Dr

 , is minimal. Hence, a - index is defined by 
)min(),(
2
2
2
2
cricri
ccm
d
r
D
D
Dr





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
    (5-2) 
Therefore if ),( ccm Dr

 ≤1, the result of -analysis for the point ),( cc Dr

 is within the 
specified acceptance criteria (i.e. passed), otherwise, it is not (i.e. failed).  
 
In this study, this analysis is extended to three dimensions for the DTA criterion, and the 
passing ratio for the treatment field is calculated for all voxels in the volume receiving >10 % 
of the maximum dose in order to minimize the effects of noise in low dose regions; such a 
threshold is commonly used in clinical practice and is consistent with other studies (Ezzell et 
al., 2009, Petoukhova et al., 2011). This work demonstrates this ‘full 3D -analysis’ for 
stereotactic fields, which are inherently more complex dosimetrically (Taylor et al., 2011c) 
and so, importantly, this work also compares planned and measured doses delivered in the 
absence of any deformation to illustrate the  agreement expected in the control case. In all 
other cases, irradiations were performed with the DEFGEL in the compressed state. The -
passing criteria of 3%/3mm were mainly used in this study as it is routinely used in most 
clinical practice. In addition, the sensitivity of -analysis to different passing criteria was 
investigated (Section 5.5.4). 
 
 
5.3.5 Dose warping validation 
The general approach for validation of dose-warping undertaken in this work is illustrated in 
Figure 5-4. The DEFGEL is scanned via x-ray CT (GE LightSpeed™ RT CT, GE Healthcare 
UK), in both deformed and undeformed states. These images are then processed and rigidly 
registered. The deformable image registration algorithm is used to generate a calculated 
image of the cylindrical DEFGEL from the deformed DEFGEL (i.e. the images of the 
physically deformed DEFGEL are the ‘moving’ images, which are morphed to approximate 
the cylindrical DEFGEL). Ultimately, it is not the generated image which is of interest in the 
context of dose-warping, but the associated deformation vector field (DVF). Dose-warping is 
effected by morphing the planned dose distribution using the DVF. This is then quantitatively 
compared via -analysis to the corresponding measured dose distribution.  
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Figure 5-4 An example of the typical workflow for comparison of calculated (dose-warped) and 
measured fields in deformed geometries. In this case, the effect of deformation into an oblate shape is 
investigated for a cross-shaped field. The image is warped from the oblate shape to the cylindrical 
shape. This is done using a DIR algorithm. The output of the DIR includes a deformation vector field 
(DVF). This DVF can then be applied to the dose distribution (rather than the image), to warp the dose. 
We first compare (via-analysis) the planned and measured distributions without any 
deformation/dose-warping directly, to evaluate the level of agreement in the absence of deformation 
(small fields are inherently complex in terms of accurate dosimetry). Subsequently, we compare (via -
analysis) the measured field in the case of a deformation with the plan that has been dose-warped 
(using the DVF). 
 
 
Source image 
(deformed) 
Target image 
(undeformed) 
Rigid registration 
(manually or based on structure and image geometries) 
+ 
Image processing 
(cropping, padding, resampling, noise reduction, etc.) 
Deformable image registration (DIR) 
(various algorithms investigated) 
Calculated image 
(output from DIR) 
Planned Measured 
Comparison (-analysis) of planned 
and measured doses for 
‘undeformed’ geometry 
Calculated Measured 
Comparison (-analysis) of warped 
and measured doses for ‘deformed’ 
geometry 
Deformation vector field (DVF) 
(output from DIR) 
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This study first presents a comparison of the results from 11 algorithms in high vs. low 
contrast regions, using a single deformation and field combination – the cross-shaped field 
and bilateral symmetric compression (Def2) (Section 5.4.1). As will be shown in the Results 
section, these results conform to the results of previous chapter that investigated the spatial 
accuracy of DIR algorithm in low-contrast region. Subsequently, the best-performing 
algorithm (the Original Horn and Schunck algorithm) was evaluated further to determine the 
achievable accuracy. Using this algorithm, detailed analysis is performed with all different 
deformation types combined with a 10 x 10 mm
2
 square field (Section 5.4.2). This is followed 
by detailed analysis with all three different field types combined with a single deformation 
(Def2) (Section 5.4.3). The following sections evaluated the sensitivity of -analysis to 
different passing criteria (Section 5.4.4), then investigated the impact of the smoothing 
parameter (i.e. DIR optimisation) on the results of dose warping (Section 5.4.5). 
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5.4 Validation of dose-warping technique: Results 
5.4.1 Comparison of different algorithms in high vs. low contrast regions 
Following the assessments of DIR performance (as shown in Chapter 4), this study 
demonstrates the variability of results from the different algorithms. To do so, dose warping 
was performed for the cross-shaped field deformed using the bilateral symmetric compression 
(Def1). The deformation and the field are depicted in Figure 5-2 and Figure 5-3, respectively. 
Of the 11 algorithms investigated (listed in Table 4-2), 7 of them (A-G) were able to non-
rigidly register the oblate source image to the circular target image, as shown in Figure 5-5 
and are represented by the single calculated image labelled ‘A-G’. The other four algorithms 
(H-K) failed to register even the circular phantom boundary in the calculated image. The 
Affine Approximation of LSM algorithm (K) is seen to be particularly dysfunctional. These 
examples illustrate that not all DIR algorithms will produce DVFs that are usable, and that 
DIR results should be scrutinised before application to dose warping. 
 
Before DIR Calculated image After DIR 
Source 
image 
Target 
image 
A-G H I J K 
       
 
Figure 5-5 The Calculated non-rigid registration of the Source image to the Target image for 11 DIR 
algorithms. The 7 successful algorithms (A-G) are represented by a single Calculated image that 
correctly matches the boundary of the Target image. The results for four unsuccessful algorithms are 
shown individually (H-K). It can be seen that the calculated boundaries are not a good fit to the shape 
of the Target. 
 
 
For each of the 11 algorithms, the DVF was applied to the planned dose distribution to 
generate a calculated approximation of the deformed dose distribution that was directly 
measured using DEFGEL. These are shown in Figure 5-6 for a dose plane at depth Dmax. The 
Horn and Schunck based algorithms, A, B and C can clearly be seen to produce the best 
results. Note that algorithms D-G, while apparently registering the phantom boundary well, 
do not necessarily provide good registration of the internal, low contrast regions. Algorithms 
H-J, derived from registrations where the boundary has not been properly ‘expanded’ to the 
circular shape, produced dose maps that more closely resemble the undeformed original cross-
shaped field as delivered. The result of the dysfunctional algorithm, K, is included for 
completeness. 
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An interesting feature of warped dose map K is the surprisingly high 3D passing ratio 
(described in detail below) of 53.2 %, which is conspicuously higher than those of maps D to 
G, despite being heavily fragmented and in no way resembling the expected dose distribution. 
This arises because of the DTA criterion of gamma comparison. Many of the high dose voxels 
(red) that can be seen where low dose (blue) is expected are within a very small distance of a 
low dose voxel that has the appropriate value. A similar argument exists for low dose voxels 
near the centre of the field where high dose is expected. Thus, it is important, as always, not 
to accept gamma passing ratios alone as evidence of the quality of dose match. They should 
be considered only in conjunction with scrutiny of DIR results and inspection of dose 
difference maps. 
 
  Measured (Gy) Warped dose distribution at Dmax 
 A B C D E F G 
        
3D passing ratio (%) 
(whole volume) 
98.8 98.7 98.4 42.2 34.4 32.7 30.7 

H I J  K 
 
 

    
 
3D passing ratio (%) 
(whole volume)
85.6 83.7 81.7 53.2  
 
Figure 5-6 The dose-warping estimation of the measured dose distribution shown at top left, for 11 
algorithms. Panels A to G are the dose maps derived from algorithms that successfully registered the 
phantom boundary in the DIR stage, while H to K are for those that did not. The 3Dpassing ratio is 
given for each relative to the measured distribution (3 % / 3 mm criteria). 
 
For the Horn and Schunck approach, agreement with experimental data was good (γ3D is over 
98 % for all three algorithms A-C); however, it is clear that the internal (low-contrast) regions 
were far less accurately deformed in the case of the Modified Demons method (γ3D = 32.7 %). 
Without this validation process, one might assume that the dose-warping was equivalently 
accurate in all cases where the algorithms were able to accurately (100 %) reproduce the 
contour of the DEFGEL phantom (i.e. Algorithms A-G). 
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As the Original Horn and Schunck (OHS) algorithm (Algorithm A) represents the best results 
that can be obtained from the algorithms tested, it is used for the remaining analysis of 
performance relative to different deformations and fields. 
 
 
5.4.2 An evaluation of OHS algorithm (Algorithm A) for different deformations with a 
small square field 
The results of dose-warping a small square field (10 x 10 mm
2
) for three different 
deformations are illustrated in Figure 5-7. The type of deformation is shown, and beneath this 
the calculated (i.e. dose-warped) and measured dose distributions are presented. To illustrate 
the level of agreement (for 3 % / 3 mm criteria), 3D maps are shown at the plane of Dmax 
along with the passing fraction for the full volume. In each case the agreement is very good. 
The ‘reference’ case – comparison of planned and measured doses in the absence of 
deformation – demonstrates the baseline level of agreement expected between measurement 
and calculation; it is important to note this, since one can expect some level of disagreement 
between pencil-beam calculations and measurements for stereotactic fields (Taylor et al., 
2011c).  
 
Consider the data shown in Figure 5-7. For the reference case (i.e. no deformation), the 
agreement between measurement and planned dose is 3%/3mm = 99.9 %. Of the deformed 
cases, Def3 exhibits the least deformation (9.4 mm maximum deformation), and in this case 
the agreement between measured and warped dose distributions is similarly 3%/3mm = 99.9 %. 
Def1 has a maximum deformation of 11.3 mm, and the dose-warped distribution matches 
measurement such that 3%/3mm = 99.1 %. Def2 has the largest deformation – about 19.9 mm. 
Dose-warping calculations for the latter case exhibit the greatest disagreement with 
measurement: 3%/3mm = 96.7 %. While probably still acceptable for many applications, it is 
important to note the obvious trend that the greater the deformation, the less accurate the 
warped dose distribution. That being said, a ~3 % failure rate in gamma analysis over the 
whole volume for such a significant deformation is still a confidence-inspiring result, since it 
is considerably lower than a typical clinical action level (Howell et al., 2008). 
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 Undeformed        Def 1               Def 2                   Def 3 
                                            
 
Deformation 
 
 
 
 
Rigid registration of 
pre- and post-
deformation images 
 
Planned Warped Warped Warped 
Calculated: 
 
Undeformed Deformed Deformed Deformed 
Measured: 
 

3D map 
(plane at Dmax shown) 
 
0              1              2 
                            
3D passing ratio (%) 
(whole volume) 
          99.9         99.1 96.7         99.9 
  
Figure 5-7 A comparison of calculated and measured doses in different states of deformation after 
exposure with a 10 × 10 mm
2
 field. Transverse planes from 3Dmatrices are shown with 3 % / 3 mm 
criteria. The gamma map for the Undeformed case (i.e. comparison of planned and measured dose 
distributions in the absence of deformation) indicates the achievable agreement.  
 
 
5.4.3 An evaluation of OHS algorithm (Algorithm A) for different fields’ irradiations 
Although the small square field (10 × 10 mm
2
) is dosimetrically interesting (being smaller 
than the range of secondary electrons and consequently in electronic disequilibrium), it is 
worth investigating other fields of greater complexity. It is also of interest because larger 
fields are essentially constructed of small rectilinear beamlets and that this is in many cases 
how they are calculated. Of three stereotactic fields examined, a four dynamic-arc treatment 
field the greatest complexity, of which measurements and calculations are shown in Figure 
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5-8 for both cases – in the absence of deformation and in the presence of deformation (Def1). 
For deformed cases, a bilateral deformation (Def1) was applied in the y-direction. Complex 
spatial re-distribution of dose in all three dimensions is observable – i.e. elongated in y-
direction and compressed in the other two directions, because the beam was delivered in the 
deformed state. 
 
 
Figure 5-8  70 % and 90 % 3D isosurface doses of a four dynamic-arc treatment field. Upper panels 
(green colour) are measurements and lower panels (red colour) are calculations of undeformed (left) 
and deformed (right) scenarios. For deformed cases, a bilateral deformation (Def1) was applied in y-
direction. Complex spatial re-distribution of dose in all three dimensions is observable – i.e. elongated 
in y-direction and compressed in the other two directions, because the beam was delivered in the 
deformed state. 
 
 
The results of dose-warping investigation into fields of greater complexity are shown in 
Figure 5-9. Again, the agreement is good; 3%/3mz = 98.8 % for the cross-field and 3%/3mm = 
95.8 % for the complex stereotactic treatment. It is important to note that both these results 
are within 1 % of the reference (undeformed) cases. 
Measured 
dose 
Calculated 
dose 
Without deformation With deformation (Def1) 
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Figure 5-9 A comparison of calculated and measured doses for different irradiations delivered to Undeformed and Deformation 1 DEFGELs. Transverse plane gamma maps 
(at Dmax) are shown with 3 % / 3 mm criteria. The gamma map for the Undeformed case (i.e. comparison of planned and measured dose distributions in the absence of 
deformation) indicates the achievable agreement. 
Field Shape 10 × 10 mm
2
 Cross Dynamic arcs 
Calculated 
Planned Warped Planned Warped Planned Warped 
   
Measured 
Undeformed Deformed Undeformed Deformed Undeformed Deformed 
   
 
3D map  
(plane at Dmax shown)  
 
0             1              2 
      
3D passing ratio (%) 
(whole volume) 
99.9 99.1 99.4 98.8 96.1 95.8 
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The figure below (Figure 5-10) shows overlaid dose profiles through the elongated (central) 
axis of the delivered field for the 1x1 cm
2
 square field (which were taken from Figure 5.7 and 
5.9) for both deformed and undeformed cases.  
 
 
Figure 5-10 A comparison of calculated and measured doses profiles, overlaid through the elongated 
(central) axis of the delivered field for the 1x1 cm
2
 square field (which were taken from Figure 5.7 and 
5.9) for both deformed and undeformed cases.  
 
 
5.4.4 An evaluation of the sensitivity of -analysis with different passing criteria 
In this study quantitative comparisons have been undertaken primarily using gamma-analysis. 
It is worth confirming that no disagreement in calculated  values is being hidden by coarse or 
‘convenient’ criteria. The results for -analysis with various criteria are shown in Table 5-2 
for Def1 combined with the small square field. For the typical 3 % / 3 mm criterion, the 
agreement is clearly very good (over 99 %). Expectedly, it is evident that the three 
dimensional -values are more sensitive to distance-to-agreement than dose difference 
(particularly when dropped to 2 mm). The results indicate that the vast majority of pixels are 
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warped correctly to < 2 mm, with a smaller fraction (5 – 15 %) accurate to within 2-3 mm, 
and all voxels correct to within 4 mm. Although the  passing ratio are consistently lower than 
those for the ‘reference’ (undeformed) cases, the agreement between measured and warped 
dose distributions is generally good.  
 
Table 5-2 This table indicates the dependency on criteria specifications for gamma analysis. Gamma 
analysis undertaken for a range of criteria (2 to 4 % dose difference, , and 2 to 3 mm distance-to-
agreement, DTA) for a small (10 mm × 10 mm) square field and deformation type 1. The ‘reference’ 
case is shown (agreement between planned and measured in absence of deformation) as well as the 
agreement between dose-warped and measured. The typically quoted 3 % / 3 mm criterion employed 
clinically is indicated in bold. 
D-analysis 
(% passing criteria) 
Reference Warped Reference Warped Reference Warped 
DTA (%) 4 % 4 % 3 %  3 % 2 % 2 % 
3.0 mm 100 99.9 99.9 99.6 99.9 98.6 
2.5 mm 99.5 98.6 99.2 97.1 98.3 94.4 
2.0 mm 95.5 91.7 94.2 88.5 91.2 83.6 
 
 
5.4.5 An evaluation of the dependency of dose-warping on the smoothing parameters 
The smoothing parameter (=2) was adjusted to investigate the impact of optimisation process 
on the resulting dose-warping. This optimal value of this parameter was found to be 0.05 for 
the Original Horn and Schunck algorithm (Algorithm A) – see Section 4.5.1. To investigate 
the influence of varying this parameters, the level of smoothing was set to half (2=0.025) or 
double (2=0.1) the optimum value as well as to be zero (i.e. no smoothing).  
 
Figure 5-11 illustrates how variation of the smoothing parameter of an algorithm can greatly 
affect the accuracy of dose-warping, while having very little effect on matching the phantom 
boundary. For completeness, the Jacobians are also presented (overlayed on the calculated 
image), which graphically reflect the smoothness of the transformation. Using the optimum 
smoothing during iterations, ~99 % of voxels passed the gamma test, while using no 
smoothing at all yielded a passing ratio of ~40 %.  Similarly, when the level of smoothing 
was set to half or double the optimum value the passing ratios were lower. It is interesting to 
note that, in certain cases, the result of a registration may appear visually to be very good (in 
terms of boundary matching), while the accuracy of the resulting dose-warping may be poor. 
This arises from the way in which most algorithms interpolate deformation in low contrast 
regions.  
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Figure 5-11 A comparison showing the effect of different levels of smoothing. Results of dose-
warping the cross-shaped field, in the case of Deformation 1, using the original Horn and Schunck 
algorithm are shown. Also shown are the transverse plane gamma maps (at Dmax) from comparison of 
calculated and measured doses using 3 % / 3 mm criteria. Four different values for smoothing were 
used: 2 = 0.05 (the optimum value), 2 = 0 (no smoothing), 2 = 0.025 (half of the optimum value) 
and 2 = 0.1 (double the optimum value). The Jacobian matrix of the DVF is shown in each case. 
Smoothing (2) 
2 = 0.05 
(Optimal)  
2 = 0 
(No) 
2 = 0.025 
(Half) 
2 = 0.1 
(Double) 
Jacobian map of DVF 
(Calculated image) 
     
Warped dose 
distribution  
at Dmax shown 
 
 
(Gy) 
    
 
3D map  
(plane at Dmax shown)  
 
0                   1                   2 
    
3D passing ratio (%) 
(whole volume) 
98.8 38.8 85.9 92.1 
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5.5 Validation of dose-warping technique: Discussion 
In this work, it was attempted to answer the question – ‘is it sensible to deform doses?’. The 
results in Figure 5-7 and Figure 5-9 indicate that it is possible to use dose-warping of planned 
dose distributions with deformable image registration deformation vector fields to generate 
accurate predictions of the true absorbed dose. It also demonstrates that the majority of voxels 
failing the gamma criteria are in areas subject to large deformation, meaning the complexity of 
deformation has far less influence than the extent of deformation. The results in Figure 5-10 
also indicates that a major contribution to the difference of measurements and calculations 
were mainly from the limitation of TPS calculation accuracy for small fields (e.g. lateral 
electron disequilibrium and collimator scatter etc.) as stated in Chapter 3 while stray light 
perturbation of OCT readout might be a secondary effect (if there is). 
 
Putting the work into a clinical context, typical displacement of the prostate, pancreas and 
lung lymph node, for instance, are of magnitudes (see Table 5-3) such that one would expect 
the warped dose predictions to be accurate. This is also the case for typical liver displacement, 
though these are noted (Rohlfing et al., 2004a) to range up to 34 mm (5-10 mm of mean 
deformation magnitude) and in this case dose-warping may be less accurate (but can still 
achieve clinically acceptable accuracy, e.g. above 95% passing rate of gamma analysis with 
3%/3mm criteria). 
 
Table 5-3 An illustration of the extent of organ displacement as evident in various published studies. 
Site N patients 
Deformation magnitude (mm) 
Mode Reference 
Mean (± ) Range 
Liver 16 ~4.6 (± 3.1) 1.7 - 
15.6 
CBCT Eccles et al(Eccles et al., 2011) 
Liver 4 ~10 < 34 MRI Rohlfing et al(Rohlfing et al., 
2004a) Pancreas 17  < 5 cineMRI Feng et al(Feng et al., 2009) 
Prostate 2 (case study) 3.7 (± 2.3) and 2.8 (± 
4.2) 
 MRI Kerkhof et al(Kerkhof et al., 
2008a) Prostate 25  < 5.4 MRI Nichol et al(Nichol et al., 2007a) 
Lung tumour 10 0.8 (SI direction) < 3 4D-CT Liu et al(Liu et al., 2007) 
Lymph node  21 7.0 (± 4.7) 2 - 23 CT Jenkins et al(Jenkins et al., 2005b)  
 
It is also important to note that the DEFGEL is mass and density conserving and so the results 
presented here do not necessarily represent the achievable accuracy in anatomy that exhibit 
significant density changes during deformation. The lung, for instance, would be poorly 
represented by DEFGEL and one would not expect a meaningful comparison. However, it 
could be feasible to develop a modified DEFGEL dosimeter using established techniques for 
lung-equivalent gel dosimetry (DeDeene et al., 2006, Olberg et al., 2000, Gum et al., 2002). 
The current DEFGEL, as described in this body of work, is more appropriate for anatomy 
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such as the prostate, liver, pancreas, oesophagus, breast et cetera. Furthermore, this study 
clearly focused on external beam radiotherapy. It is worth noting that the approach also shows 
promise in brachytherapy (Yeo et al., 2013). 
 
Regardless of dose-warping accuracy, one can consider its clinical need and ask ‘is it 
necessary to deform doses?’ If the paradigm of uniform PTV dose coverage is employed, an 
adequate approach to determine delivered target dose would be to register the GTV with the 
planning CT to form a composite GTV and check if this composite GTV lies within the 
uniform 3D PTV dose distribution. Clearly, this approach does not necessitate dose 
deformation but only image deformation. However, in the case of dose painting where target 
dose is intentionally heterogeneous, dose warping is necessary to ensure dose to 
corresponding spatial locations are accurately accumulated. A more typical example for the 
necessity of dose deformation is SBRT case delivered by IMRT/VMAT techniques that yield 
heterogeneous dose distributions in PTV as well as around the target volume (i.e. OARs). 
Potential uncertainties on target doses are not only detrimental to estimate local tumour 
control, but are also critical for risk estimates of organs-at-risk (OARs), such as normal tissue 
complication probability (NTCP). For the evaluation of such techniques with the presence of 
anatomy changes it is necessary to appropriately compensate for dose re-distribution in 
moving/deforming anatomy. Of course, real-time tracking of PTVs with multi-leaf 
collimators (MLCs) would need somewhat less consideration of dose re-distribution 
(nonetheless, dose can be still re-distributed due to organ deformation).  
 
As mentioned in the intro section, the recent Point-Counterpoint article (Schultheiss and 
Tomé, 2012) discusses the proposition: ‘It is not appropriate to “deform” dose along with 
deformable image registration in adaptive radiotherapy’. Dr Tomé – who is against the 
proposition – addresses inspiring points in the validity of dose-warping technique in both 
intra-fraction and inter-fractions: 
“Using image sets acquired just prior to delivery of radiotherapy is, however, only a 
first order approximation, since things might change during the course of delivery. 
Before discussing how this point can be addressed, let me just state that the 
approximation based on a single image set acquired just prior to delivery is still better 
than assuming that patients are static CT scans and “flying blind.” Ultimately, 
however, we have to go further: ideally one would acquire anatomical image 
information and record the machine state and dose delivery status at time points 
during the delivery. This information could then be used, employing deformable dose 
accumulation across image sets that are highly correlated, to arrive at a more accurate 
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estimate of dose received for both the target and organs at risk for a given fraction. 
Dose could then be accumulated over the course of treatment by adding to the record 
new imaging information along with the dose delivery information from each fraction. 
The realization of this vision of both dynamically deforming the image and 
accumulating dose is not too far off into the future and will become clinical reality 
with the introduction of MR-guided radiation therapy.” 
The former point, i.e. implementation of intra-fraction dose warping, combined with four-
dimensional CT (4DCT) is addressed in the next chapter (Chapter 6) for liver stereotactic 
body radiotherapy (SBRT). 
 
Another key question in terms of anatomy (also identified in Schultheiss’ and Tomé’s 
discussion) is: what is the accuracy of such methods whereby the mass or density of the tissue 
in question is not conserved? This is, in fact, far less well established and is very much a 
fertile area for research. The complexities of such changes are manifold, including tissue mass 
changes (e.g. atrophy or oedema), organ content changes (e.g. where the bladder wall needs to 
be conserved whilst contents depart along with the dose therein) and density changes (e.g. 
inflation/deflation). To some extent, this could be incorporated into ‘algorithm limitations’, in 
as far as the ideal algorithm could handle such complexities. Recent work published by 
Nithiananthan et al in Medical Physics demonstrated the potential for handling missing tissue 
(e.g. excisions) by modifying the DVF to allow for change beyond the dimensionality of the 
image (Nithiananthan et al., 2012). There is a pressing need for such methodologies 
accounting for mass/density changes and such investigations ought to be the focus of future 
work. 
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5.6 Validation of dose-warping technique: Conclusion 
Using a deformable three dimensional dosimeter (DEFGEL), this work has demonstrated that 
dose-warping using deformation vector fields obtained via deformable image registration can 
accurately represent the true (measured) dose in a deformed medium. Analysis of a range of 
DIR algorithms available in the public domain indicate quite variable results, and shows that 
careful algorithm selection and evaluation is required. For several types and extents of 
deformation, we have compared measured and ‘warped’ dose distributions arising from a 
small (10 x 10 mm
2
) field, cross-shaped (20 x 20 mm
2
) field and a four-dynamic-arc 
stereotactic field adapted from a patient plan. Achievable gamma analysis shows agreement 
of 3%/3mm ≈ 99 % in each case using the Original Horn and Schunck algorithm after 
optimisation and algorithm selection process. Rather than the complexity of the treatment 
delivered, it is the extent of deformation which most greatly affects the accuracy of the 
warped dose distribution. Considering the square field case, the smallest deformation (~9 
mm) yields agreement of 3%/3mm = 99.9 %, whilst the most significant deformation (~20 mm) 
yields agreement of 3%/3mm = 96.7 %. Typical organ deformations are of the order of 3 to 10 
mm. The present study indicates dose-warping may be justified for small deformations in 
particular, and those that do not involve significant density changes. Dose-warping allows 
existing patient plans to be morphed according to new/different patient images. Furthermore, 
it facilitates the calculation of cumulative doses over different states of deformation. 
From this work, one may draw the conclusion that dose deformation can be accurate and 
justifiable – within well-defined contexts. In summary, one may state the following regarding 
the present status of dose-warping and future needs: 
- Dose warping has been shown to be quite accurate with comparison to known 
(measured) data in 3D, within certain contexts. 
- Users must be aware that it is possible for algorithms to accurately reproduce the 
outer contours of structures but inaccurately evaluate internal (low-contrast) volumes. 
- Validation of not only algorithm type but also deformation parameters (e.g. 
smoothing, number of passes, number of iterations per pass etc.) is necessary. 
- One must be cautious with ‘off-the-shelf’ commercial DIR implementations for dose-
warping, which may be insufficiently flexible to allow comprehensive validation and 
optimisation. 
- DIR performance when dealing with mass or density changes needs to be validated to 
make dose-warping confidently applicable to such a case. 
The next chapter (Chapter 6) discusses the application of dose-warping methods validated in 
this chapter into patient cases to retrospectively evaluate 3D planning in a 4D manner. 
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CHAPTER SIX  
: 4D evaluation of conventional 3D treatment plan 
 
Application of the dose-deformation calculation method to a patient 
treatment plan 
 
 
 
“Zwischen die Leber und die Milz past immer noch ein Pils.”
**
 
Tomas Kron, the author’s clinical supervisor. 
                                                     
**
 English translation: Between the liver and the spleen still fits a Pilsner. 
This beautiful rhyme had been made during the preparation for the conferences – IC3DDose and 
EPSM2012, where this chapter’s work had been presented Dec and Nov 2012 respectively. 
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6.1 Overview 
The final objective of this thesis is to apply the validated dose-warping method to the 
evaluation of several SBRT liver patient plans (conventional 3D plans). These plans feature 
steep dose gradients and respiratory movement as well as the associated deformation of the 
target (liver) and nearby organs-at-risk (OARs) including surrounding healthy liver. 4DCT 
data exists for these patients, as such, the 4D dose accumulation method was applied to give a 
better dose estimate, and compare to the 3D plan which assumes no movement or deformation 
exists, i.e. 4D evaluation of conventional 3D plan via dose-warping technique. 
 
Several studies are presented. The first study is to investigate dosimetric discrepancies 
between conventional 3D dose calculation and dose-warping based 4D dose accumulation for 
target as well as OARs. In addition, it aims to investigate how extensive 4D information is 
required in order to perform accurate enough 4D dose accumulation. This study is to 
systematically quantify discrepancies of 4D dose accumulation when different numbers of 
phases from 4DCT are used. The last study is to assess a consequent reduction of healthy 
tissue sparing at OARs, which may increase risk for surrounding healthy tissues. Estimates 
for normal tissue complication probabilities (NTCP) based on the two dose calculation 
schemes are compared.  
 
 
6.2 4D evaluation of 3D SBRT plans: Introduction 
Anatomic changes involving organ deformation due to respiratory motion may introduce 
discrepancies between planned and delivered doses in radiotherapy (RT). This could result in 
significant under-dosing of the tumour and overdosing of healthy tissues, particularly for 
highly conformal techniques applied to thoracic and abdominal malignancy treatments 
(Nehmeh et al., 2002, Brock et al., 2003, Keall et al., 2005). In order to give a better dose 
estimate, one approach for calculation of cumulative doses in moving and deforming targets 
for both inter- and intra-fraction effects is via the ‘dose-warping’ technique using DIR to 
redistribute dose before summation (Schaly et al., 2004a, Janssens et al., 2009b, Paganetti et 
al., 2004). The previous chapter (Chapter 5) has demonstrated using ‘DEFGEL’ (refer to 
Chapter 3) that this may be performed accurately with certain DIR algorithms (refer to 
Chapter 4); the original Horn and Schunck (Horn and Schunck, 1981a) optical flow method 
was found to be suitable when optimised appropriately.  
 
In the past several years, four-dimensional CT (4DCT) scanning techniques have been 
developed to provide information regarding temporal anatomic changes, in which sequential 
image datasets are acquired over multiple phases of the respiration cycle (Keall, 2004, Rietzel 
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et al., 2005). The synergy of these techniques – ‘DIR based dose-warping’ and ‘4DCT 
scanning’ – have made possible 4D dose calculation, which facilitates incorporation of 
temporal information pertaining to tumour motion and deformation. However, previous 
studies have, understandably, focused primarily on the case of pulmonary lesions (Starkschall 
et al., 2009, Zhang et al., 2008, Rosu et al., 2007, Huang et al., 2010b).  
 
Stereotactic body radiotherapy (SBRT), in principle, allows high dose conformity to the 
tumour with minimal dose to the normal tissue (Dawson et al., 2006, Guckenberger et al., 
2007). There is a growing interest in SBRT of the liver (Chang et al., 2011, Sahgal et al., 
2012, Lee et al., 2009) and, while there is growing evidence for clinical efficacy, it is vital 
that the doses actually delivered to tumours and normal tissues are accurately reported 
(Jackson et al., 2010a, Taylor et al., 2011a). While the impact of respiratory motion is likely 
to be much reduced with comparison to the lung case, liver SBRT is nonetheless subject to 
the uncertainties introduced by delivering inherently inhomogeneous dose distributions to 
deforming and moving organs (Taylor et al., 2011b). As such, SBRT of the liver can offer 
excellent local control (Rusthoven et al., 2009, Goodman et al., 2010, Guckenberger et al., 
2008), but is subject to the difficulties introduced by respiratory motion and associated organ 
deformation (Taylor et al., 2011a). Consequently, associated discrepancies between planned 
and delivered doses could result in the potential risk of reduced target coverage and/or 
increased dose to organs at risk. In this way the correlation between dose and clinical 
outcome may be better known; this can be particularly relevant when dose prescriptions and 
resultant treatment plans yield doses to adjacent organs (e.g. the kidney and healthy liver) 
close to (or over) its dose constraints, thus a clinical decision is required.  
 
In the present work, there are two distinct focuses: firstly for targets (i.e. tumours) and 
secondly for untargeted normal tissue (i.e. healthy organs). The primary objective of this 
study is to quantify the extent of dosimetric differences between conventional 3D (static) dose 
calculation and path-integrated quasi-4D cumulative dose calculation, effected via DIR based 
dose-warping, in the context of liver stereotactic body radiotherapy. 4D plan evaluation of 
ITV-based 3D plan can provide a more accurate approximation of the actual planned dose 
than the 3D methodology. Hence, the 4D path-integrated approach will be able to estimate 
more accurately the delivered dose than ITV-based 3D plan.  This is particularly relevant in 
terms of accurate retrospective analysis of outcome-dose correlation, with regards to both 
tumour control and normal tissue exposure. The 4D approach is inherently more time 
consuming and we consequently also explore the number of phases required to accurately 
represent the nominal full 10 phase calculation approach. The secondary objective is to 
answer to the question – what is the impact on untargeted healthy organs and corresponding 
 119 
risk estimates? For comparison between 3D and 4D calculations, we specifically consider 
whether organ dose metrics derived from contours defined on the average intensity projection 
(AIP) or on a single reference phase, provide the better approximation of the 4D dosimetric 
values. Subsequently, we seek to assess the risk of detriment calculated using conventional 
3D and 4D dose-warping approaches in terms of normal tissue complication probabilities 
(NTCP) (Yorke, 2001, Kong et al., 2007, Miller et al., 2009). Whether for prospective 
estimation of patient risks or retrospective analysis of plan efficacy, we demonstrate that the 
quasi-4D dosimetry methodology is important for accurate estimation of doses and 
corresponding risks. 
 
This chapter has focused on application, in particular, to liver stereotactic body radiotherapy 
(SBRT) for the reasons described below:  
i) The liver often presents the largest degree of anatomic distortion with mass and 
density conserving deformation, which can cause significant intra- and/or inter-
fractional effects throughout fractioned treatment courses; 
ii) SBRT is fast increasing as one of the most common advanced modes of radiotherapy 
for treatment of liver lesions, allowing high dose conformity to the tumour with 
minimal dose to the normal tissue; 
iii) It is nonetheless subject to the uncertainties introduced by delivering inherently 
inhomogeneous dose distributions to deforming/moving organs; 
iv) Comparing, for instance, an alternative advanced mode of radiotherapy such as 
IMRT, the doses delivered per fraction in SBRT are typically much higher, ranging 
from approximately 5 – 25 Gy, compared to 1.8 – 3 Gy for IMRT;  
v) The consequent number of fractions is fewer, typically 1 – 5 fractions as opposed to 
10 – 30; 
vi) Furthermore, the margins in conventional radiotherapy may be of the order of 
centimetres, whilst in SBRT the margins are of the order of millimetres. 
 
These factors emphasise that the liver lesion in conjunction with SBRT treatment modality is 
the most relevant clinical scenario to perform 4D evaluation of 3D treatment plans by 
applying the findings presented in previous chapters of this thesis. Liver SBRT involves large 
mass- and density-conserving deformation with high doses which must necessarily be 
delivered with high spatial accuracy. Consequently, associated discrepancy between planned 
and delivered doses is likely to be pronounced, and could result in the risk of reduced dose 
conformity and tumour control. For these reasons, liver SBRT is likely to gain the most 
benefit from implementation of 4D dose accumulation. As such, the issues of dosimetry are of 
critical importance for more effective treatments, and thus improved patient outcomes. 
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6.3 4D evaluation of 3D SBRT plans: Methods and Materials 
Plans were evaluated for four consecutive patients, with five lesions, treated with SBRT for 
liver metastases and for whom 4DCT imaging had been performed at the time of treatment 
planning. The datasets exhibited various degrees of tumour motion and shape change, as well 
as tumour size and location. Table 1 lists the patients’ characteristics, including the tumour 
sizes and motion ranges, where the latter was determined as the distance between the GTV 
centroids on the two extreme respiratory phases. 
 
6.3.1 Patient data acquisition using 4DCT imaging 
Patients were imaged using respiratory correlated x-ray CT (Brilliance CT Big Bore Philips 
Medical System, Cleveland, OH, USA). Patients were advised to perform free regular 
breathing, and a respiration signal was acquired via a pressure sensor fixed to the abdominal 
region by an elastic belt. CT slice thickness and spacing were both 3mm. Respiratory-
correlated 4DCT data sets were comprised of a total of 10 phases, acquired at equally-spaced 
time intervals (0-90% of respiratory period) across the entire breathing cycle. The 0% and 
50% phases were confirmed to correspond to end-inspiration and end-expiration, respectively. 
All acquired 4DCT data sets were imported into the Eclipse treatment planning system 
(Varian Medical Systems, Palo Alto, CA).   
 
6.3.2 3D treatment planning 
i) Tumour definition: Gross tumour volumes (GTVs) were delineated on the two extreme 
phases (the end-exhalation and the end-inhalation of the breathing cycle). An internal target 
volume (ITV) was defined as the sum of GTV positions at the extreme phases (0% and 50%) 
in accordance with an established target volume concept (Rietzel et al., 2006, Wambersie and 
Landberg, 1999), with no CTV margin applied. A 5 mm margin was isotropically added to 
the ITV for generation of the planning target volume (PTV) in order to compensate for errors 
in tumour position.  
 
ii) Anatomical structures contouring process: In clinical practice, our group performs 
conventional 3D planning using contours derived from the average CT dataset (average 
intensity projection, AIP) – referred to as 3DAIP. However, contouring on the reference phase 
(3DREF) is an alternative and equally acceptable workflow practice, as described by others 
(Jung et al., 2013). In this study, as an additional point of comparison, we assess the 
implications of contouring with either methodology in terms of 4D dosimetric accuracy. As 
such, for the 3DAIP case, the liver, as well as other normal anatomic structures (specifically the 
left and right kidney, spinal cord, heart, small bowel, and stomach) were contoured at the AIP 
image. On the other hand, normal anatomic structures were contoured at the end-exhalation 
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phase (at 50% of the total breathing cycle) which was chosen as the reference phase where the 
smallest tumour motion and consequently minimum motion artefacts would be expected 
(Keall et al., 2006, Keall et al., 2005). The normal liver is defined in the conventional manner 
(i.e. total liver on AIP image minus ITV for the 3DAIP case and total liver on the reference 
image minus GTV+5mm for the 3DREF case). The ‘original’ dose distribution (the conventional 
3D-static plan) was calculated using the average CT dataset.  
 
iii) Equipment and planning parameters: 
SBRT treatments were planned on Eclipse v8.9 for treatment on a Varian 21EX (Varian 
Medical Systems, Palo Alto, CA), equipped with a multi-leaf collimator (5-mm leaf width). 
Between seven and nine fields (co-planar/non co-planar) were used for stereotactic body 
radiotherapy (SBRT) delivery via 6 MV photons at 600 MU/min. Dose was calculated using 
the Eclipse analytical anisotropic algorithm (AAA) with a grid size of 3 mm according to a 
departmental protocol for liver SBRT (i.e. abdominal lesions). Total doses of 42 Gy in 6 
fractions or 50 Gy in 5 fractions were prescribed to a minimum surrounding isodose between 
80% – 87%. The resultant prescribed dose, delivered to at least 95% of the volume of interest 
(VOI) in the PTV, is shown in Table 6-1. 
 
Table 6-1 Patient characteristics (tumour volume and motion range) and D95 from dose prescription 
with fractionation schemes for each patient. GTVavg = gross tumour volume averaged from all 10 phase 
images; r3D = magnitude of 3D vector; SI = superior-inferior; AP = anterior-posterior; LR = left-right; 
D95 = prescribed dose to at least 95 % of PTV. 
  Motion range (mm)  
Lesion 
GTVavg 
(cm
3
) 
r3D SI AP LR D95 (Gy) 
       A (patient 1) 22.7 8.8 7.5 4.6 0.9 43.7    (7.28 Gy  6) 
B (patient 1) 12.4 10.6 10.5 0.5 1.0 41.7    (6.95 Gy  6) 
C (patient 2) 54.5 7.5 7.5 0.0 0.1 46.3    (7.72 Gy  6) 
D (patient 3) 6.7 16.6 16.5 1.8 1.2 54.5    (10.9 Gy  5) 
E (patient 4) 86.2 10.7 10.5 1.6 1.1 44.5    (7.42 Gy  6) 
        
 
6.3.3 Deformable image registration  
The end-exhalation (50%) phase was defined as the reference (target) image for the treatment 
plan and the nine remaining phases (0 to 90%, except 50%) were used as the source (moving) 
images. The latter were morphed to approximate the target image using the optical flow 
method of deformable image registration (DIR). Selection of the algorithm employed for this 
study was justified based on our previous study (refer to the two previous chapters, Chapter 4 
and Chapter 5) as well as those of other groups (Zhang et al., 2008, Huang et al., 2010b) who 
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have used it for the lung case. Difference maps (between calculated and ‘target’ images) were 
employed to evaluate the accuracy of the calculated deformations generated via DIR. We 
have used the DIRART implementations (Yang et al., 2011a) of these algorithms as these are 
freely available in the public domain and thus the present approach may be easily reproduced 
by interested readers. Furthermore, the calculated deformation vector fields (DVF) are 
accessible to the user for application to dose-warping, which may not necessarily be the case 
for commercial software algorithms. 
 
 
6.3.4 4D-cumulative dose calculations 
For each patient, the 3D-static plan was applied individually to each of the ten respiration 
phases of the CT sets and recalculated. All planning parameters (prescribed monitor units, 
beam arrangement, leaf positions, isocentre position etc.) remained unchanged. The doses 
were warped to follow anatomic changes by applying the DVF derived from DIR of each 
image phase. The resulting dose distributions from all other respiration phases were warped to 
the reference (end-expiration) phase for summation. The warped doses were equally weighted 
to estimate the path-integrated 4D-cumulative dose distribution, which constitutes a more 
accurate approximation of the actual delivered dose than the 3D methodology.  
 
We also explored the number of phases required in the 4D evaluation to obtain an 
approximately equivalent estimate as the ten-phase approach (with a view to minimising 
calculation time). Accumulated dose distributions were investigated using fewer phases (p = 
2, 3, 5). For p = 5, two alternative sets of five phases were used (labelled 5even and 5odd). In 
each scenario, warped doses from the different number of the respiration phases were 
averaged with equal weighting: 
i)  4Dp = 2   – two extreme phases (0% and 50 %),  
ii)  4Dp = 3   – 30%, 60%, and 90% phases,  
iii)  4Dp= 5,even   – 0%, 20%, 40%, 60%, and 80% phases,  
iv) 4Dp=5,odd     – 10%, 30%, 50%, 70%, and 90% phases.  
Each of the above four-dimensional cumulative dose calculations were compared to that 
calculated from the nominal full ten phases (4Dp=10 dose).  
 
 
6.3.5 Dosimetric evaluation of 3D-static and 4D-cumulative dose calculations  
Dose–volume histogram (DVH) analyses of the target volumes (GTV, CTV, and PTV) and 
the normal liver were performed. The GTV was defined from the reference phase (50%). The 
conventional 3D-static and quasi-4D accumulated doses were compared using dose-difference 
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maps and in terms of dose-homogeneity of target volumes. The latter involves computation of 
Dx, the absorbed dose delivered to at least x % of the VOI. The dose to 98 % of target volume 
(D98, or “near-minimum” dose) and the dose to 2 % of the target volume (D2 or “near-
maximum” dose) describe the spectrum of dose that a target volume receives (Grégoire and 
Mackie, 2011). The resultant ratio of D2/D98 was adopted as a parameter which we henceforth 
term the homogeneity index (HI) (Guckenberger et al., 2007). This parameter describes dose-
homogeneity that is related to the sharpness of the fall-off in the DVH shoulder; an HI value 
of unity implies perfect homogeneity.  
  
The biological effective dose (BED) was also calculated (Fowler, 1989b) using the DVH-
based approach: 
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where n = the number of fractions, di = the dose per fraction in bin i of the DVH, and the 
value  Gy was used for late toxicity in the normal liver (Dawson et al., 2002) and the 
commonly used value  Gy was applied for the tumour (Wulf et al., 2006).  
 
Organ doses calculated using both the standard contouring on the reference phase (3DREF) and 
on the AIP (3DAIP) were compared to the 4D method, 4DREF (also contoured on the reference 
phase). Comparisons were undertaken in terms of the mean dose, Dmean, and near-maximum 
dose, D2. The former comparison (3DREF vs. 4DREF) is of course the focus of the work, since 
the organ volumes are then consistent between the two dose calculation schemes. However, 
3DAIP is used for organ dose calculation in routine clinical practice. Hence, it is desirable to 
investigate both cases (3DREF and 3DAIP) for organ doses, in particular when comparing it to 
4DREF. As such, the latter comparison (3DAIP vs. 4DREF) was also performed; in this way, 
3DAIP and 3DREF could be investigated. This also allows identification of the preferred 
contouring methodology, i.e. whether contours defined on the AIP or reference phase provide 
the best approximation to the 4D case. 
 
4D evaluation using fewer than 10 phases was performed by comparing DVHs. The ratio of 
the fractional volumes was considered over the dose sub-range D98-D50 for the target (PTV) 
and normal liver. 
 
 
6.3.6 Calculation of NTCP for deterministic effects 
Calculation of the NTCP in this work follows the Niemierko approach (Niemierko, 1996), 
and first involves determination of the isoeffective biologically equivalent dose (B). Since the 
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calculations are based on dose volume histograms (DVH), initially matrices of [B] values are 
evaluated in terms of the matrix of dose values, [D]. Thus, for each dose element Di,  
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in terms of the alpha-beta ratio, /, the number of fractions, fn, and the standard dose per 
fraction, Df (2 Gy). The total irradiated volume is then normalised to unity over all N sub-
volumes Vj: 
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The equivalent uniform dose (EUD) may then be evaluated 
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(6-4)  
where a is a fitting parameter (a is the inverse of the volume dependence parameter n in the 
Lyman model). In terms of the EUD, the normal tissue complication probability (NTCP) may 
be defined as: 
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where TD50 has the usual definition of the ‘tolerance dose’ corresponding to a 50 % 
likelihood of a complication and γ50 is the slope of the dose response curve (Niemierko, 
1996). The parameters of interest are given in Table 6-2. Note that the fractionation scheme 
employed is 6  7 Gy (42 Gy) and, except where otherwise stated (i.e. comparison with 
different schemes), all data correspond to this fractionation. 
 
Accurate estimation of normal tissue complication probabilities relies on minimal 
uncertainties in model parameters. Due to the limited clinical data available in model 
parameters for hypofractionated treatments, such certainty does not exist for the OARs 
considered in liver SBRT. In the case of normal liver, Xu et al (Xu et al., 2006) have provided 
model parameters derived from a dose fractionation scheme of 54 Gy delivered to the 
isocentre with a median fraction size of 4.6 Gy. We therefore repeated the NTCP calculations 
using the Lyman/Kutcher-Burman (Kutcher and Burman, 1989) (LKB) model for comparison 
with the Niemierko estimates that were derived from standard fractionation schemes 
(Kavanagh et al., 2006, Emami et al., 1991, Fowler, 1989a). The model parameters of Xu et 
al were also used to demonstrate the differences in NTCP estimates for normal liver with 
different, commonly used fractionation schemes.  
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Table 6-2 Organ-specific parameters associated with calculation of the NTCP. 
Organ a γ50 TD50 / Endpoint and references 
Liver (healthy) 1 3 40 3 Liver failure 
Kidney  1 3 28 2.5 Nephritis 
Spinal cord 13 6.7 66.5 3.3 Myelopathy/necrosis 
Heart 2.9 3 49.2 2.5 Pericarditis 
Bowel 6 2.6 55 4.3 Perforation/morbidity 
Stomach 14 3 65 5 Perforation 
 
 
 
6.4 4D evaluation of 3D SBRT plans: Results 
6.4.1 4D-CT and 3D-static plan 
The tumour displacement (3D vector magnitude) due to breathing motion varied from 7.6 mm 
(Lesion C, with the largest volume) to 16.6 mm (Lesion D, with the smallest volume); see 
Table 6-1. As an example of an intermediate magnitude of tumour displacement, Figure 
6-1(a) shows sagittal views of Patient 1, generated from ten phases of 4D-CT sets through the 
same plane. The upper and lower horizontal lines of the figure are placed to guide the eye and 
help indicate the deformation of the liver and the right kidney. Minor artefacts were observed, 
especially at the edge of the liver at mid-ventilation phases; however, these did not influence 
the results as none of the target volumes incorporated regions exhibiting artefacts. Figure 
6-1(b) presents dose distributions in three orthogonal planes encompassing the maximum 
doses for Lesion C and Lesion D, illustrating the dose gradient in the PTV. The existence of 
the latter dose gradient combined with the impact of deformation and motion is immediate 
evidence that discrepancies will exist between the 3D and 4D dose calculations. 
Consequently, this could imply overestimated dose conformity and tumour control for typical 
planning methodologies.  
 
 
6.4.2 Deformable image registration 
The results of DIR were assessed using difference maps to confirm that the registration was 
acceptable for all patients. The registration result for two extreme phases (end-inhalation to 
end-exhalation) is shown in Figure 6-2 as an example (coronal view). In the first row, the 
upper (red, short dash) and lower (green, long dash) lines show the alignment of the top of the 
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liver and the kidneys respectively, before and after DIR (simply as a point of reference to aid 
visual comparison of the images). In the second row, a difference map before performing DIR 
illustrates the difference between the source and target images; the post-DIR difference map 
compares the target and calculated images. The high level of agreement demonstrates the 
good performance of the optical flow method. 
 
Figure 6-1 (a) Example of sagittal planes generated from the 4D-CT sets for Lesion B. The arrow at 
0% indicates the target region (indicated with a dotted line). (b) Dose distribution in liver; the planning 
target volumes (PTV) are indicated for Lesion C (the largest volume with the smallest motion) and 
Lesion D (the smallest volume with the largest motion) in three planes.  
 
 
 
Figure 6-2 Example result of deformable image registration (DIR) using the optical flow method 
shown in the coronal view (for Patient 1). The scale in the difference map is in HU. 
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6.4.3 Comparison of 3D and 4D doses 
Deformation vector fields resulting from DIR were applied to planned doses at different 
breathing phases to morph them back to the reference (end-expiration) phase for 4D dose 
calculations. Difference maps between these warped doses and the reference dose calculated 
from 3D-static plan were computed. Dose-difference maps of a coronal slice are shown in 
Figure 6-3 for Lesion D, which exhibited the smallest tumour size with the largest 
displacement due to breathing motion amongst all five lesions. The value in the bottom-left 
corner of each figure indicates the maximum point dose difference inside the liver. As 
expected, dose-differences are greatest for the greatest motion. These maximum differences 
ranged from ~22% to ~88% with respect to the reference plan. 
 
 
 
Figure 6-3 An example of dose-difference maps between warped doses from each phase (0% to 90%) 
and the reference dose (50%) for Lesion D. The percentage in the bottom-left corner of each figure 
indicates the maximum point dose difference inside the liver. Hot (red) and cold (blue) spots indicate 
positive and negative differences, respectively.  
 
 
The warped doses were equally weighted to estimate the path-integrated 4D-cumulative dose 
distributions. Figure 6-4 (c) depicts dose-volume histograms (DVH) of targets and normal 
liver for Lesion C and Figure 6-4 (d) shows the DVH ratio of the 3D to 4D calculated doses. 
In this case, the 3D approach provides a very good estimate of the target doses up to 45 Gy, 
beyond this the 3D approach overestimates target doses. On the other hand, the normal liver 
dose is underestimated up to 40 Gy; beyond this the deviation becomes more significant (up 
10% – 50% 0% – 50% 20% – 50% 
30% – 50% 40% – 50% 60% – 50% 
70% – 50% 80% – 50% 90% – 50% 
87.6% 87.1% 78.4% 
60.1% 
26.0% 
41.8% 22.2% 
77.5% 86.5% 
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to 50%). These results illustrate that the conventional 3D dose calculation overestimated dose 
for the targets (particularly PTV), whilst underestimating the dose to the normal liver, 
compared to the quasi-4D dose calculation. This general trend is observed in all other lesions 
– detailed DVH results are shown in Figure 6-5. 
 
 
Figure 6-4 Illustration of 4D evaluation of 3D plan. (a) 4D calculated dose distribution for Lesion D 
(coronal plane shown). (b) Dose difference between 3D and 4D in the same plane. All units of dose are 
gray. (c) Dose-volume histograms for targets and normal liver. (d) The ratio of the 3D to 4D calculated 
doses up to 55 Gy. In this case, the 3D approach provides a very good estimate of the target doses up to 
45 Gy, beyond this the 3D approach overestimates target doses. On the other hand, the normal liver 
dose is underestimated up to 40 Gy, beyond this the deviation becomes more significant (up to 50%). 
Straight and dashed lines illustrate 3D and 4D dose calculations respectively (red: GTV, blue: CTV, 
green: PTV, and black: normal liver).  
(a) 3D and 4D dose distribution (Lesion D) (b) Dose diff.4D – 3D (Lesion D) 
(c) DVH (3D vs. 4D) (d) DVH ratio (3D/4D) 
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Figure 6-5 DVH comparisons of 3D vs. 4D dose calculation methods (a) Lesions A, (b) Lesion B, (c) 
Lesion C and (d) Lesion E. 3D approach overestimate target doses in particular high dose region (i.e. 
dose falloff region of DVH shoulder). On the other hand, the normal liver dose is underestimated up to 
40 Gy, beyond this the 3D approach overestimate dose received by the normal liver. Straight and 
dashed lines illustrate 3D and 4D dose calculations respectively (red: GTV, blue: ITV, green: PTV, and 
black: normal liver).  
 
6.4.4 Target volumes 
Table 6-3 summarises the dose-volume relationships for target volumes in the 3D and 4D 
dose calculations, for all lesions studied. All values in the table are obtained from DVH 
results shown in Figure 6-4 and Figure 6-5. In order to compare the dosimetric differences 
between the two calculation schemes, the mean dose (Dmean), the 2 % near-maximum dose 
(D2) and the 98 % near-minimum dose (D98) are tabulated for GTV, ITV, and PTV. The 
homogeneity index (HI) was calculated based on the two latter quantities and the ratio of HI 
of the 3D and 4D calculations HI3D/4D %) was also calculated. Expectedly, smaller volumes 
receive more homogeneous coverage (HIGTV > HIITV > HIPTV). 
 
(a) DVH (Lesion A) (b) DVH (Lesion B) 
(c) DVH (Lesion C) (d) DVH (Lesion E) 
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In the case of the conventional 3D dose calculations, the PTV Dmean ranges from 41.1 Gy 
(BED 68.6 Gy) to 52.7 Gy (BED 105.4 Gy). In the case of the 4D calculation, the BEDmean 
(4D) of the PTV was 1.5 to 8 % lower across all lesions. HI for the 3D dose calculations 
ranged from 1.02 – 1.08, 1.05 – 1.17, and 1.17 – 1.37 for GTV, ITV, and PTV respectively, 
across all lesions. HI in the 4D case were higher (less homogeneous), ranging from 1.03 – 
1.09, 1.06 – 1.28 and 1.36 – 1.64 for GTV, ITV and PTV, respectively. In other words, the 
conventional 3D approach overestimates the homogeneity by on average over 1 %, 4 % and 
17 % for the GTV, ITV and PTV, respectively, relative to the 4D calculation. The volumes 
GTV+5mm show a similar trend as ITV/PTV results, receiving less dose and poorer 
homogeneity than predicted by the 3D calculation (see Table 6-4). 
 
Table 6-3 Comparison between conventional 3D dose calculation and path-integrated 4D-cumulative 
dose calculation in target volumes; dose in Gy, HI is dimensionless. 
Lesion 
Target 
(volume in 
cm3) 
Dmean  
(3D / 4D) 
BEDmean 
(3D / 4D) 
D2 
(3D / 4D) 
D98 
(3D / 4D) 
HI  
(3D / 4D) 
HI3D/HI4D 
(=HI3D/4D%) 
A 
GTV (22.7) 45.0 / 44.8 79.2 / 78.9 46.8 / 46.7 43.1 / 42.7 1.08 / 1.09 99.1 
ITV (31.1) 45.1 / 44.7 79.4 / 78.7 46.7 / 46.7 42.6 / 38.9 1.10 / 1.20 91.7 
PTV (66.4) 44.0 / 43.4 77.4 / 76.4 46.7 / 46.7 36.8 / 30.9 1.27 / 1.51 84.1 
B 
GTV (12.4) 42.7 / 40.4 71.3 / 67.5 43.4 / 43.2 41.1 / 39.8 1.06 / 1.08 98.2 
ITV (17.9) 42.1 / 39.0 70.3 / 65.1 43.3 / 43.2 36.9 / 33.8 1.17 / 1.28 91.4 
PTV (39.3) 41.1 / 37.8 68.6 / 63.1 43.3 / 43.2 31.7 / 26.4 1.37 / 1.64 83.5 
C 
GTV (54.5) 48.2 / 47.8 81.9 / 81.3 50.2 / 49.8 46.1 / 45.6 1.08 / 1.09 99.7 
ITV (87.0) 48.0 / 47.4 81.6 / 80.6 50.2 / 49.8 44.7 / 44.1 1.12 / 1.13 99.1 
PTV (168.7) 47.4 / 46.3 80.6 / 78.7 50.1 / 49.8 42.8 / 36.6 1.17 / 1.36 86.0 
D 
GTV (6.68) 55.3 / 55.0 111.0 / 110.0 55.8 / 55.6 54.3 / 53.9 1.02 / 1.03 99.6 
ITV (21.28) 54.8 / 54.4 109.6 / 108.8 55.7 / 55.5 53.0 / 52.2 1.05 / 1.06 98.8 
PTV (71.36) 52.7 / 50.7 105.4 / 101.4 55.6 / 55.4 46.3 / 35.3 1.20 / 1.57 76.5 
E 
GTV (86.16) 46.2 / 45.0 82.2 / 80.1 46.7 / 45.9 43.8 / 41.9 1.07 / 1.08 99.1 
ITV (100.5) 46.0 / 44.8 81.9 / 79.7 46.6 / 45.8 43.2 / 41.2 1.08 / 1.11 97.0 
PTV (187.24) 44.3 / 42.4 78.9 / 75.5 46.3 / 45.4 38.2 / 31.0 1.21 / 1.46 82.8 
Abbreviation: 3D = three-dimensional dose calculation; 4D = four-dimensional dose calculation; Dmean 
= mean dose; BEDmean = biologically effective mean dose, D2 = 2% near-maximum dose; D98 = 98% 
near-minimum dose; HI = homogeneity index (the ratio of D2 to D98, D2/D98), HI3D/4D% = the 
percentage ratio of HI for 3D to 4D (HI3D/HI4D). All doses in Gy. 
 
Quantitatively, the HI ratioHI3D/4D) of the GTV was universally >98 %, indicating good 
agreement. Physically, this implies that the GTV dose may be well estimated using 
conventional 3D dose calculation. In contrast, HI3D/4D values were significantly lower for the 
ITV (ranging from 91.4% to 99.1 %) and PTV (ranging from 76.5% to 86.0 %). These results 
illustrate that the conventional method of 3D dose calculation overestimates dose 
homogeneity by up to ~24%, particularly in the high dose gradient region around the PTV 
margin.  Healthy liver tissue adjacent to the PTV could move in and out of the treatment 
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beam field over the breathing cycle, resulting in undesired dose to healthy liver and a 
reduction in dose conformity to the PTV. In quantifying such effects, the 4D methodology 
clearly demonstrates its advantage.  
 
Table 6-4 Comparison between conventional 3D dose calculation and path-integrated 4D cumulative 
dose calculation in the volume of GTV + 5 mm margin. 
GTV+5mm 
Vol (cc) 
Dmean  BEDmean  D2  D98  HI  HI3D/HI4D 
Lesion 3D 4D  3D 4D  3D 4D  3D 4D  3D 4D  % 
A 46.4 44.4 42.8  77.3 73.3  46.6 46.4  40.4 37.6  1.15 1.23  93.5 
B 29.2 42.0 39.8  71.4 66.2  43.3 43.2  38.3 34.0  1.13 1.24  90.9 
C 100.4 47.8 47.5  85.9 85.0  49.6 49.8  45.3 44.8  1.09 1.11  98.5 
D 18.6 54.8 54.5  114.9 113.9  55.6 55.5  53.1 52.3  1.05 1.06  98.7 
E 143.3 45.3 43.6  79.5 75.3  46.6 45.9  40.6 35.9  1.15 1.28  89.8 
Abbreviation: Vol (cc) = volume in cubic centimetre (cm
3
); GTV+5mm = GTV plus 5 mm margin; others are same as those 
in Table 6–3. All doses in Gy. 
 
 
Consistent with expectation, it is worth emphasising that the smaller volume with larger 
motion yielded a greater discrepancy between 3D and 4D dose calculations than the larger 
volume with smaller motion (see Table 6-4), in agreement with previous findings (Dunn et 
al., 2012). This highlights that while ITV/PTV concepts ensure GTV coverage, the evaluation 
of dose coverage and homogeneity in these volumes is not an appropriate indicator of plan 
quality for 4D evaluation of 3D plans. 4D dose warping explicitly accounts for motion in the 
treatment field, including ingress of healthy tissue. These discrepancies arise principally in 
circumstances whereby the dose gradient is most prominent in the PTV periphery (but well 
beyond the ITV). 
 
 
6.4.5 4D approach with <10 phases 
Although ten is generally the number of phases required to adequately approximate the 
motion of a typical tumour due to respiratory motion (Dunn et al., 2012), using fewer phases 
would reduce calculation time and is consequently worth exploring in terms of accuracy. 
Figure 6-6 shows, for Lesion E, the coronal view of the dose-difference maps between 4D-
cumulative dose calculated from the full ten phases and that calculated from various subsets 
of phases (p = 2, 3, 5even, and 5odd). Doses in all cases were mapped back onto the reference 
image set (end-expiration). 
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Figure 6-6 Dose-difference maps between 4D doses calculated with different numbers, p, of phases (p 
= 2, 3, 5even and 5odd) and the standard p = 10 phases. The example is shown for Lesion E, in which the 
PTV is contoured. The maximum point dose difference is shown as a percentage in the bottom-left of 
each panel. Hot (red) and cold (blue) spots indicate positive and negative differences, respectively. 
 
 
The maximum point dose difference in PTV, displayed as a percentage in the bottom-left 
corner of each figure, varied from 7.5% to 25.4%. As expected, this result illustrates that the 
more phases used for 4D dose calculation, the better the approximation of the delivered dose 
(p = 10). These point-wise discrepancies, however, do not generate a significant difference in 
DVHs between the two calculation schemes, as shown in Figure 6-7.  
 
Figure 6-7 shows DVH for targets and normal liver in Lesion E. The inset figure panels are 
ratios of 4D calculations of different numbers of phases (p = 2, 3, 5even, 5odd) relative to the 
standard number of phases (p = 10). The most striking observation one makes from Figure 
6-8 is that even the use of as few as two phases results in a more accurate estimate of the dose 
than the conventional 3D calculation. In this case (Lesion E), the 4Dp=3 dose or even 4Dp=2 
give a good approximation of the full ten-phase dose for the PTV as well as GTV, ITV and 
normal liver; agreement within 3% is demonstrated over the D98 and D50 interval. 
 
 
7.5% 7.5% 
12.9% 25.4% 
4D(p=10) – 4D(p=2) 
 
4D(p=10) – 4D(p=3) 
 
4D(p=10) – 4D(p=5odd) 4D(p=10) – 4D(p=5even) 
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Figure 6-7 DVH for targets and normal liver in Lesion E: (a) GTV, (b) CTV, (c) PTV and (d) Normal 
liver. Various numbers of phases (p = 2, 3, 5even, 5odd, and 10) were used for the 4D dose calculation. 
The 3D dose calculation is depicted as a black line and the 4D dose calculation as coloured lines; red: p 
= 2 phases; orange: p = 3; yellow: p = 5even; green: p = 5odd, and blue: p = 10. The inset figures show the 
ratio of fractional volume relative to the 4Dp=10 calculation over the D98 and D50 interval derived from 
the 4Dp=2 PTV and normal liver histograms.. 
 
 
For the other patients in this study, generally at least three phases are required to achieve a 
reasonable approximation of the delivered dose as represented by the ten phase set. This is 
shown in Figure 6-8, which depicts DVH of the PTV for Lesions A – D, respectively; the 
insets are ratios to the ten phase case. In these cases, 4D dose calculation using two extreme 
phases yielded differences of up to 10% and 17% for Lesion B and Lesion D, respectively 
(large motions with small target volumes), compared to the full 10-phase method. In all cases, 
using three phases was enough to limit differences to less than 5%.  
 
(a) GTV 
(c) PTV (d) Normal liver 
(b) CTV 
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Figure 6-8 DVHs for PTV: a) Lesion A, b) Lesion B, c) Lesion C and d) Lesion D. Inserts show the 
ratio of fractional volume relative to the 4Dp=10 calculation over the D98 and D50 interval derived from 
the 4Dp=2 histogram for each lesion. All lines are as described for Figure 6-7. 
 
6.4.6 Organs at risk: dosimetric comparisons 
It is the aim of the current study to highlight the utility of 4D path-integrated dose 
accumulation (to supplement conventional 3D planned dose calculations) for better estimation 
of the dose received by both targeted and untargeted volumes in liver SBRT. The foremost 
objective in planning is to achieve coverage of the primary tumour, as was described in the 
previous sections, while minimising any potential harm to the patient. With this in mind we 
note that the estimated doses to healthy peripheral organs vary dramatically depending on the 
calculation method (3D or 4D). This is illustrated by the dosimetric comparison shown in 
Figure 6-9 – examples (e.g. spinal cord) of disparity between 3D and 4D approaches. Motion 
compensation strategies such as the ITV concept serve to ensure GTV coverage, but the TPS 
calculation of the dose distribution will not account for the movement of healthy tissue into 
the treatment fields.  
(a) Lesion A 
(d) Lesion D 
(b) Lesion B 
(c) Lesion C 
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Figure 6-9 (a) Dose volume histogram (DVH) of the spinal cord of Patient 1. The inset figure shows the ratio of 
the 3D to 4D calculated dose up to 20 Gy. In this case, the 3D approach poorly estimates the dose to the healthy 
spine. (b) Dose volume histogram (DVH) of the spinal cord of the second patient treated. The inset 
figure shows the ratio of the 3D to 4D calculated dose up to 20 Gy. In this case, the 3D approach 
provides a very good estimate of the dose to the healthy spine.  
 
Consider Figure 6-9 (a) and (b), which shows the dose to the same healthy structure for two 
different patients; in one case, (a), the 3D method is a poor estimate of the dose, while in the 
other case, (b), it is a very good estimate. Referring Section 6.3.5, although organ doses were 
calculated using both the standard contouring on the reference phase (3DREF) and on the AIP 
(3DAIP), note that 3DREF and 3DAIP are not differentiated in Figure 6-9 because the two cases 
yield essentially same DVH results for the case of spinal cord in Patient 1. In general, it is 
clear that the doses to healthy tissues calculated using the conventional 3D approach may 
differ greatly from those determined using the 4D methodology, and this is what has 
prompted this part of the present study. 
 
Figure 6-10 summarises dosimetric results for critical organs such as normal liver, spinal 
cord, right/left kidney, stomach, small bowel and heart in both dose calculation schemes. This 
figure shows two sets of comparison: i) 3DREF vs. 4D and ii) 3DAIP vs. 4D, which allow 
illustration of whether contours defined on the AIP or reference phase provide the best 
approximation to the 4D case. Figure 6-10 (a) and (c) show the mean doses, Dmean, and the 
near-maximum doses, D2, (maximum dose received by at least 2 % of the volume), 
respectively, calculated using 4D path-integrated dose accumulation method (i.e. taking into 
account organ motion/deformation). The error bars indicate maxima and minima observed for 
the patient cohort studied. The ratio of the conventional 3D calculated doses to the 4D path-
integrated cumulative dose are shown in Figure 6-10 (b) Dmean and (d) for D2. Overall, the 
average difference (between 3D and 4D) in Dmean is about 10 % and in D2 is around 5 %.  
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Figure 6-10 Comparison of 3D and 4D dose calculations. The data presented is the average over all 
patients studied. (a) The mean healthy organ doses (Dmean). The error bars indicate maximum and 
minimum observed values. (b) The ratio of the mean dose as calculated via conventional 3D methods 
relative to the 4D case; shown for both contouring on the reference phase and on the AIP. (c) The near-
maximum dose (D2). The error bars indicate maximum and minimum observed values. (d) The ratio of 
the near-maximum dose as calculated via conventional 3D methods relative to the 4D case; shown for 
both contouring on the reference phase and on the AIP. The average difference (between 3D and 4D) in 
the mean dose is about 10 % and in D2 is around 5 %. (e) The near-minimum dose (D98). The error bars 
indicate maximum and minimum observed values. Values less than 0.1 Gy are not shown. (f) The ratio 
of the near-minimum dose as calculated via conventional 3D methods relative to the 4D case; shown 
for both contouring on the reference phase and on the AIP. Labelled values in (a), (c) and (e) are the 
average of (Dmean), (D2) and (D98), respectively, from all patients studied. 
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For normal liver, there is an observable trend such that Dmean calculated from the 3D-static 
dose calculation were up to 8% lower compared to 4D-cumulative dose calculation. On the 
other hand, for right kidney, the mean doses calculated from the 3D-static dose calculation 
were up to 21% higher compared to 4D-cumulative dose calculation. Doses to other organs 
are low and consequently differences between 3D (both 3DREF and 3DAIP) and 4D methods are 
not as troubling in an absolute sense. This illustrates that reduced doses in tumours due to 
organ motion/deformation can lead to increased doses to the normal liver (which 
encompasses the entire tumour volume) as well as the right kidney and/or small bowel (which 
are adjacent to the normal liver). In particular, such results can be more clearly observed in 
the case of Patient 1; see Figure 6-11 that shows an example of DVHs comparisons for 
critical organs (e.g. healthy liver, spinal cord, right kidney, stomach and small bowel). 
 
 
 
Figure 6-11 An example of dose-volume histograms (DVHs) comparisons for critical organs in Patient 
1: (a) 3D AIP vs. 4D, (b) 3D REF vs. 4D. Straight and dashed lines illustrate the results calculated from 
3D-static and 4D-cumulative dose calculation, respectively (black: normal liver, red: spinal cord, blue: 
right kidney, green: stomach, and purple: small bowel). 
 
 
For more details, Table 6-5 lists Dmean, D2 (=Dnearmax) and Dmax of the aforementioned critical 
organs – which were source data used to plot Figure 6-10. Comparing two 3D contouring 
methods (3DREF and 3DAIP) used for the conventional 3D-static dose calculation, there is little 
differences in the results between 3DREF and 3DAIP contouring methods for most of organs, 
such as the left kidney, spinal cord, small bowel and heart. This is expected, as mentioned 
previously, because of low doses to such organs; consequently no strong trend can be found 
in the two 3D contouring methods and dose differences relative to 4D methods are negligible 
in an absolute sense. Nonetheless, exceptions are the normal liver for all patients and the right 
(a) 3DAIP vs. 4D (b) 3DREF vs. 4D 
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kidney and small bowel for Patient 1. Focusing on these organs received relatively high 
doses, it seems that, in a conservative manner, contouring on the reference phase (the 3DREF 
case) provides a more accurate estimate of the dose (i.e. reduced disparity between 3D and 4D 
methods).  
 
 
Table 6-5 Comparison of 3D and 4D dose calculation in critical organs; dose in Gy. The normal liver 
is defined as total liver minus GTV. The ‘3DAIP’ data refers to that contoured on the AIP. 
Patient 
no. 
Organs 
(AIP / REF volumes in cm3) 
Dmean 
(3DAIP/ 3DREF /4DREF) 
D2 (nearmax) 
(3DAIP/ 3DREF/ 4DREF) 
Dmax 
(3DAIP/ 3DREF/ 4DREF) 
1 
Normal Liver (1049.2 / 1166.1) 14.5 / 14.5 / 15.4 43.1 / 43.7 / 44.1 46.9 / 46.9 / 46.9 
Spinal Cord (30.7 / 30.7) 6.0 / 5.9 / 6.0 19.5 / 19.5 / 19.3 19.9 / 19.9 / 19.7 
Right Kidney (119.2 / 118.5) 11.6 / 11.4 / 9.6 28.1 / 27.9 / 25.0 30.3 / 30.1 / 28.3 
Left Kidney (131.8 / 113.1) 1.2 / 1.6 / 1.2 5.0 / 6.0 / 5.5 6.7 / 6.7 / 6.5 
Stomach (224.3 / 223.9) 5.4 / 5.3 / 5.3 23.7 / 23.8 / 22.0 36.7 / 37.3 / 36.7 
Small Bowel (49.9 / 35.4) 2.9 / 1.7 / 1.5 23.0 / 5.4 / 5.7 32.1 / 9.5 / 7.7 
Heart (534.3 / 459.3) 1.6 / 1.4 / 1.6 8.9 / 8.4 / 9.5 27.3 / 27.3 / 28.7 
2 
Normal Liver (2038.0 / 2258.7) 12.3 / 12.7 / 13.3 45.6 / 47.1 / 47.5 49.9 / 49.9 / 50.3 
Spinal Cord (52.4 / 52.4) 3.2 / 3.7 / 3.4 20.5 / 20.5 / 20.5 21.3 / 21.3 / 21.3 
Right Kidney (238.7/ 212.4) 0.4 / 0.4 / 0.3 0.7 / 0.7 / 0.6 0.9 / 0.9 / 0.9 
Left Kidney (232.2 / 201.1) 0.4 / 0.4 / 0.4 0.8 / 0.8 / 0.7 1.1 / 1.1 / 0.9 
Stomach (326.9 / 322.2) 3.4 / 3.7 / 3.4 11.5 / 11.9 / 11.5 16.7 /  16.7 / 16.3 
Small Bowel (447.5 / 426.4) 0.3 / 0.3 / 0.3 1.5 / 1.5 / 1.4 2.5 / 2.9 / 2.3 
Heart (587.5 / 588.0) 4.7 / 4.6 / 5.4 28.9 / 28.1 / 33.7 46.1 / 46.3 / 47.1 
3 
Normal Liver (1776.6 / 1838.5) 11.3 / 11.6 / 12.1 50.9 / 51.6 / 52.6 55.7 / 55.9 / 55.7 
Spinal Cord (13.4 / 12.3) 3.9 / 3.8 / 3.8 8.0 / 7.7 / 7.7 8.9 / 8.5 / 8.5 
Right Kidney (227.8 / 219.9) 0.5 / 0.5 / 0.4 2.0 / 2.3 / 1.8 6.5 / 7.5 / 5.3 
Left Kidney (191.6 / 194.4) 0.2 / 0.2 / 0.2 0.7 / 0.8 / 0.7 2.9 / 2.9 / 2.3 
Stomach (169.3 / 177.6) 6.8 / 6.9 / 7.0 16.6 / 16.6 / 16.6  17.5 / 17.5 / 17.5 
Small Bowel (245.2 / 206.0) 1.3 / 2.1 /1.8 15.7 / 16.7 / 16.3 18.9 / 18.7 / 18.7 
Heart (768.3 / 757.1) 0.2 / 0.2 / 0.2 0.6 / 0.6 / 0.6 1.7 / 1.7 / 2.3 
4 
Normal Liver (887.3 / 949.3) 16.6 / 16.9 / 17.0 43.1 / 46.6 / 45.8 46.7 / 46.9 / 46.5 
Spinal Cord (54.9 / 54.3) 1.8 / 1.9 / 1.9 4.6 / 4.6 / 5.7 5.3 / 5.3 / 7.3 
Right Kidney (301.3 / 282.9) 1.8 / 2.0 / 2.1 9.5 / 9.3 / 10.1 13.5 / 12.5 / 13.9 
Left Kidney (98.6 / 93.8) 0.2 / 0.2 / 0.2 0.4 / 0.4 / 0.6 0.9 / 0.7 / 2.1 
Stomach (366.5 / 346.1) 2.8 / 3.0 / 3.2 5.3 / 5.9 / 6.4 8.1 / 13.7 / 14.1 
Small Bowel (662.3 / 507.7) 0.5 / 0.5 / 0.5 8.5 / 9.8 / 9.7 22.3 / 22.3 / 25.5 
Heart (494.2 / 468.3) 1.8 / 1.8 / 2.1 3.1 / 2.9 / 2.9 3.3 / 3.3 / 3.3 
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6.4.7 Organs at risk: NTCP 
It is generally accepted that the expected toxicity associated with radiotherapy cannot be 
defined by the prescription dose alone (Kong et al., 2006), and it is for this reason that 
physical models and simple dosimetric descriptors are essential in plan evaluation. One such 
means of assessing the impact on healthy tissues is via normal tissue complication 
probabilities. We have computed these, using the Niemierko approach, for the healthy liver 
volume, kidneys, oesophagus, spinal cord, heart, bowel, stomach and duodenum. The 
equivalent uniform doses (EUD, see Eq. (6.4)) are shown in Figure 6-12. The percentage 
increase in disparity in EUD when organs are contoured on the average is: liver 3.3%, left 
kidney 1.7%, right kidney 21%, oesophagus 0%, spinal cord 1.7%, heart 1.1%, bowel 36% 
and stomach 0.7%.  
 
 
Figure 6-12 The mean ratio of EUD (3D/4D) for various healthy organs; the error bars indicate 
maxima and minima for the patient cohort studied. 
 
The NTCP for all OARs were found to be very small (<0.2%) for the fractionation scheme 
used. Repeating the calculations for normal liver using the Lyman/Kutcher-Burman (LKB) 
approach (Kutcher and Burman, 1989) and model estimates based on Xu et al (Xu et al., 
2006), results in higher NTCP estimates, but exhibit similar differences in the ratios of NTCP 
for the 3D and 4D approaches; see Table 6-6. Differences in absolute values of NTCP were 
expected based on the data and methods used to derive model parameters (including 
differences in fractionation schemes) and also differences in toxicity endpoints. 
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Table 6-6 NTCP (%). Investigation of the effect of common(Pan et al., 2011) alternative fractionation 
schemes on the NTCP of healthy liver and comparison of the 3D and 4D dose calculation approaches 
and comparison of the Niemierko- (2 Gy per fraction) and Xu-based (4.6 Gy per fraction) estimates. 
The ‘reference’ fractionation scheme (i.e. that actually delivered and to which the other data in this 
paper corresponds) is 6  7 Gy. Some cases would have been rejected or replanned but are shown here 
for completeness. While the dose fractions employed in the Xu work differ from those in this study, 
this table nonetheless highlights the sensitivity of NTCP estimation to fractionation; the NTCP 
calculated using the Xu data are in general higher, but exhibit similar differences between 3D and 4D. 
 
Fractionation scheme 
Patient 1 Patient 2 Patient 3 Patient 4 
3D 4D 3D 4D 3D 4D 3D 4D 
6  7 Gy (Emami) 0.06 0.11 0.01 0.02 <0.01 <0.01 0.20 0.18 
6  7 Gy (Xu) 1.3 1.6 0.7 0.9 0.5 0.6 2.0 1.9 
3  15 Gy (Xu) 16.1 20.1 8.2 10.8 5.3 6.1 24.0 23.1 
4  12 Gy (Xu) 10.2 12.8 5.2 6.8 3.4 3.9 15.6 15.1 
 
 
 
6.5 4D evaluation of 3D SBRT plans: Discussion 
The results indicate that the mean dose to the PTV is consistently underestimated by the 3D 
approach by, on average, 4 %. The minimum dose (received by at least 98 % of the volume) 
is more notably affected, i.e. with the 3D AIP method resulting (on average) in overestimation 
of the GTV, ITV and PTV doses of 2 %, 5 % and 22 % respectively, while the near maximum 
dose in each volume is similar regardless of whether 3D or 4D methods are used. The mean 
ITV dose is similarly overestimated by 3 %. Unexpected deficiencies in dose coverage at the 
periphery may result in the risk of inadequate tumour control. In terms of the GTV, the results 
described in this work are consistent with other work undertaken concurrently with the 
present study (Jung et al., 2013), which found that the GTV dose is estimated with sufficient 
accuracy using conventional 3D methods, but when comparing to the 4D approach it is clear 
that the dose to other regions (particularly healthy organs) is poorly predicted. This study 
found that, on average, the mean GTV dose is overestimated by 2 % when planning on the 
average intensity projection.  
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As one might expect, the greater consequences – in terms of absolute difference between 3D 
and 4D – occur for untargeted organs at risk (OAR). These include critical organs such as the 
normal liver, spinal cord, right kidney and duodenum; however, one might argue that these 
are less concerning because the absolute doses are small. However, inaccurate estimation of 
healthy organ doses leads to inaccurate outcome correlation, tissue complication estimation 
and so forth. Expectedly, volumes of contoured organs are consistently higher when 
contouring on an AIP (compared to reference-phase contouring), with the exception of the 
healthy liver, the volume of which is underestimated due to its definition as the liver minus 
the PTV, where the PTV is larger than the GTV in the reference phase. Although the two 
methods result in significant differences in predicted healthy organ doses (many tens of 
percent), there was ultimately no strong trend for over- or under-prediction of doses to 
particular organs. This negates the possibility of applying generic correction factors or similar 
to doses estimated using AIP-based 3D methods, and implies that – particularly for sensitive 
patient groups (Suit et al., 2007, Taylor and Kron, 2011, Tubiana, 2009, Xu et al., 2008) – the 
4D method ought to be employed. The expectation of a correlation between the magnitude of 
motion and/or deformation and the magnitude of errors quantifiable by the 4D approach, 
suggests the possibility for patient selection rather than routine 4D calculations. For instance, 
a typical clinical workflow might involve: 
• Patients exhibiting large tumour excursion to be flagged for additional analysis  
• Cross-check using 4D methodology undertaken by physics/RT 
• Dose coverage and risk data presented to complement 3D information 
• If large differences in dose calculations are noted, it is recommended that the treating 
clinician be notified to decide whether the initial plan is to be re-optimised or not – 
more conservative approach to be adapted in estimating clinical risk to critical organs 
 
Relative homogeneity indices, HI3D/4D, of as low as 76.5% in the PTV were observed, which 
illustrates that conventional 3D dose calculation approach overestimates homogeneity by up 
to ~24%, occurring primarily in the high dose gradient region around the PTV margin. The 
GTV is of course less affected, though HI3D/4D of 98 % nevertheless reflects an underestimate 
of homogeneity. There are of course arguments (de Pooter et al., 2007, Nagata et al., 2007, 
Okunieff et al., 2006, Ruggieri et al., 2010, Taylor et al., 2011b) for and against the 
‘necessity’ of dose homogeneity, or at least the prioritisation thereof, but regardless of the 
philosophy to which one subscribes there is the unarguable necessity to know whether or not 
the dose is homogeneous. Extending these results to other cases, one would expect even more 
pronounced effects in the case of, for instance, very small fields, lung tumours, high-energy 
treatments and so on (Jin et al., 2007, Miller et al., 1998, White et al., 1996). It is worth 
noting that HI3D/4D of the PTV was well correlated to the motion-volume relationship (see 
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Table 6-1): a smaller volume with larger motion yields greater HI3D/4D than a larger volume 
with smaller motion. In other words, where the volume is small and the motion is large, the 
3D approach results in poor homogeneity estimation, whereas in the converse case it may not 
be necessary to pursue the 4D method, and the conventional AIP-based calculations may be 
sufficient. 
 
Since such 4D calculation is relatively resource intensive – increasing proportionally to the 
number of datasets analysed – we investigated alternative reduced phase binned solutions. 
The objective of this was to determine whether fewer than the typical ten-phase 4DCT dataset 
is sufficiently accurate. Together, the magnitude of the 3D motion vector and the GTV 
volume may be suitable indicators facilitating determination of whether a large number of 
phases is necessary for the 4D methodology and deserves further investigation. Notably, we 
found that for our patient cohort 4D dose calculation with at most three phases was a 
reasonable approximation of the standard ten-phase approach. Quantitatively, agreement was 
found to be within 5 % over the D98 and D50 intervals in the PTV DVH for all lesions. The 
authors regard 5% deviation as a borderline for acceptability when accounting for other 
uncertainties specific to the treatment technique. Nevertheless, the implication of this finding 
is that a strategy of utilising an abbreviated dose-accumulation process may be adopted, 
which is potentially useful as resource restrictions are likely to serve as a barrier to clinical 
implementation of non-adaptive 4D dose calculation. 
 
Differences in absolute values of NTCP were expected based on the data and methods used to 
derive model parameters (including differences in fractionation schemes) and also differences 
in toxicity endpoints (Marks et al., 2010, Bentzen et al., 2010). Whilst the absolute values for 
the NTCPs were different (0.5 – 2.0 % using the parameters of Xu et al, compared with < 
0.1– 0.2 % using the parameters in Table 6-2), all values in this study were less than 5 %. 
This result is unsurprising within the context of fractionation schedules at our clinic (PMCC), 
which are informed by NTCP calculations to provide an estimated risk of radiation induced 
liver disease (RILD) of < 5%.  In this case the dose of 42 Gy in 6 fractions of 7 Gy each was 
delivered. However, exploration of alternative fractionation schemes does reveal significant 
differences, as shown in Table 6-6 which shows NTCP data for the (healthy) liver for several 
of the most common (Pan et al., 2011) liver SBRT fractionation approaches. The results in 
Table 6-6 demonstrate that significant uncertainties exist in the estimation of NTCP and that 
substantial differences in these values may exist across the different fractionation schemes. 
These model parameters are derived from clinical observations and estimates of the doses 
delivered. Whilst the estimates of NTCP for the OAR appear to be low, considerable 
uncertainty exists in the modelling parameters. Furthermore, it is likely that this uncertainty 
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increases when the dose fractionation scheme differs notably from that employed when the 
parameters were originally derived. As clinical data emerges from this rapidly growing 
treatment modality, one may believe that realistic estimates of the dose actually delivered to 
the liver (e.g. through the quasi-4D method presented here) will lead to greater confidence in 
the model estimates. Such information is vital if treatment prescriptions are to be informed by 
NTCP estimates. 
 
It is important to note that dose-warping cannot be experimentally validated in density 
changing media because, to date, there is no measurement tool available for such validation. 
Hence, it is acknowledged that there it is possible for slight source of uncertainty when dose-
warping is implemented near and/or within density changing media, e.g. the superior border 
of the liver in this study. 
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6.6 4D evaluation of 3D SBRT plans: Conclusion 
This work has investigated the potential limitation of conventional 3D dose calculation 
methods for liver SBRT by implementing quasi-4D dose-warping based dose-accumulation 
and comparing it with the former. This study has demonstrated that the use of conventional 
3D dose estimates (that do not take into account temporal changes) may be insufficiently 
accurate for this purpose, and that a quasi-4D dose-warping based dose-accumulation method 
may yield more suitable data. The key findings are that conventional 3D planning based on an 
AIP may:  
- Overestimate target dose 
- Underestimate healthy liver dose 
- Poorly predict dose to proximate OAR 
- Overestimate target dose homogeneity 
- Influence estimates of normal tissue complications (while its risks are low) 
This has obvious implications for treatment plan evaluation, retrospective plan analysis and 
outcome correlation. The quasi-4D methodology described here provides additional 
information for clinical decision making. Accurate DVH-based plan evaluation and indeed 
appropriate reporting of doses associated with observed endpoints necessitate accurate 
dosimetry. 
 
In this study, it is clearly demonstrated that conventional 3D planning on an AIP appears to 
accurately calculate dose to the GTV and ITV, while significantly overestimating doses to the 
PTV (by up to 9%) and underestimating dose to the surrounding healthy liver (by up to 8%), 
compared to the dose-warping based 4D calculation methodology. In 3D calculations, 
contours defined on the full expiration phase (REF) yield better dose estimates for healthy 
liver than AIP contours. For most other OARs, AIP and REF contours yield similar estimates. 
Where differences occurred, REF contours yielded better estimates than AIP contours in most 
cases indicating that contouring should be performed on a full expiration reference phase 
image (even if AIP contours are used for plan design). This study has furthermore 
demonstrated that 4D dose calculation with at most three phases is a reasonably accurate 
approximation of ‘full’ 4D dose calculation with the nominal ten phases, facilitating more 
expeditious calculations and reduced overhead burden. While estimates of the NTCP risks are 
low for the fractionation scheme employed, significant uncertainty exists in model parameters 
used for hypofractionated treatments. Providing dose estimates that most closely represent the 
actual dose delivered will provide valuable information to improve our understanding of the 
dose response for partial volume irradiation using hypofractionated schedules. The 4D 
approach more accurately informs treatment plan evaluation, retrospective plan analysis and 
outcome correlation.  
 145 
 
 
 
 
 
 
 
CHAPTER SEVEN  
: Conclusions and Recommendations 
 
Final comments on the significance of the work and recommendations 
regarding the adaptation of deformation in both medical imaging and 
radiation oncology 
 
 
 
“One must have a good memory to keep the promises one has made.”
††
 
Friedrich Nietzsche 
                                                     
††
 The promises the author has made in this thesis? 
: Not to conjecture at random but to provide a concise summary of results and conclusions of the 
studies overviewed in the introduction (Chapter 1) of this thesis. 
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7.1 A major challenge in contemporary radiotherapy 
The primary objective of this thesis has been to model and validate delivered doses on 
deformable moving targets. Specifically, this refers to  
i) measurements of complex and re-distributed dose distributions by developing a tissue-
equivalent deformable dosimetric phantom (an experimental model);  
ii) calculations of the deformed dose distribution following assessment of deformable image 
registration algorithms’ accuracy via the developed phantom (a mathematical model);  
iii) by comparison thereof, validation of the dose-warping technique; and  
iv) application of the validated method to conventional 3D plan evaluation, in this case liver 
stereotactic body radiotherapy, as the final objective of this thesis. 
The issues of dosimetric discrepancies between initial treatment plans and verification 
measurements, thereby allowing re-optimisation of original plans, are important for improved 
patient outcomes. The method developed in this work and consequent results have addressed a 
major challenge facing physicists and clinicians in contemporary radiotherapy – the inter- and 
intra-fractional variation in anatomic shape due to organ motions and associated deformations. 
This issue is related to the entire radiotherapy procedure, from image acquisition for pre-
treatment dose calculation to dose delivery verification and risk assessment. The existence of 
organ deformation accompanying anatomic motion adds a further layer of complexity to the 
problem. While dosimetric uncertainties arising from the patient motion have been dealt with 
through a number of strategies, conventional dose-calculations by treatment planning systems 
(TPS) have not accounted for the associated organ deformation in current clinical practices.  
This thesis has addressed the need to investigate dose distribution/re-distribution in deformable 
moving targets that can occur during and/or between treatments. Consequently, this work has 
helped establish a framework that ensures more accurate measurements and calculations for 
dose accumulation, which can reduce the probability of potential detriment to the patient and 
thus enhances the positive treatment outcome.  
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7.2 The measurement of dose delivered to deformable moving targets 
The development of a tool for deformed dose measurement corresponds to the first part of this 
thesis (i.e. an experimental model). Dosimetry for highly conformal and small radiation fields 
has inherent complexities. For instance, issues related to detector volume averaging due to the 
coarse resolution of a large detector relative to the conformal fields and perturbation of the field 
due to the difference between detectors and the medium, in terms of radiological and physical 
properties (i.e. water equivalence). Polymer gel dosimetry is a promising tool for verification of 
such radiation field delivery. Gel dosimeters are tissue-equivalent and volumetric, yielding 
three-dimensional dose information, thereby functioning as both the phantom and dosimeter 
material. A further layer of complexity in addition to the above is the dose measurements on 
deformable moving targets, which is, in this author’s opinion, one of the principle challenges in 
contemporary RT. In this thesis, this need was addressed by developing a novel system for 
deformable dosimetry. This refers to a 3D volumetric deformable polymer gel, dubbed 
DEFGEL, as the first inherently coupled dosimeter and deformable phantom. 
4D EVALUATION FRAMEWORKS 
Experimental evaluation:  
Deformed dose measurement in 
deformable moving dosimeter/target 
/ 
 
(4D deformable dosimetry using 
DEFGEL) 
Mathematical evaluation: 
DIR evaluation in low-contrast region 
using deformable moving phantom 
 
(Deformable image registration) 
3D verification of Dose-warping technique 
4D dose evaluation of 3D conventional treatment plan 
4D cumulative dose calculation via dose-warping on patient 4DCT image set 
Provide the feedback on original treatment plans to improve target coverage/OARs sparing 
i.e. 4D-Adaptive Radiotherapy (4D-ART)  
Figure 7–1 The framework developed in this thesis for four-dimensional dose evaluation. This 
framework consolidates a novel deformable dosimetry, image guidance, deformable image registration 
(DIR) and dose-mapping; such can be applied to dose reconstruction, accumulative dose calculation 
and treatment plan evaluation to fully elucidate the dosimetric impact and make corresponding 
corrections throughout the treatment course, i.e. re-optimisation of the plan. 
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In summary, development of the dosimetric measurement system in this study involved the first 
three-dimensional, tissue-equivalent deformable integrating dosimeter (DEFGEL) by modifying 
conventional PAG and using latex membrane as a container. DEFGEL was characterised in 
terms of radiological and physical properties for tissue equivalency, as well as dose sensitivity 
and stability for calibration (dose vs. change in optical density). This study demonstrated robust 
structural integrity and reproducibility of deformation even after hundreds of deformations, and 
also verified that multiple CT-scanning does not impact on sensitivity. Dose delivery to the 
DEFGEL phantom was performed in three arrangements: (i) without deformation, (ii) with 
deformation, and (iii) within cumulative exposures with and without deformation, i.e., dose 
integration. In the absence of deformation as a ground truth, results showed high agreement 
with treatment planning system (pencil beam algorithm) calculations for all fields tested with 
different degrees of complexities (3D -evaluation indicated ~ 97% agreements with criteria of 
2%/2mm for even stereotactic small field adapted from a patient plan. Comparison of dose 
profiles and 2D isodose distributions from the aforementioned three arrangements illustrated 
complex spatial redistribution of dose in all three dimensions occurring as a result of the change 
in shape of the target between irradiations, even for a relatively simple deformation (bilateral 
compression). Discrepancies of up to 30% of the maximum dose were evident from dose 
difference maps for three orthogonal planes taken through the isocenter of a stereotactic field. 
This study also demonstrated that consecutive irradiations delivered in different states of 
deformation can be integrate and read out as a single distribution. 
 
In conclusion, this study has experimentally proven that a change of geometry due to 
deformation can induce a significant change in the absorbed dose distribution and that such a 
change can be measured. Therefore, this work has obvious potential for a number of 
applications for not only external beam radiotherapy and brachytherapy, but also the verification 
of deformable image registration, validation of dose warping strategies based on DIR, and the 
evaluation of motion/deformation compensation strategies in radiotherapy. These studies were 
conducted and the summary of results thereof is provided in the following three sections. 
 
 
7.3 The validation of deformable image registration 
The validation of deformable image registration (DIR) algorithms is a clinically-driven 
requirement of image-matching for dealing with organ deformation; it is also a necessary 
component in achieving accuracy in the mathematical model for dose deformation. The focus of 
this thesis was primarily concerned with the calculation of dose in deforming geometries and the 
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validation of dose-deformation operations, whereby doses are morphed based on deformation 
matrices generated by DIR algorithms. However, clearly the accuracy of such an approach is 
critically dependent upon the accuracy with which DIR algorithms are able to morph the 
geometry of interest. Consequently, it is important to investigate the accuracy of available 
algorithms. 
 
In summary this work has used a tissue equivalent, mass and density preserving deformable gel 
(DEFGEL) phantom implanted with high contrast fiducial markers (FMs), to evaluated three 
different representative types of deformation via DEFGEL phantoms. The performance of a set 
of DIR algorithms has been assessed within areas of near-uniform intensity, rather than only at 
known landmarks, using a method of mathematically erasing the markers prior to registration. 
This is in order to eliminate bias introduced from the fact that high contrast features drive the 
registration, in particular for intensity-based algorithms. This study demonstrated that the 
performance of all algorithms is critically dependent upon the parameters set, thereby one 
cannot simply use the “default” parameters and must undertake a thorough optimisation process 
before implementation for clinical use. Subsequently, this work has shown that algorithm 
performance varied substantially after each algorithm was optimised – up to 72 combinations 
were undertaken. Some were unable even to register the phantom boundary contour 
satisfactorily; of those that could, there was a wide range of errors between calculated marker 
positions and the measured locations. 
 
Using this evaluation process, this work yielded the following key findings: 
The best performing algorithm – original Horn and Schunck – yielded positional errors in the 
order of ~1 mm up to about 20% of the magnitude of displacement of individual markers. For 
the worst of the results – modified demons algorithm, larger errors in the order of ~5 to 7 mm 
were observed and were poorly correlated with the magnitude of displacement, indeed 
sometimes exceeding the magnitude of actual displacement of individual markers. For most 
algorithms, larger deformation induced displacements generally resulted in larger errors while 
there was no trend with respect to the complexity of deformation. The distribution of individual 
errors was generally characterised by a standard deviation of about ½ to ⅔ of the mean error for 
all the tested algorithms. The sensitivity of DIR performance to the number of fiducial markers 
present was quantified. This showed that if deformable registration is evaluated by analysis of 
features that are present during the calculations, then the outcome will be biased and the results 
will not be representative of the true performance in low-contrast regions. On the other hand, it 
should be identified that the technique presented in this study has enabled quantification of 
improvements achievable using fiducial markers for DIR. For instance, a greater number of high 
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contrast features per volume increases registration accuracy, by 6 times for the best case. As an 
example of clinical relevance, the use of three FMs in a 40 ml volume (comparable to a typical 
prostate volume) halves the mean error from ~2 to ~1 mm in the low-contrast region, compared 
to reliance on the boundary contour alone. 
 
Overall, this work has facilitated a qualitative and quantitative evaluation process to 
systematically investigate a range of DIR algorithms in terms of their capacity to generate 
accurate deformation vector fields. Consequently, the findings in this study have identified the 
performance of each DIR algorithm, in particular, in low-contrast regions. This has also enabled 
calculation of dose deformation inside the target volume with a known degree of confidence in 
the spatial accuracy. 
 
 
7.4 The calculation of dose delivered to deformable moving targets 
The verification of methodologies for deformed dose calculation corresponds to the second part 
of the primary objective in this thesis (i.e. mathematical model and verification). In this study, 
the calculation of warped (deformed) dose distribution is directly compared to the 
corresponding measured dose distribution via DEFGEL, in order to experimentally validate the 
dose-warping technique.  
 
Several key findings are summarised here: 
Analysis of a range of DIR algorithms available in the public domain indicates quite variable 
results. This showed that careful algorithm evaluation and selection are required before clinical 
implementation of this technique for 4D dose evaluation or 4D planning purposes. For the 
comparisons between “warped” dose distributions and the corresponding measured dose 
distributions using the best DIR algorithm, 3D -analysis shows agreement of 3%/3mm ≈ 99% in 
each case of several types and extents of deformation. Rather than the complexity of the 
treatment delivered, it is the extent of deformation which most greatly affects the accuracy of 
the warped dose distribution. Note that these results are consistent with the results of DIR 
performance, as described in the preceding chapter. For a square field case, the smallest 
deformation (~9 mm) yields agreement of 3%/3mm = 99.9%, whilst the most significant 
deformation (~20 mm) yields agreement of 3%/3mm ≈ 96.7%. The results indicate dose-warping 
can be justified for even fairly large deformations, relative to both field and target sizes and for 
those deformations that do not obviously involve significant density changes (e.g. lungs). Dose-
warping techniques together with proper validation and selection of DIR algorithms/methods 
allows existing patient plans to be morphed according to new/different patient images. 
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Furthermore, this technique facilitates the calculation of cumulative doses over different states 
of deformation.  
 
In summary, this work has demonstrated a full 3D experimental validation of results from a 
range of dose deformation algorithms available in the public domain. Consequently, this work 
showed that DIR based dose-warping can accurately represent the true (measured) dose in a 
deformed medium, thereby enabling dose-warping techniques to be implemented for 4D 
evaluation of conventional patient treatment planning. 
 
The variability of results highlights the need for vendors to perform robust clinical evaluations 
of their algorithms to ensure the optimal parameter settings are used in DIR software 
implementations, or provide flexibility in parameter selection to the user so that they can 
optimise the accuracy for clinical scenarios. It also suggests the need for a range of tools to be 
available in DIR software implementations which allow individual users to verify DIR 
performance in quantifiable and clinically relevant ways. These tools are now beginning to 
emerge on the market; examples of these tools provided by vendors include IMSimQA™ by 
Oncology Systems, Ltd. (Shropshire, UK), MIM Symphony™ by MIM Software, Inc. 
(Cleveland, OH, USA), Velocity™ by Varian Medical Systems, Inc. (Palo Alto, CA, USA), and 
RTx™ by Mirada Medical (Oxford, UK), which utilises DIRs for different RT applications. 
 
 
7.5 The 4D evaluation of conventional 3D planning  
The application of the validated calculation method to a patient treatment planning system is the 
final objective of this thesis, following the development of both methodologies for deformed 
dose measurement and the corresponding calculation. This study has focused on application to 
liver stereotactic body radiotherapy (SBRT), which is fast increasing as one of the most 
common advanced modes of radiotherapy for liver lesions. Liver SBRT involves large mass and 
density conserving deformation with high doses, which must necessarily be delivered with high 
spatial accuracy. Consequently, associated discrepancies between planned and delivered doses 
may be pronounced; such uncertainties are not accounted for in current practice, which may 
result in reduced dose conformity and tumour control.  
 
Such issues underscore the relevance of the findings presented in this thesis. In this context, 4D 
evaluation of conventional 3D treatment planning in liver SBRT has been performed using 
dose-warping based dose calculation and subsequent dose accumulation.  
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This yielded several key findings: 
Dose-volume histogram analysis (DVH) clearly indicated that the typical 3D planning approach 
appears to accurately calculate dose to the GTV while overestimating doses to PTV as well as 
ITV (= CTV) by up to 9% of Dmean and underestimating dose to normal liver by up to 8% of 
Dmean, compared to the 4D evaluation methodology. The homogeneity of the dose distribution is 
overestimated when using conventional 3D calculations on an AIP by up to 24%. Doses to other 
organs are low and consequently differences between 3D and 4D methods are not as troubling 
in an absolute sense, although discrepancies between the two methods in terms of mean doses 
were up to a factor of two. Hence, dose differences are typically small for untargeted critical 
organs. Consequently, OAR dose differences between two contouring methods, defined on the 
AIP or reference phase, are not quantitatively substantial in terms of an absolute dose. A further 
interesting finding is that we have shown 4D-cumulative dose calculation with at most three 
phases is a reasonably accurate approximation of a ‘full’ 4D dose calculation with the nominal 
ten phases for all patients. This indicates that judicious selection of phases may allow 
representative planning from as few as 3, which is useful from a patient throughput perspective. 
The general consequence can thus be that reduced doses/dose conformity in ITV/PTV due to 
organ motion/deformation mainly lead to excessive doses to the healthy liver which 
encompassed the entire tumour volume, but not to other adjacent organs. This study has 
quantitatively demonstrated this, which is currently not considered in most treatment planning 
systems and subsequent plan evaluations.  
Overall, the 4D evaluation technique highlights that reduced doses/dose conformity in ITV/PTV 
due to organ motion/deformation mainly lead to excessive doses to an organ surrounding 
target(s) and also other organs whose exposed area varies due to breathing motion/deformation, 
which are not reflected on 3D plans. It is also worth noting that the coverage of a time-resolved 
target (i.e. GTV) is ensured by additional margins with ITV/PTV approach, although undesired 
reduction of dose conformity in ITV (=CTV) can also potentially cause reduced tumour control. 
Resultant 4D accumulated dose distributions reveal excessive organ doses that are not directly 
reflected on NTCP calculation of the healthy organ surrounding target(s); this is because a part 
of the surrounding organ receiving excessive doses is not included in the volume of normal 
tissues but is included in the margin around GTV. In this study, the absolute values for the 
NTCP to the healthy liver were less than 5%, which is not surprising as 6 x 7 Gy fractionation 
schedule used in this study at our clinic (PMCC) is informed by NTCP calculations to provide 
an estimated risk of radiation induced liver disease (RILD) of < 5%. However, the exploration 
of alternative fractionation schemes does reveal significant differences (see Table 6-5), 
demonstrating that significant uncertainties exist in the estimation of NTCP across the different 
 153 
fractionation schemes. Although it is ideal to implement biological parameters as plan quality 
indicators, there is too little multi-institutional data available for TCP/NTCP to be accurately 
modelled with correlations of DVH metrics. Until there are data demonstrating outcomes as 
good or better, it is unlikely that a clinician would accept extremely cold regions in a CTV or 
hot regions in a PTV, despite having acceptable TCP values which was highlighted by a recent 
point-counterpoint article in Medical Physics (Deasy et al., 2015). 
We believe that realistic estimates of the dose actually delivered to the liver (e.g. through the 
quasi-4D method presented here) will lead to greater confidence in the model estimates. Such 
information is vital if treatment prescriptions are to be informed by NTCP estimates. Clearly, 
the more accurately we can estimate the true delivered dose to the patient, the better we can 
define model parameters to predict clinical outcomes in the era of hypofractionated treatments 
(Jackson et al., 2010b). Although the deterministic effects appear to be low for the fractionation 
scheme ultimately employed, one cannot ignore the notable differences in calculated healthy 
organs dose for the two methods. Ultimately, the most efficacious treatment approach will 
always be to follow the goal of radiotherapy – delivering a lethal dose of radiation to a tumour 
whilst minimising damage to surrounding healthy tissues. 4D evaluation methodology described 
in this work has the potential to quantify such issues of under- and/or over-dosage, so as to 
allow more accurate dose prediction and consequently enhance the positive treatment outcome.  
The expectation of a correlation between the magnitude of motion and/or deformation and the 
magnitude of errors quantifiable by the 4D approach, suggests the possibility for patient 
selection rather than routine 4D calculations. For instance, a typical clinical workflow might 
involve: 
• Patients exhibiting large tumour excursion to be flagged for additional analysis  
• Cross-check using 4D methodology undertaken by physics/RT 
• Dose coverage and risk data presented to complement 3D information 
• If large differences in dose calculations are noted, it is recommended that the treating 
clinician be notified to decide whether the initial plan is to be re-optimised or not – more 
conservative approach to be adapted in estimating clinical risk to critical organs 
As a final note on the topic of dose-warping based 4D plan evaluation and potential re-
optimisation of plan, it is important to mention the observation that the 4D dose calculation 
using as few as three phases followed by judicious selection of phases may allow representative 
planning of using the full 10 phases (agreement within 3% is demonstrated over the D98 and D50 
interval), despite significant differences of computational time between the two. This may 
influence decision making, particularly given the relatively laborious nature of 4D planning and 
associated potential reduction in patient throughput. 
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7.6 Clinical significance 
The outcomes of this thesis have direct clinical impact and utility, summarised as follows. The 
development of: 
(i) Novel deformable dosimetry with DEFGEL. This work provides a tool to directly measure 
deformed dose distributions in 3D. This research has attracted attention because of the absence 
of such a tool in the past and because of the numerous potential applications which can made 
utilising this system; such as verification of dose delivery in various cases – breast, prostate, 
liver, kidney etc. – and anthropomorphic phantom for QA process.  
(ii) A systematic method for DIR assessment. While there is fast increasing interest in 
deformable image registration, there is a lack of knowledge in the performance of DIR 
algorithm in low-contrast regions for mass and density conserving deformation. The method 
described in this study builds upon current research, enabling assessment of the accuracy of DIR 
algorithms within areas of near-uniform intensity, rather than only through known landmarks. 
This eliminates bias introduced from the fact that high contrast features drive the registration. 
This is important because of the clinically-driven requirement that knowledge of the error 
arising from DIR process is needed for various state-of-the-art techniques such as image-fusion, 
dose-mapping, auto-contouring, tumour atrophy calculation, 4D planning etc. 
(iii) A methodology to validate dose-warping technique. This study contributes towards 3D 
empirical evidence demonstrating the accuracy of dose-warping, which has been a contentious 
topic because some of such image calculations are not constrained by physical laws. This study 
has demonstrated the 3D experimental validation of results from a range of dose deformation 
algorithms available in the public domain. This work has direct clinical relevance, evidenced by 
the development of dose-warping based 4D treatment planning system (TPS) currently being 
marketed by vendors, such as RaySearch TPS (RaySearch Laboratories, Stockholm, Sweden). 
(iv) 4D evaluation of liver SBRT plan. This current work highlights the discrepancies between 
planned dose and actual delivered dose resulting from anatomic variations in the case of 
conventional 3D treatment planning of SBRT. The application of the framework detailed in this 
work has quantified such issues of under- and/or over-dosage at the target and the surrounding 
organs, respectively. The impact of this study is also reflected by further collaboration for 
kidney VMAT/SBRT study at the Peter MacCallum Cancer Centre (Melbourne, Australia)  
 
In conclusion, the framework designed in this study consolidates a novel deformable dosimetry, 
, a deformable phantom, deformable image registration (DIR) and dose-mapping. Such tools can 
be applied to dose reconstruction, accumulative dose calculation and treatment plan evaluation 
to fully elucidate the dosimetric impact and make corresponding corrections throughout the 
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treatment course, i.e. plan re-optimisation. It is worth noting that there are several groups that 
have contributed to each of topics set out above. Of many relevant studies, some examples are 
that i) Juang et al introduced and characterised a novel deformable plastic dosimeter 
(PRESAGE-Def) and investigated the accuracy of a b-spline based commercial DIR (Juang et 
al., 2013); ii) Kirby et al demonstrated an optical method of validating DIR using non-
radiopaque markers, optical camera and 2D deformable phantom (Kirby et al., 2011); iii) Brock 
et al developed a biomechanical DIR algorithm (finite-element-model based) (Brock et al., 
2003) and Velec et al validated this DIR using PRESAGE-Def dosimeter (Velec et al., 2015); 
iv) Jung et al demonstrated 4D dose calculations using an intensity-based DIR for liver cases 
(Jung et al., 2013). Along with such important studies by other groups, the results shown in this 
thesis provide practical means (beyond issues of purely academic interest) to efficiently deal 
with a major challenge in contemporary RT. 
 
 
7.7 Outlook 
In this thesis, the principle focus has been dosimetric discrepancies associated with deformation 
in both dose measurements and dose calculations. However, there are many challenges in 
accurately predicting such deviated dose distributions, and the present thesis has therefore some 
limitations that should be noted. 
 
For instance, there remain a number of challenges associated with gel dosimetry, the 
recommended method for measurement of deformed dose distribution, which present challenges 
to routine clinical implementation. This includes the requirement for a toxic/carcinogenic 
chemical handling (e.g. Acrylamide) and gel preparation laboratory, equipped with acid safe, 
chemical disposal facilities, fume cupboard and associated circulation system. Other issues 
include the fact that the dosimeters are single-use per day and readout systems, such as optical 
CT scanners or MRI, require careful corrections for scatter or noise respectively, and may not 
always be readily available.  
 
There are also several limitations on the recommended method for calculation of deformed dose 
distribution – dose-warping technique – which morph doses using deformation matrices 
obtained via deformable image registration. It is important to mention that clinics ought to 
thoroughly research the suitability of the algorithms they employ, because the algorithm-
specific optimisation process is a critical necessity which is not only nontrivial but is also 
computationally-demanding. It has been our own experience that commercial algorithms may 
perform very poorly in this regard and are designed with simplicity in mind; consequently the 
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real limitation is that many computational parameters are unavailable to the end-user. Although 
there are several attempts in commercial treatment planning systems to implement 4D dose 
calculations via DIR-based dose-warping, the available systems are currently mainly used for 
research purposes and need to undergo rigorous investigation before clinical usage. 
 
In addition, there are various difficulties associated with the sophisticated nature of tumour 
behaviour that are beyond the scope of this thesis; in particular, the handling of density changes 
and atrophies are issues as all tumours change in size, and in some cases do so during and/or 
between treatment fractions. For example, the method and results presented in this thesis may 
not be applicable to the cases of organ atrophy and tumour density change over the course of 
treatment, where the notion of dose (the absorbed energy per mass) as a surrogate for biological 
response becomes complicated by changing target mass and volume. This is further complicated 
if the targeted tumour is located in heterogeneous media, such as the lung or any other anatomy 
incorporating or juxtaposed with, for instance, airways, cavity or bone. This is an arising issue 
in radiotherapy that physicists and clinicians ought to acquaint themselves with. There are a 
number of studies being undertaken both internationally and locally at RMIT University, 
including the 4D experimental method for the assessment of intra-fraction motion and 
deformation of targeted organs; auto-contouring of atrophy in breast tumour lesions; breathing 
corrected VMAT for kidney tumours and so on. 
 
While liver SBRT was primarily studied for immediate clinical application, it is hoped that the 
findings of this thesis can be applicable to other organs with various RT modalities where 
conformal fields are used in the existence of anatomic motion and associated organ deformation 
(although it has not been shown/demonstrated in the thesis). It is because most organs are 
subject to no (or minimal) density changes, e.g. tissue, fat, light bone etc., except the lungs 
which noticeably exhibit density changes generally in a range of 0.2 to 0.5 g/cc. Despite it has 
not been experimentally investigated, what is obvious is that GTV plus margin yields excessive 
dose to surrounding healthy lungs which can be better quantified by a 4D method (although its 
accuracy is still not exactly known). Ultimately, daily CBCT images could be utilised to account 
for inter-fraction effect, however, it should be acknowledged that such assessments are outside 
the scope of the current thesis, while this topic could be a valuable extension of this project as 
future work. It may be also worth noting that MR-linac could be available in routine clinical 
practice in near future, so that changes in patient anatomy could be constantly monitored during 
delivery and then possibly adapted online for both intra- and inter-fraction effects. In such a 
case there is no doubt that the 4D evaluation data via deformable dose accumulation could be 
more applicable in order to better correlate planed/delivered doses and clinical outcome. The 
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framework developed in this thesis also relates to investigating various state-of-the-art 
radiotherapy tools such as image-fusion, dose-mapping, auto-contouring, and tumour atrophy 
calculation. Most importantly, however, it is hoped that the outcomes of this thesis will help to 
improve treatment plan accuracy, and thus to contribute to the impact on patient treatment 
outcome. By considering both computation and measurement, it is also hoped that this work 
will open new windows for future work and hence provide the building blocks to contribute to 
further the enhancement and the benefit of radiotherapy treatment. 
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Appendix I: Deriving DIR mathematical formulations 
I-1. Theory of the Optical flow method  
As set out in Section 4.2.5, optical flow is the distribution of apparent velocities of movement of 
brightness patterns within an image (i.e. tracking the movement of high brightness gradients). 
Before deriving a mathematical formulation for optical flow method, the fundamental 
assumptions are described which yield an intuitive idea of constraints that should be included in 
such a model. These assumptions include:  
(1) Brightness constancy– the intensity of a point in an image does not change with the 
displacement and time, 
(2) Gradient constancy – the gradient of the intensity of a point in an image does not vary due 
to the displacement and time, 
(3) Spatial smoothness – the nearby points move in the same manner,  
(4) Multistage approach – there is at least one local minimum as well as the global minimum 
in the similarity measure.  
In the human body, the density of most organs does not change notable with time. The first 
assumption of OFM should apply to those organs, with exceptions such as the lungs. The lungs 
are slightly denser at the end of expiration than that at the end of inspiration. This slight density 
change is handled by introducing a non-zero term ε in the equations. The second and third 
assumptions also hold for the human body. The main example of shearing motion is the 
interface between the lungs and chest wall. Since this is not a very sharp shearing motion, 
especially between multi-respiratory phases, it does not present a problem in the image 
registration (Zhang et al 2008). 
 
The first assumption can be expressed as: 
),,,(),,,( dttdzzdyydxxItzyxI      (I-1) 
where I(x, y, z, t) is the intensity (or the brightness) of the image at location (x, y, z) and time t. 
This assumption has one obvious drawback: it is quite susceptible to slight changes in 
brightness, which often appear in natural images with different time frames. It is, hence, useful 
to allow some small variations in the intensity and help to determine the displacement vector by 
a criterion that is invariant under intensity changes. Such a criterion is the gradient of the image 
intensity resulting in the second assumption (Uras et al, 1994). This gives 
),,,(),,,( dttdzzdyydxxItzyxI  , where  denotes the spatial gradient. This 
constraint is particularly helpful for translatory motion, while it can be better suited for more 
complicated motion patterns. The Taylor series expansion of Eq. (I-1) is 
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where Ix, Iy, Iz and It are the partial derivatives of I in respect to x, y, z and t at (x, y ,z, t) 
respectively. The notation ε contains the second and higher order terms in dx, dy, dz and dt. 
Eliminating ε and combining with Eq. (I-1) as implied in the first assumption, Eq. (I-2) leads to 
the well-known optical flow constraint (Horn and Schunck, 1981): 
0or0  ttzzyyxx IIIvIvIvI v

    (I-3) 
where vx = dx/dt, vy = dy/dt, vz = dz/dt, are the three components of the spatial displacement (= 
optical flow or motion vector field) for location (x, y, z) at time t towards time t +dt. It has been 
widely used in the literature (Iu and Liu 1999, Zhang et al 2008, Horn and Shunck 1981 and 
Joshep 1987). In order to allow some intensity change between images, a non-zero term εg is 
introduced to Eq. (I-3): 
gtIvI  )(

 ,    (I-4) 
where εg denotes the global smoothness constraint (or data conservation constraint). The validity 
of ignoring the right hand side of Eq. (I-2) is dependent on the magnitude of the displacement 
and the spatial frequency content of the intensity pattern relative to the size of VOI, e.g. large 
displacement or frequent pattern change leads to greater second and higher order terms of 
Taylor series for the intensity. The first assumption is satisfied only without considering density 
change or occlusion of features in the images. It is well-known that this constraint by itself is 
not sufficient to solve ),,( zyx vvvv

 (Brox et al, 2004).  
 
Using the first two assumptions the model estimates the displacement of a voxel only locally, 
without considering any interaction with neighbouring voxels. The differential constraint 
equation, Eq. (I-3), can be used in motion detection (Fennema and Thompson, 1979). It is a 
single equation in the two unknown vectors which forms a single constraint line in velocity 
space. Any velocity on this line satisfies the constraint. This was called the "aperture problem" 
since it implies that locally the velocity cannot be determined uniquely when the intensity 
gradient vanishes somewhere, or if only the flow in normal direction to the gradient can be 
estimated. In addition, some outliers could be expected in the estimates. Hence, it is useful to 
introduce the third assumption- that the apparent velocity of the brightness pattern is assumed to 
vary smoothly almost everywhere in the image (Horn & Schunck, 1981). As the optimal 
displacement field will have discontinuities at the boundaries of objects in the image, it is 
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sensible to generalise the smoothness assumption by demanding a piecewise smooth flow field 
(Black 1991 and Black 1996). Horn and Schunck (1981) introduced a smoothness constraint in 
order to solve uniquely for displacement, so as to deal with points within areas of zero 
brightness gradients by assigning them the averages of the neighbouring velocity estimates. Due 
to the iterative nature of the Horn and Schunck method with combining the fourth assumption, 
areas of uniform brightness will be filled from the boundary inwards. This is known as the 
velocity smoothness constraint (εs
2
). A number of other authors (Tretiak and Pastor 1984; Nagel 
1987; Uras et al. 1988; Verri et al. 1990 and Srinivasan 1990) produced two or more linear 
equations in ),,( zyx vvvv

 by assuming constancy of partial derivatives and other functions of 
the intensity. A third approach (Lucas and Kanade 1981 and Campani and Verri 1990) is to 
assume the velocity field is locally constant and to combine constraint equations from 
neighboring pixels (note they dealt with 2D planar images at that time). A review of these and 
other similar approaches such as correlation and energy models, can be found in Baron et al. 
(1993). 
 
In the Horn and Schunck method, which is the most commonly used over the others (Castadot et 
al, 2008), the velocity smoothness constraint was introduced to further constrain the solution for 
),,( zyx vvvv

 by combining the second assumption of a smooth flow field in the form of a 
smoothness, or regulariazation term (εs
2
). The most common formulation of the regularizing 
term is the first-order, or membrane, model which is the Laplacians (=
2 ) of the three 
components of the derivative of the spatial displacement: 
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(I-5) 
, where εs
2
 denotes the velocity smoothness (constant intensity) constraint. 
 
The problem of determining optical flow (motion vector field) ),,( zyx vvvv

 can be formulated 
to minimize the objective function ‘ε’, as least-squares estimation, the sum of a combination of 
Eg and Es over VOI with weighting factor λ (=α
2
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, where ε denotes the velocity smoothness constraint and the weighting factor λ controls the 
relative importance of the brightness constancy and the spatial smoothness terms. In computer 
and vision science the objective function ‘ε’ and is referred to as ‘energy’ and so ‘energy 
minimisation’ refers to the above process. Applying the Euler-Lagrange equations from 
variational calculus, it can be derived as below: 
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,where zyx v and v ,v
222   are the Laplacian of vx, vy and vz, respectively. They can be 
approximated by  and 222 ),vvκ(v ) vvκ(v),vvκ(v zzzyyyxxx   where 
zyx v  v,v and  denote the local average of vx, vy and vz, respectively, and κ ≈ 3. The calculation 
of the local average depends on the decision function as detailed in the later section (Section I-
3). Horn and Schunck solves the non-linear differential equation in Eq. (I-7) by a numerical 
approach with linearization (Horn and Shucnk, 1981). This can be briefly described as: 
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I-2. Iterative approach  
One main drawback of Horn and Schunck’s algorithm is that it fails to handle larger motion as 
so to be trapped to the local (i.e. the lack of the fourth assumption in the previous section). This 
is because the majority of images where the higher order derivatives of the intensity function are 
not all zero, so the first-order approximation in Eq.(I-2) and Eq.(I-3) can no longer lead to good 
motion estimates when the motion is large. Iterative approach is based on the following 
argument: 
Assuming each iteration improves the estimates of the flow field (i.e.,
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(calculated) image, I(x+dx
n
,y+dy
n
,z+dz
n
,t+dt), with the target (reference) image I(x, y, z, t), in 
order to improve the current estimates in the next iteration. 
 
This approach aims to find the adjustment of the velocity vx, vy and vz  at each iteration. The 
solution of the spatial displacement for each voxel in Eq.(I-8), then, is obtained using three 
Gauss–Seidel iterations (Zhang et al 2008) by applying variational calculus: 
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Many techniques have been implemented to make the OFM accurate and practical for medical 
physics research and eventually clinical practice, which include: 
 
1. A multi-resolution feature which calculates the deformation matrix from coarse resolution 
level to fine, which keeps the displacement between two corresponding voxels always small 
in the calculation. This helps in increasing accuracy as well as in decreasing calculation time. 
2. A multi-pass approach (Iu and Liu 1999) in which multi-loop calculation updates the 
deformation matrix after each loop of calculation. The idea is to perform registration multiple 
times on the same image resolution stage. Because the result of image registration is often not 
good enough in one computation, registration can be computed again in a new pass based on 
the result of the previous pass. As iterations progress in each pass Taylor's series expansion of 
the intensity function starts from a same reference point (initial moving image in each pass). 
However, as each pass progresses, the Taylor's series expansion of the intensity function 
starts from the updated reference point calculated by a previous pass (i.e. the observation 
point in the Taylor's series expansion moves accordingly with the current motion estimates). 
We have demonstrated that by doing so, the so-called constant intensity constraint can be 
better and better satisfied as the iteration process continues. This concept can be readily 
adapted to many optical flow algorithms where ε = 0 is assumed for performance 
improvement. Comparing with a traditional method, this new concept can offer faster and 
better convergence, and the capability to handle larger motion.  
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I-3. Outlier rejection  
A set of assumptions – the brightness constancy and spatial smoothness – for calculating optical 
flow in the algorithms, by necessity, is a simplication of the real world and hence may be 
violated in some circumstances. For example, the common assumption that the optical flow 
varies smoothly is violated when motion boundaries are present. In the medical imaging 
perspective, part of an organ may not be contained in the target image but it could occur in the 
source image by moving into the field of view (FOV) and vice versa. The existence of occlusion 
and multiple motions between image sets in time interval dt causes the discontinuity to arise in 
the motion field (Iu and Liu 1999) (e.g. shearing motions at the interface between the lungs and 
chest wall or between the lungs and diaphrams). At motion discontinuities, the smoothness 
constraint is no longer valid. Violations such as these result in significant measurement errors 
referred to as outliers (Black et al 1996). To handle these errors, the sensitivity of the calculated 
optical flow (i.e. the motion vector field) to violations of the assumptions must be reduced by 
doing outlier detection/rejection which is used to stop the smoothness constraint from 
propagating across the motion boundaries. Outlier rejection (OR) refers to the mechanism of 
excluding data which do not fit into the underlying model and so to play the role of an edge 
preserving filter. Normally, a decision function, combined with a deterministic optimization 
scheme, is defined in order to detect and reject the outlier. 
 
Let’s recall the velocity smoothness constraint (=ε), Eq.(I-4) can be expressed as below: 
)()( vEvE sg

       (I-10) 
where ε denotes the velocity smoothness constraint and the weighting factor λ controls the 
relative importance of the brightness constancy and the spatial smoothness terms. The velocity 
smoothness constraint ε can be regarded as an error measurement. As the size of VOI tends to 
zero, the solution for ),,( zyx vvvv

 is under-constrained. A large ROI is needed to sufficiently 
constrain the solution and provide some insensitivity to noise. The larger the VOI, however, the 
less likely the assumptions about the motion will be valid over the entire region. For example, 
the assumption of constant velocity used in Eg above will be violated by affine flow, 
transparency, motion boundaries, etc. The dilemma surrounding the appropriate size of VOI is 
referred to as the generalised aperture problem. The assumption of spatial smooth flow used in 
Es also forces the local flow vector ),,( zyx vvvv

 to be close to the average of its neighbours. 
When a motion discontinuity is present, this results in smoothing across the boundary which 
reduces the accuracy of the flow field and obscures important structural information about the 
presence of an object boundary. 
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There are a number of formulations to define the outlier rejection mechanisms. In principle, the 
outlier rejection mechanism can be naturally carried out by changing the way that the averages 
of local motion field, ),,( zyx vvvv

, are calculated for each voxel, by discarding the outlier in 
the neighbourhood. Let  ivivivi zyx ))(),(),(()( ν  be the motion of voxel i. Without outlier 
rejection, the local motion average depends on all the neighbours in the pre-defined 
neighbourhood. 
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where N (i) denotes the neighbourhood of the current voxel located at i, and w (j) is the 
weighting factor for neighbour j, j є N (i), depending on where the j’s located relative to the i. 
For instance, when a 3x3x3 matrix is used (i.e. the size of N is twenty-six), the corresponding 
weight w (j) = 3 for facet sharing six non-diagonal neighbours, w (j) = 2 for twelve edge-sharing 
diagonal ones and w (j) = 1 for eight vertex-sharing diagonal ones.  
The calculated matrix is closer to the true values after each loop. Multiple passes with small 
number of iterations in each pass generate better results than one pass with larger number of 
iterations (Yang et al, 2011). This is a major improvement that makes OFM an accurate 
algorithm.  
 
 
For detecting outliers, the similarity measure of motion field is defined using the squared 
Euclidean distance (=d) between two motion vectors, (see Section 4.2.5.1). Eq.(I-11) becomes 
the distance measure  
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where d(i , j) = || v(i) – v(j) ||2 ,i and j are two neighbouring voxels, and g(i, j) is the decision 
weighting function for controlling the local outlier rejection process. g(i, j) = g(d(i, j)) is a 
function of the motion similarity measure (see Section 4.2.5.1) between two neighbouring 
voxels. In smooth areas of having a low gradient of intensity, all the neighbours will be accepted 
because their similarity measures are similar there by definition.  
 
Normally, a decision weighting function, combined with a deterministic optimisation scheme, is 
defined in order to detect and then either accept or reject the outlier. For example, in a 
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thresholding approach, a decision weighting function can be described with the threshold 
constant (T) 
.
0
1
)),((),(


 
else       
T  j)d(i, if      
jidgjig    (I-13) 
or g-functions can be also various continuous functions (see below example functions which are 
depicted on the left Figure I-1 (Black et al, 1995). The right column of Figure I-1 shows 
influence functions (ψ), which is the derivative of decision weighting function g, to characterises 
the behaviour of a decision weighting function g. 
1. The quadratic g-function :  
. 2x  (x)        ,x  g(x) 2    
2. The hyperbolic tangent g-function : g(x) = tanh (x), ψ (x) = 1 – tan2(x). 
. (x)tan - 1  (x)          ,(x) tanh  g(x) 2   
3. Skipped mean (Truncated quadratic) (Hampel et al., 1986): 
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4. Huber’s minimax function(Huber, 1981):  
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6. Andrew’s Sine (Andrew, 1972): 
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Figure I-1 Six examples of a decision weighting function (estimators). 
b) Hyperbolic tangential f) 
i) 
a) Quadratic  
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I-4. Demons method  
As set out in Section 4.2.5, Thirion’s demons method uses a model where the boundary of an 
object in one image can be thought of as a semi-permeable membrane through which the 
corresponding object in the other image can diffuse (Thirion, 1998b). For clarity, Figure 4–2 is 
duplicated here. 
 
 
Figure I-2 Diffusing models: a deformed image, considered as a deformable grid, is diffusing through the 
contours of the objects in the static image, by the action of effectors, called demons, situated in these 
interfaces (image reproduced from Thirion, 1998). 
 
There are two approaches to using the demons algorithm: The first approach is to consider the 
contour of the object in the reference (target) image, R to be a membrane with demons placed 
along the contour (where the boundary of the object is determined from the gradient of the 
brightness pattern). The demons will pull (attract) points on the object in the moving (source) 
image, M inside the contour in R using optical flow to estimate the “demons forces” (Thirion, 
1998b).  The second approach is to put a demon at every voxel location and calculate the 
“demons force” (again, estimated using optical flow) required to push the voxels in M to match 
R (Wang et al., 2005e).   
 
Consider a mathematical expression briefly for the “demons force”. For a given point, P, in an 
object, let r be the intensity in R, and m be the intensity function in M. The object in the image 
M has to be deformed to match that in the image R. In this notation, the optical flow constraint 
of Eq. (I-4) can be rephrased: 
.rmrv 

     (I-14) 
As this constraint is not sufficient to define the velocity v

, one solution is to regularize the 
problem to obtain the local values of v

as shown in Section 4.2.5.1. Another solution is to 
consider that the end point of v

 is the closest point of the hypersurface m, with respect to 
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spatial (x, y, z) translation, in other words, multiply both sides of Eq.(I-14) by the spatial 
gradient ( r

), which leads to: 
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This equation is unstable for small values of the spatial gradient r

. Ideally, the expression 
should be close to zero for small r

. A solution is to multiply Eq. (I-15) by the estimated 
displacement required, v

, for point P to match the corresponding point in M is given 
by ]})()[( /){( 222 rmrr 
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, which gives: 
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,where v

= (vx, vy, vz) and r

 is the spatial gradient of the reference image. With this 
expression for the “demons force”, the optical flow can be calculated in two steps: first compute 
the instantaneous optical flow for every point in R, and then regularize the deformation field. As 
explained in Section 4.2.5.1, in optical flow, v

is considered to be a velocity because the images 
are two successive time frames: v

 is the displacement during the time interval between the two 
image frames. In fact, when comparing images of two different patients, there is no such 
temporal consideration and it is more general to consider v

 as being simply a displacement. 
 
There is a need for smoothness to balance the “demons forces” with physical constraints and 
maintain geometric continuity, which is a corresponding consideration with a process of Eq. (I-
5) and Eq. (I-6) for the original optical flow algorithm. This is handled by passing a Gaussian 
filter with variance of σ2 over the deformation field following each iteration (Weiguo et al., 
2004). For more details, the interested reader is referred to numerous studies of the demons 
algorithm for use in medical image registration (Guimond et al., 2001, Wang et al., 2005e, Xie 
et al., 2003).  
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